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Sch725674 is a 14-membered macrolactone isolated from the culture of an Aspergillus sp. by a 
group at Schering-Plough in 2005.  A two-dimensional structure with four stereocenters was 
proposed for Sch725674, leaving sixteen candidate stereostructures for the natural product.  
Herein, we report the fluorous mixture synthesis (FMS) of all sixteen candidate stereoisomers of 
Sch725674 to determine its relative and absolute configuration.  Initially, the synthesis of a 
single stereoisomer of Sch725674 was executed to secure a route to the natural product and to 
confirm the 2D connectivity of Sch725674.  The synthesis established in the single isomer pilot 
study was then applied to the FMS of the 4,5-trans-dihydroxy isomer family of Sch725674, in 
which all eight members bear a trans relationship between the C4 and C5 stereocenters.  An 
eight-member library of ring-open Sch725674 analogs was also prepared by demixing and 
detagging two intermediate mixtures from the FMS of the 4,5-trans-dihydroxy  isomer family.  
We then executed a second, parallel FMS of the 4,5-cis-dihydroxy family of Sch725674, in 
which each member has a cis relationship between the C4 and C5 stereocenters.  All three of 
these libraries employed a new minimalist tagging strategy which used two sorting tags in an 
FMS, only one of which was fluorous.  By comparing spectra of the macrocycle library members 
with each other and the natural product, we confidently assigned the absolute configuration of 
natural Sch725674 as (4R,5S,7R,13R). 
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1.0  INTRODUCTION 
A natural product stereoisomer library is a partial or full set of possible enantiomers and 
diastereomers for a given natural product.  The synthesis and biological evaluation of such 
libraries is valuable due to the intrinsic relationship between the three-dimensional structure of a 
natural product and the binding site of its biological target, usually the active site of a protein.  
Stereochemistry is therefore a relevant parameter for variation in any structure-activity 
relationship study.
1-3
  In addition, a stereoisomer library is a useful tool for rigorously assigning 
the absolute configuration of non-crystalline natural products whose stereoisomers may have 
similar, or even indistinguishable, spectral or optical properties.  Natural product stereoisomer 
libraries are rare, however, because they are relatively inaccessibile by typical “one-at-a-time” 
reaction sequences.
4-6
  The main problem with the traditional serial or parallel synthesis of 
stereoisomer libraries lies in the exponential doubling of work during the course of the synthesis.  
The reaction products must be divided into two portions prior to the installation of each new 
stereocenter and then carried along separately.
7
   
1.1 FLUOROUS MIXTURE SYNTHESIS 
The problem of synthesizing natural product stereoisomers one at a time began to fade in the 
1990s with the emergence of combinatorial synthetic methods, particularly solid-phase mixture 
 2 
synthesis,
8,9
  in which reactions are conducted on mixtures of compounds to reduce the number 
of individual reactions executed.  For instance, Takahashi and coworkers reported the 
combinatorial synthesis of a macrosphelide library on solid support.
10
  Waldmann and coworkers 
later synthesized all stereoisomers of cryptocarya diacetate on polymer support.
11
  Compared to 
conventional solution-phase methods, however, the solid-phase mixture synthesis approach for 
small molecules is limited by unfavorable heterogenous reaction kinetics, longer development 
times, and difficulties during analysis of resin-bound intermediates.
12
  To date, the breadth of 
mixture synthesis reactions developed for solid-phase synthesis remains limited. 
 By the turn of the millennium, techniques of solution-phase mixture synthesis had 
emerged which complemented solid-phase methods.
13,14
  While such mixture synthesis reactions 
are straightforward, the analysis, identification, and ultimate separation of individual, pure target 
molecules by solution-phase methods were longstanding problems.  The new technique of 
“fluorous mixture synthesis” (FMS) solves these problems with the use of perfluoroalkyl sorting 
tags.
15-17
  Precursors are labeled with “fluorous tags” differing in fluorine content, and the 
resulting tagged substrates are mixed and carried through a sequence of reactions.
18
  Throughout 
the FMS, intermediate mixtures can be separated at any point based on the fluorous tags 
(“demixed”) to isolate pure, single compounds.  The demixing stage of FMS is performed over a 
fluorous stationary phase by using high-performance liquid chromatography (HPLC) and relies 
on elution of tagged substrates in order of increasing fluorine content.
19,20
  The combination of 
fluorous tags as “molecular labels” with this systematic HPLC separation method makes FMS 
the first solution-phase mixture synthesis technique that allows for isolation of pure, individual 
compounds.  
 3 
1.1.1 Tagging Strategies in FMS  
In recent years, two main tagging methods have emerged for the incorporation of fluorous tags 
into organic substrates for the purpose of natural product stereoisomer library synthesis – single-
tagging and double-tagging.  In single-tagging, the encoded stereocenters are premade and 
pretagged with one tag.  The common approach was illustrated by the synthesis of all sixteen 
stereoisomers of the pinesaw fly sex pheromone.
21
  The problem with single-tagging is that one 
tag is needed for each isomer.  This problem can be mitigated by splitting, though extra reactions 
are needed.  The single-tagging strategy successfully encoded the configurations of all library 
members, requiring only 44 individual reactions and four fluorous tags to synthesize the full 
library.  Compared to a traditional “one at a time” approach, FMS saved a total of 132 steps, 
thereby providing more compounds per unit work.  
The efficiency and throughput of FMS were extended when the double-tagging method 
was introduced in a synthesis of sixteen stereoisomers of the acetogenin murisolin.
22
  Fluorous 
tags were used in conjunction with orthogonal oligo-ethylene glycol (OEG) tags and isolation of 
the final products synthesis was achieved by “double demixing” with two separate demixing 
processes that target each class of sorting tag.  Double tagging in the murisolin synthesis 
economized the available fluorous tags and OEG tags by using eight tags to encode sixteen 
compounds.    
The double-tagging strategy was further expanded by only using fluorous tags with en 
route tagging used in a library synthesis of passifloricin A.
7
  Pairwise combinations of three 
different fluorous tags were used en route after introduction of each new stereocenter in both 
possible configurations.  The aggregate fluorine content of the tagged molecules was determined 
by two fluorous tags, whereas a single fluorous tag had been used in all previous work.  Only 
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three tags were needed to encode four compounds in a mixture.  The en route double tagging 
approach economizes steps because the route diverges during stereocenter introduction and 
tagging, but then immediately reconverges.   
To illustrate the different stages of FMS in the context of a natural product stereoisomer 
library with double-tagging, Scheme 1.1 shows an abridged sequence from the Curran group’s 
synthesis of the passifloricin A stereoisomer library.  During the premixing stage alkene 1 was 
subjected to a hydroboration-oxidation sequence to afford aldehyde 2.  The next phase involved 
the splitting of 2 into two nearly equal portions, then treatment of one portion with the (S,S)-
Duthaler-Hafner (DH) allytitanocene,
23
 and the other with the (R,R)-DH-reagent.  The resulting 
homoallylic alcohols were separately tagged by perfluoroalkyl silyl triflates to afford the 
quasiisomers
24
 (“quasi” because the compounds are not true isomers due to the fluorous tags) 
SR-3 and RR-3.  The fluorous tags used in the passifloricin synthesis were the perfluoroalkyl 
analogs of the triisopropylsilyl (TIPS) ether (hereafter referred to as TIPS
Fn
, where n is the 
number of fluorine atoms in the perfluoroalkyl chain).  As shown in Scheme 1.1, the tags on SR-
3 and RR-3 differ by only two fluorine atoms.  The uniquely tagged compounds SR-3 and RR-3 
were then mixed in nearly equal batches to form the first mixture M-3ab, thus initiating the 
mixture synthesis stage.  The mixture M-3ab was taken through several additional steps (not 
shown) during which a second stereocenter was introduced in both possible configurations and 
tagged, to conclude the mixture synthesis stage with the four-compound mixture (R)-M-4abcd.  
Here, two- and four-compound mixtures are denoted with the prefix “M” and the letters of the 
respective quasiisomers.  The contents of any mixture can thus be traced to the original 
quasiisomers by letters.       
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Scheme 1.1.  Premixing and mixture synthesis stages during passifloricin FMS 
C14H29
OTBDPS
1. 9-BBN, H2O2
2. Swern
C14H29
OTBDPS
O
1. (R,R)-DH
2. tagging
C14H29
OTBDPS
O
1. (S,S)-DH
2. tagging
C14H29
OTBDPS
O1 (R)-2
SR-3a
M-3ab O
O
O OTIPSF7,F9
C14H29
TIPSF0,F7
OTBDPS
(R)-M-4abcd
Si
C4F9
Si
C3F7
(R)
RR-3b  
 
 The pairwise combination of tags employed in the en route tagging strategy provided 
four products, each having different numbers of fluorine atoms.  The unambiguous demixing of 
(R)-M-4abcd was accomplished in accordance with the principle of fluorine additivity during 
fluorous chromatography.  The four products in (R)-M-4abcd were demixed with the 
quasiisomer RRRR-4a (bearing seven fluorine atoms) eluting first, followed by those bearing 9 
(RRSR-4b), 14 (SSRR-4c), and 16 (SSSR-4d) fluorine atoms.  These final, demixed compounds 
were next subjected to four parallel detagging reactions in the post-mix stage to afford four 
individual isomers of the natural product.  Likewise, four additional stereoisomers of 
passifloricin A were isolated from the demixing and detagging of (S)-M-4abcd (steps not 
shown).  
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Scheme 1.2.  Post-mix stage of passifloricin FMS 
O
O
O OTIPSF7
C14H29
TIPSF7
O
O
O OTIPSF7
C14H29
TIPSF0
O
O
O OTIPSF9
C14H29
TIPSF0
O
O
O OTIPSF9
C14H29
TIPSF7
demixing detagging
4 isomers
from (R)-M-4
+
4 isomers
from (S)-M-4
(not shown)
OTBDPS
OTBDPS OTBDPS
OTBDPS
(R)-M-4abcd RRRR-4a RRSR-4b
SSRR-4c SSSR-4d  
 
Thanks to these kinds of “proof-of-principle” studies, it is now possible to make 
stereoisomer libraries of natural products for structural assignment and/or biological testing.  Our 
group has recently applied the single or double FMS tagging strategies to the synthesis of four 
diastereomers each of lagunapyrone,
25
 cytostatin,
26
 ()-dictyostatin,27 and petrocortyne A.28  To 
move the field forward, it is important to expand the scope of FMS by targeting stereoisomer 
libraries of more structurally diverse natural products.  New minimalist tagging strategies in 
FMS to economize the available perfluoroalkyl sorting tags would also be beneficial. 
1.2 MACROLACTONE NATURAL PRODUCTS 
A common structural motif present in many natural products is a macrocyclic ester.
29
  Such 
“macrolactones” are believed to balance conformational preorganization with flexibility to 
achieve optimal binding properties to their biological targets.
30
  Macrolactones are attractive 
synthetic targets because of their interesting structures, and because many macrolactones harbor 
potent biological activity often unrivaled by smaller-ring compounds.
31
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1.2.1 Sch725674 
Sch725674 is a novel macrolactone recently isolated from a culture of an Aspergillus sp. by a 
group at Schering-Plough and assigned the 2D structure shown as 5 (Scheme 1.3).
32
  Sch725674 
displayed antifungal activity against Saccharomyces cerevisiae and Candida albicans with MICs 
8 and 32 μg/mL, respectively.  The connectivity of 5 was established by extensive 2D NMR 
spectroscropic analysis, including HMBC, HSQC-TOCSY, and HSQC experiments.  The 
structure of 5 consists of a 14-membered α,β-unsaturated lactone, containing a 4,5,7-hydroxyl 
stereotriad as well as a pentyl sidechain at C13.  The E-geometry of the double bond was 
assigned based on the coupling constant between the olefinic protons (15.8 Hz).  Due to the 
small quantity of the isolated sample (~1 mg), the configurations of the four oxygenated methine 
stereocenters could not be established.  This leaves sixteen candidate stereostructures for natural 
Sch725674.    
 
Scheme 1.3.  Proposed 2D structure of Sch725674 
O
OH
OH
OH
O
5, Sch725674
4
5
7
13
 
 
Most macrolactones feature both hydroxyl and methyl groups along their carbon skeleton 
(Scheme 1.4).
33,34
  Macrocycles with 14-membered mono-lactone skeletons lacking extensive 
methyl substitution on the ring are very rare in nature, with gloeosporone being the only other 
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well-known member of this class.
35-38
  Once we isolate all sixteen stereoisomers of Sch625674, 
we can assign the absolute configuration of the natural product and evaluate the biological 
activity of the full library.  Synthesis of the Sch725674 stereoisomer library will also provide 
insight on how stereochemistry affects the overall optical, spectroscopic, and biological 
properties of this natural product.   
1.2.2 Macrolactone Stereochemistry 
While the library should provide a firm assignment, the assignment of absolute configuration to 
Sch725674 is complicated by a lack of an optical rotation measurement and by a lack of a pure 
sample of the natural product.  Interestingly however, the structural assignment of many 
macrolides can be predicted by a striking stereochemical regularity that exists within this class of 
molecules.
39
  Celmer’s rule, as anunciated by Seebach,36 states that all 14-membered 
macrolactones for which absolute configurations have been determined bear the 13R 
configuration.  In addition, all 14- to 18-membered macrolactones which contain the 4,7- or 
4,5,7-oxygenation pattern have the 7R configuration.   Applying the Celmer rule to Sch725674, 
therefore, the (7R,13R) configuration of 5 is more probable than that of its enantiomer.  A few 
14-membered macrolactones obeying Celmer’s rule are shown in Scheme 1.4.   
Since there are no known exceptions to Celmer’s rule, we propose that Sch725674 has 
the R configuration at C13.  This proposition cannot be tested.  However, Celmer’s rule also 
provides the relative configuration of C7 and C13 (both R), and this proposition can be tested by 
the stereoisomer library synthesis.  Thus, if Celmer’s rule provides the correct relative 
configuration, then it should also provide the correct absolute configuration. 
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Scheme 1.4.  Representative 14-membered macrolactones obeying Celmer’s rule 
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1.3 INITIAL STUDIES BY DR. XIAO WANG 
The first objective of a stereoisomer library synthesis is often to conduct a pilot synthesis of a 
single stereoisomer to develop a concise and selective route toward the natural product.  In 
addition, an effective tagging strategy of the precursors must be identified for the analysis and 
demixing of mixtures.  The (4R,5R,7S,13R)-5 stereoisomer of Sch725674 was made by Dr. Xiao 
Wang
40
 by a ring-closing metathesis (RCM)
41-46
 approach for closing the 14-membered ring, as 
shown by the retrosynthesis in Scheme 1.5.  The triol 5 could be produced by a partial 
hydrogenation and global deprotection of the ring-closed macrolactone 6.  The key intermediate 
6 in turn could be produced by RCM of the Horner-Wadsworth-Emmons (HWE) olefination
47-49
 
product of phosphonate ester (R)-7 and α-chiral aldehyde SRS-8. 
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Scheme 1.5.  Retrosynthetic analysis of (4R,5R,7S,13R)-5 
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1.3.1 Preparation of Aldehyde SRS-8 
Wang’s synthesis started with the cleavage of commercially available diol 9 with sodium 
metaperiodate to deliver D-glyceraldehyde acetonide 10 (Scheme 1.6).
50
  Addition of allyl 
magnesium bromide to 10 provided a 0.7/1.0 mixture of diastereomeric alcohols, 11-syn and 11-
anti.  The mixture was directly benzylated and the resulting known isomers
51
 12-syn and 12-anti 
were separated by flash chromatography.  
 
Scheme 1.6.  Synthesis of key intermediates 12-anti and 12-syn 
AllylMgBr O
O
OH
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O
O
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The acetal of the 12-syn isomer was then cleaved with FeCl3•6H2O, and the primary 
alcohol was subsequently protected as the t-butyldimethylsilyl (TBS) ether 13 (Scheme 1.7).  
The free alcohol 13 was protected as the secondary TIPS ether, which was subjected to an 
ozonolysis of the terminal olefin to yield the aldehyde 14.  Asymmetric allylboration of 14 with 
the commercially available ()-Ipc2B(allyl) reagent followed by protection of the homoallylic 
alcohol with TIPSOTf gave silyl ether 15.  The TBS ether was selectively desilylated, and the 
free alcohol was oxidized by PCC to afford the key intermediate SRS-8. 
 
Scheme 1.7.  Completion of fragment SRS-8 
1. protection
2. ozonolysis
O
OBn
OTIPS
TBSO
1. ()-Ipc2B(allyl) OTIPS
TBSO
OTIPS2. protection
O
O
OBn
2. protection
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OBn
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12-syn 13 14
15, 93:7 dr
OTIPS
O
OTIPS
1. deprotection
2. PCC
SRS-8
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1.3.2 Completion of the Pilot Synthesis of a Single Stereoisomer 
Fragment (R)-7 was synthesized by Mr. Claude Ogoe in three steps starting from racemic 1,2-
epoxy-5-hexene, rac-17 (Scheme 1.8).  The racemate was resolved by a hydrolytic kinetic 
resolution (HKR)
52
 by reaction of (S,S)-19 with rac-17 to afford (S)-17.  The epoxide was then 
opened upon exposure to dibutyllithium cyanocuprate
53
 to furnish alcohol (R)-18, which was 
esterified with phosphonic acid 16 to deliver fragment (R)-7 in  about 30% yield over three steps.  
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The enantiomer (S)-7 (not shown) was prepared analogously by using the (R,R)-19 catalyst in 
this three step sequence. 
 
Scheme 1.8.  Preparation of fragment (R)-7 
O O
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CuCN, BuLi
THF, -78o
C5H11
OH
(S,S)-19, AcOH,
THF, 20 h
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HO
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O O
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(S)-17 (R)-18 (R)-7, 30%
over 3 steps
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OO
N N
OAc
tBu
tBu
tBu
tBu
(S,S)-19
16
 
 
 Fragments (R)-7 and SRS-8 were subjected to an HWE olefination under the Masamune-
Roush
54
 conditions to afford ester 20 as a single E-isomer (Scheme 1.9).  The ester was cyclized 
by RCM upon reaction with a stoichiometric amount of the 1
st
 generation Grubbs catalyst 
(Grubbs I, 1 equiv) in CH2Cl2 at reflux for 14 h.  The resulting macrolactone was partially 
hydrogenated
55
 using the Rosenmund catalyst under an atmosphere of hydrogen gas to afford 27.  
The pilot synthesis was completed by a global deprotection with BF3•Et2O and ethanethiol
56
 to 
afford the final triol (4R,5R,7S,13R)-5 in 85% yield.  The 2D connectivity prescribed in the 
isolation of 5 was supported, but the NMR spectra of synthetic (4R,5R,7S,13R)-5 did not match 
the natural product.  Therefore, the (4R,5R,7S,13R) configuration is not correct for Sch725674. 
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Scheme 1.9.  Completion of the single isomer synthesis 
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1.3.3 FMS of the 4R Series of Sch725674 
Dr. Wang then applied the pilot synthesis to an FMS of eight stereoisomers of Sch725674, all 
containing the 4R configuration.  However, a major problem was encountered at a late stage of 
the FMS - the selective cleavage of the TBS ether in the two-compound mixture M-22 (Table 1-
1).  As shown in entries 1-3, all attempts to selectively cleave the primary TBS ether of M-22 
resulted in concomitant desilylation of the C5 fluorous tag, providing low yields of the desired 
alcohol M-23 and the diol M-24.  Ultimately, the low yield of mixture M-23 upon reaction of 
mixture M-22 with H2SiF6 in buffered acetonitrile (entry 1) was accepted and the FMS resumed.          
 
Table 1-1:  Chemoselective cleavage conditions for the TBS ether in M-22 
TBSO
OTIPSF7,F9
OBn OTIPSF7
conditions
HO
OTIPSF7,F9
OBn OTIPSF7
H2SiF6, Et3N, MeCN, 0°C-rt, 1h M-23, 29%; M-24, 27%
BF3
.Et2O, CHCl3, 0°C-rt, 1h M-24, 75%
HO
OTIPSF7,F9
OBn OH
K2CO3, MeOH, rt, 24 h no reaction
(2R) 3 5
entry
1
2
3
conditions yield
+
M-22 M-23 M-24
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Later, reproducibility problems were encountered with both the RCM and partial 
hydrogenation steps.  Despite the problems, eight stereoisomers of 5 were isolated (Scheme 1.10) 
in very low quantities (<1 mg for each isomer).  Based on Celmer’s rule and comparison of the 
1
H NMR spectra of the four triols to the literature, Dr. Wang tentatively assigned the absolute 
configuration of the natural product as (4R,5S,7R,13R)-5.  Although the 4R enantioseries of 
Sch725674 was successfully prepared by Dr. Wang, the low isolated quantities posed a problem 
for full spectroscopic characterization and biological evaluation.   
 
Scheme 1.10.  Isolation of eight 4R diastereomers of Sch725674 by FMS 
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4
  
1.3.4 New Directions for the FMS of the Sch725674 Stereoisomer Library 
My objective was to prepare more of the 4R-Sch725674 enantiomeric series for biological 
evaluation and adequate spectroscopic characterization.  In addition, the 4S enantioseries was to 
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be prepared along with a library of ring-open Sch725674 analogs.  To meet these objectives, a 
better-yielding synthesis needed to be developed.  Also, a better fluorous tagging strategy that 
leverages the available fluorous tags was to be realized. 
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2.0  2ND GENERATION PILOT SYNTHESIS OF A SINGLE STEREOISOMER OF 
SCH725674 
2.1 REVISED RETROSYNTHESIS OF ALDEHYDE 8 
To avoid the late-stage desilylation problem with Dr. Wang’s FMS plan, a new synthetic route 
was devised and a fresh pilot synthesis of a single stereoisomer of 5 was executed.  A 
retrosynthesis of key fragment RSR-8 is shown in Scheme 2.1.  We hypothesized that the vicinal 
diol of RSR-8 could be installed by the Sharpless asymmetric dihydroxylation (SAD)
57,58
 of ester 
25.  The homoallylic stereocenter at C7 could then be set and encoded by a reagent-controlled 
asymmetric allylation followed by protection of the homoallylic alcohol.  Finally, a partial 
reduction of the ester will deliver the key aldehyde RSR-8 and avoid the chemoselectivity issues 
that Dr. Wang encountered.  In addition, the use of only silyl protective groups was expected to 
simplify the global deprotection step.   
 
Scheme 2.1.  Retrosynthesis of fragment RSR-8 
OTIPS
O OTIPS
TIPS
O
MeO2C
Asymmetric
allylation
Asymmetric
dihydroxylation
OPMB
25
RSR-8
7
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The initial task in the synthesis of RSR-8 was to develop a concise method for preparing 
the unsaturated methyl ester 25 (Scheme 2.2).  Treatment of commercially available 1,3-
propanediol with NaH, p-methoxybenzyl chloride (PMB-Cl), and tetrabutylammonium iodide 
(TBAI) afforded a primary alcohol, which upon Swern oxidation
59
 gave the known aldehyde
60
 26 
in 38% yield over two steps.  Treatment of 26 with trimethylphosphonoacetate (TPA) and NaH 
as base with no additive
49
 (a in Scheme 2.2) afforded 25 as a 5:1 E/Z mixture as determined by 
1
H NMR analysis of the crude product.  Flash chromatography afforded the desired ester E-25 in 
62% yield.  Treatment of 26 with TPA in the presence of 1,8-diazabicyclo-[5.4.0]-undec-7-ene 
(DBU) and LiCl
54
 under the Masamune-Roush conditions afforded a 12.5:1 mixture of E/Z 
isomers as determined by 
1
H NMR analysis of the crude product.  Flash chromatography 
afforded pure E-25 in 82% yield.  This three step sequence was scaled up to provide >13 g of 
pure E-25.  
 
Scheme 2.2.  Preparation of methyl ester E-25 
HO OH O OPMB OPMB
MeO2C
1,3-propanediol
NaH, PMBCl
TBAI, DMF
then Swern
a or b
a: NaH, TPA, 5:1 E/Z, 67%
b: DBU, LiCl, TPA, 12.5:1 E/Z, 82%
E-2526, 38%
over 2 steps
 
 
The ester E-25 was then subjected to the typical SAD conditions as shown in Scheme 2.3. 
Treatment of E-25 with AD-mix-α in the presence of methanesulfonamide (2 equiv) in 1:1 
tBuOH/H2O afforded diol (2R,3S)-27 in 82% yield.  Likewise, reaction of E-25 with AD-mix- 
afforded (2S,3R)-27 in 62% yield.  The configurations of the products 27 were assigned by the 
mnemonic device developed by Sharpless and coworkers.
57,58
  To assess enantiomeric excess 
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(ee), each enantiomer of 27 was treated with excess (R)-α-methoxy-α-trifluouromethyl-α-
phenylacetyl chloride (MTPA-Cl, or Mosher chloride) in pyridine to furnish the bis-Mosher 
esters RSSS-28 and SRSS-28.
61-63
  Integration of the major and minor singlets in the 
19
F NMR 
spectra of the two crude Mosher ester samples indicated enantiomeric excesses of 92% and 96% 
for the AD-mix products (2R,3S)-27 and (2S,3R)-27, respectively.   
 
Scheme 2.3.  Synthesis and enantiomer analysis of SAD diols 27 
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OPMB
MeO2C
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AD-mix-,
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SRSS-28, 96% de
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(R)-MTPA-Cl
pyridine
(R)-MTPA-Cl
AD-mix-,
1:1 tBuOH/H2O,
CH3S(O)NH2
 
 
The next several steps of the pilot synthesis set the stage for the asymmetric allylation to 
install the homoallylic stereocenter (Scheme 2.4).  Bis-silylation of diol (2R,3S)-27 with 
triisopropylsilyl triflate (TIPSOTf, 2.5 equiv) and 2,6-lutidine provided 29 in 81% yield.  
Oxidative cleavage of the PMB group with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)
64
 
was followed by Swern oxidation
59
 to provide the key aldehyde 30 in 79% yield over two steps.   
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Scheme 2.4.  Preparation of aldehyde 30 
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The optimized conditions of the diastereselective allylation reaction for aldehyde 30 are 
shown in Figure 1.   Reaction of 30 with the commercially available Brown allylborane
65,66
 (+)-
32 at 78 °C in Et2O was followed by silylation of the crude product with TIPSOTf to afford a 
4:1 mixture of diastereomers 31c (major) and 31d (minor) in 60% yield (Figure 1, entry 1a).  The 
crude product from the allylboration was taken directly to the next silylation step because the 
silylated homoallylic alcohol was very easily separable from silylated 3-pinanol (resulting from 
oxidative workup of 32).  Similarly, reaction of 30 with antipodal ()-32 followed by silylation 
of the crude product with TIPSOTf afforded a 4:1 mixture of diastereomers 31d (major) and 31c 
(minor) in 55% yield (Figure 1, entry 1b).  The configuration of each newly formed stereocenter 
in 31c and 31d was assigned by the transition state model described by Brown.
65
   
Seeking to improve the diastereoselectivity of the allylation, we treated 30 with the 
Duthaler-Hafner allyltitanocene,
23
 (R,R)-33 (Figure 1, entry 2a).  Reaction of (R,R)-33 with 30 at 
78 °C in Et2O afforded the homoallylic alcohol 31b in 44% yield.  
1
H NMR analysis of the 
crude product indicated a 10:1 dr (31a:31b).  Accordingly, treatment of 30 with antipodal (S,S)-
33 provided 37a in 77% yield as a single diastereomer, with no minor isomer detected by crude 
1
H NMR spectroscopy.   
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Ultimately, the Brown allylboration was the method of choice for the pilot synthesis 
because of the convenience of an inexpensive commercially available reagent.  Despite the 
higher levels of stereoselectivity and ease of product purification, the Duthaler-Hafner allylation 
was not selected due to the expense and sensitivity of the reagents.  The Keck allylation is also 
attractive due to its catalytic nature and commonly robust levels of stereoselectivity,
67
 but neither 
enantiomer of the Keck catalyst 34 provided any desired product upon reaction with 30.     
   
entry reagent/catalyst conditions time Yield (%)a dr (31a:31b)b dr (31c:31d)
1a (+)-32 Et2O/78
°C 4 h 60% -------- 4:1
1b ()-32 Et2O/78
°C 4 h 55% -------- 1:4
2a (R,R)-33 Et2O/78
°C 3 h 44% 1:10 --------
2b (S,S)-33 Et2O/78
°C 3 h 77% >20:1 --------
a Isolated yields
b Determined by crude 1H NMR analysis
MeO2C
O
OTIPS
OTIPS reagent/
catalyst
MeO2C
OTIPS
O OR
TIPS
MeO2C
OTIPS
O OR
TIPS
+
30
O
Ti
O
OO
Cp
Ph
Ph
Ph
Ph
(R,R)-33
Me
Me B
2
(+)-32
O
O
Ti
iPrO
iPrO
(R,R)-34
31a: R = H
31c: R = TIPS
31b: R = H
31d: R = TIPS
 
Figure 1:  Diastereoselective allylations of aldehyde 30 with 32 and 33 
 
Scheme 2.5 shows attempts to complete the synthesis of fragment RSR-8.  Reduction of 
31c with diisobutylaluminum hydride (DIBAL-H, Scheme 2.5)
68
 did not produce the 
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corresponding aldehyde or alcohol even after the addition of excess reagent.  Likewise, attempts 
to produce the alcohol with lithium borohydride,
69
 lithium triethylborohydride,
70
 lithium 
aluminum hydride,
71
 and alane,
71
 were equally unsuccessful.  A contingency plan to hydrolyze 
the ester to the free acid was thwarted when ester 31c proved unreactive toward excess LiOH in 
4:1 THF/H2O,
72
 as well as methanolic KOH under reflux for 3 h.
73
   
 
Scheme 2.5.  Attempted completion of fragment RSR-8 
MeO2C
OTIPS
O OTIPS
TIPS
OTIPS
O OTIPS
TIPS
O
DIBAL-H
RSR-831c  
2.2 REVISED RETROSYNTHESIS OF KEY INTERMEDIATE 35 
Due to the difficulty in finding a concise route to fragment RSR-8, a revised retrosynthetic 
analysis of the RCM substrate 35 was devised as shown in Scheme 2.6.  Ester 35 can be prepared 
by an esterification of the acid 36 with the chiral alcohol 18.  Compared to the original approach, 
the revised route installs the trans-alkene of the natural product by HWE olefination early in the 
synthesis.  Changing the fragment coupling strategy to an esterification saves steps and bypasses 
the unreactive ester 31c. 
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Scheme 2.6.  Comparison of retrosynthetic analyses of 35 
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The acid 36 can be prepared from a similar sequence of reactions as RSR-8, relying on the 
Sharpless asymmetric dihydroxylation (SAD) and an asymmetric allylation (Scheme 2.7).  
Prospects of a chemoselective SAD on the (2E,3E)-dienoate 37 are good because Sharpless and 
coworkers showed that osmylation of unsymmetrical, conjugated dienes occurred at the - 
double bond, leaving the other olefin as a spectator.
74
  
 
Scheme 2.7.  Retrosynthesis of fragment 36 
HO2C
OSiR3
O OSiR3
SiR3
36
Asymmetric
dihydroxylation
Asymmetric
allylation
MeO2C
OPMB
37  
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2.2.1 Pilot Synthesis of (4R,5R,7R,13R)-Sch725674 
To implement the new retrosynthetic strategy, the first task was to develop a convenient 
synthesis of diene 37. Scheme 2.8 summarizes two approaches that feature a cross-metathesis 
(CM) reaction.
75,76
  In a one-step approach patterned after ene-diene CM reactions of Grubbs,
77,78
 
alkene 38, ethyl sorbate and the second-generation Grubbs catalyst (Grubbs II, 5 mol %) were 
refluxed in DCM for 16 h.  Smooth conversion occurred but the expected product 44 was not 
produced.  Instead, the truncated product 46 was isolated in 80% yield.  Apparently, the 
metathesis of the diene component of ethyl sorbate occurred at C2 rather than C4.   
The successful two-step approach also started with a cross-metathesis reaction.  Grubbs 
ene-ene CM
75,76
 of 38 and E-crotonaldehyde (5 equiv) mediated by the second generation 
Hoveyda-Grubbs catalyst (1 mol %) provided 40 in 94% yield as a single E-isomer.  HWE 
olefination of 40 under the Masamune-Roush conditions with TPA, DBU, and LiCl in MeCN 
solvent gave the target E,E-37, again as a single stereoisomer.  The two-step sequence was 
conveniently scaled up to make about 10 g of 37. 
 
Scheme 2.8.  Alternative cross-metathesis routes to the ester 37 
OPMB
5% Grubbs II,
ethyl sorbate
DCM, reflux
EtO OPMB
O
Ene-Diene Cross Metathesis
Cross-Metathesis/HWE Approach
OPMB
1% Hoveyda-
Grubbs 2nd gen.
E -crotonaldehyde,
DCM, reflux
OHC
OPMB
TPA
DBU, LiCl
OPMB
MeO2C
39, 80%
37, 87%40, 94%
38
38  
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The results of the SAD of 37 are shown in Scheme 2.9.  Treatment of 37 with AD-mix-α 
in 1:1 tBuOH/H2O gave syn-diol (4S,5S)-41 in 67% yield.  Diol (4S,5S)-41 was esterified with 
excess (R)- and (S)-MTPA-Cl in pyridine to form the bis-MTPA esters SSSS-42 and SSRR-42 
(not shown), respectively.
63
  Comparative integration of the major and minor singlets in the 
19
F 
NMR spectra of SSSS-42 and SSRR-42 indicated a diastereomeric excess of 92% in each case, 
reflecting an enantiopurity of 92% ee for (4S,5S)-41.  The (4R,5R)-41 enantiomer (not shown) 
was likewise obtained by reaction of diene 37 with AD-mix- in 61% yield.   
 
Scheme 2.9.  Synthesis and Mosher ester analysis of (4S,5S)-41 
MeO2C OPMB
AD-mix 
OH
OH
(4S,5S)-41, 67%
MeO2C OPMB
OMTPA-S
OMTPA-S
SSSS-42, 92% d.e.
37
1:1 tBuOH/
H2O
pyridine
(R)-MTPA-Cl
 
 
Because of the desilylation problem encountered by Dr. Wang during his FMS (see 
Section 1.1.3), we used fluorous tags for protection of all hydroxyl stereocenters in the single 
isomer pilot study to ensure that the tags survive all reaction conditions.  Treatment of (4R,5R)-
41 with TIPS
F5
OTf (2.5 equiv) and 2,6-lutidine in CH2Cl2 furnished the PMB ether 42b in 79% 
yield (Scheme 2.10).  The bis-silylation was followed by oxidative cleavage of the PMB ether in 
RR-42b with DDQ
64
 and Swern oxidation
59
 to afford aldehyde RR-43 in 82% yield over two 
steps.   
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Scheme 2.10.  Preparation of aldehyde RR-43 
MeO2C OPMB
OH
OH
MeO2C OPMB
OTIPSF5
OTIPSF5TIPSF5OTf
2,6-lutidine
DCM
1. DDQ
2. Swern
MeO2C
O
OTIPSF5
OTIPSF5
RR-42b, 79% RR-43, 82%,
2 steps
(4R,5R)-41
TIPSF5OTf = Si C2F5TfO
 
 
We next tested the reaction of RR-43 with the allylboranes (+)- and ()-32 (Scheme 
2.11).  The (+)-allylboration was conducted as described in Section 2.1.1 for 31c, while the ()-
allylboration was carried out by generating ()-32 in situ with ()-DIP-Cl and allylmagnesium 
bromide.
79
  The reaction of RR-43 with (+)-32 followed by silylation of the crude product with 
TIPS
F5
OTf provided a 4:1 mixture of diastereomers RRR-45d (major) and RRS-46d (minor) in 
49% yield.  Likewise, reaction of RR-43 with ()-32 followed by silylation of the crude product 
with TIPS
F5
OTf showed the same two products only now in a reversed 1:4 ratio and 70% yield.  
The Maruoka
80,81
 and Duthaler-Hafner
23
 asymmetric allylation reactions were also attempted 
with RR-43, but formed no useful product.  For the purpose of the single isomer pilot synthesis, 
emphasis was placed on obtaining an isomerically pure sample of RRR-44 prior to the silylation 
step.  About 1 g each of the free homoallylic alcohols RRR-44 and RRS-44 was isolable by 
careful flash chromatography of the crude product.  These were obtained as essentially single 
diastereomers in 73% and 77% yields, respectively.   
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Scheme 2.11.  Diastereoselective allylations of RR-43 with (+)- and ()-32 
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Each enantiomer of fragment 18 was next prepared by Ogoe’s two-step sequence (see 
Section 1.4.2).  The epoxide (S)-17 was obtained by the Jacobsen hydrolytic kinetic resolution,
52
 
and then opened to form the free alcohol (R)-18 upon treatment with dibutyllithium 
cyanocuprate
53
 (Scheme 2.12).  Enantiomeric alcohol (S)-18 (not shown) was obtained in the 
same manner.  The enantiopurity of each enantiomer of 18 was established by Mosher ester 
analysis as shown in Scheme 2.12.  Alcohols (R)- and (S)-18 were derivatized with excess (S)-
MTPA-Cl in pyridine as described for diol 41.  Analysis of the resulting (R)-MTPA esters RR-47 
and SR-47 (not shown) by 
19
F NMR spectroscopy indicated only a single diastereomer present in 
each crude sample.
63
     
 
 27 
Scheme 2.12.  Preparation and Mosher ester analysis of (R)-18  
O
CuCN,
nBuLi
THF,
78oC
C5H11
OH
(R)-18, 64%,
>99% ee
Pyridine
C5H11
OMTPA-R
RR-47,
>99% de
(S)-17
(S)-MTPA-Cl
 
 
The conversion of isomerically pure methyl ester RRR-45d to the key intermediate 49 is 
shown in Scheme 2.13.  Although conventional methods of saponification led to decomposition, 
reaction of RRR-45d with a large excess of potassium trimethylsilanolate
82
 (TMSOK, 15 equiv) 
in Et2O gave the free acid 48 in 87% yield.  Yamaguchi esterification
83,84
 of the untagged alcohol 
(R)-18 and fluorous-tagged acid 48 was then carried out with 2,4,6-trichlorobenzoyl chloride, 
N,N′-dimethylaminopyridine (DMAP, 2.2 equiv), and triethylamine (NEt3, 2.0 equiv) in toluene 
to deliver the RCM precursor 49 in 95% yield. 
 
Scheme 2.13.  Key esterification to form ester 49 
RO2C
OTIPSF5
O OTIPSF5
TIPSF5
RRR-45d, R = Me
48, R = H, 87%
TMSOK,
Et2O
Cl
OCl
ClCl
NEt3, DMAP,
(R)-18, toluene, rt
O
O
C5H11
OTIPSF5
OTIPSF5
OTIPSF5
49, 95%  
 
The 14-membered ring was next closed by means of RCM under highly dilute conditions 
(3 mM) as shown in Scheme 2.14.  Preliminary attempts to close 49 under Dr. Wang’s 
conditions with Grubbs 1
st
 generation catalyst (Grubbs I) were not encouraging.  Low 
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conversions were observed even with large catalyst loadings (1.0 equiv).  However, reaction of 
49 with Grubbs 2
nd
 generation catalyst 50 (Grubbs II, 20 mol%) over two days at 50 °C in 
freshly distilled CH2Cl2 resulted in clean cyclization to the target macrolactone 51 in 76% 
yield.
85,86
  Integration of the distinct proton resonances of the newly-formed C9-C10 double bond 
in the 
1
H NMR spectrum of 51 indicated about 5:1 E/Z-selectivity. 
 
Scheme 2.14.  RCM of 49 to form macrolactone 51 
O
O
C5H11
OTIPSF5
OTIPSF5
OTIPSF5
20 mol %
49 51, 76%, 5:1 E:Z
9
10
DCM, 50 °C
2 d
O
O
C5H11
OTIPSF5
OTIPSF5
OTIPSF5
Ru
Cl
PCy3
Ph
Cl
NMsMsN
50
 
 
The completion of the single isomer pilot synthesis of (4R,5R,7R.13R)-5 is shown in 
Scheme 2.15.  A partial hydrogenation of 51 was conducted under an atmosphere of hydrogen 
gas with Pd/SrCO3 (1.0 equiv) in ethanol (20 mM) to afford the reduced product 52 in 75% 
yield.  A 
1
H NMR spectrum of 52 recorded after flash chromatography showed that the C9-C10 
olefin of 51 was fully reduced, while the vinyl protons from the C2-C3 olefin remained in full 
proportion.  The hydrogenated compound 52 was treated with tetrabutylammonium fluoride 
(TBAF, 6.0 equiv)
87
 to afford 24.8 mg of the final triol (4R,5R,7R,13R)-5 as an amorphous white 
solid in 79% yield after flash chromatography.  As expected, the 
1
H and 
13
C NMR spectra of 
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(4R,5R,7R,13R)-5 did not match those of the natural product.  Copies of the 
1
H and 
13
C NMR 
spectra for (4R,5R,7R,13R)-5 are included in the Appendix.   
 
Scheme 2.15.  Completion of the single isomer pilot synthesis of (4R,5R,7R,13R)-5 
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In summation, the single stereoisomer (4R,5R,7R,13R)-5 was synthesized by a revised 
route in only 16 individual reactions in an overall 6.8% yield.   Starting from 3-buten-1-ol, the 
longest linear sequence contained only 10 steps and each of the reactions was reliable on multi-
milligram scale.  We projected that multiple stereoisomers of Sch725674 could be made by this 
synthetic route provided that a convenient tagging strategy could be identified. 
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3.0  FMS OF THE 4,5-TRANS-DIHYDROXY FAMILY OF SCH725674 
3.1 INITIAL MULTI-TAG FMS STRATEGY 
With the single isomer synthesis complete, we set out to synthesize eight stereoisomers of 
Sch725674 by FMS.  Scheme 3.1 shows the initial mixture synthesis stages in the FMS of the 
4,5-trans-dihydroxy series of Sch725674.  The diol (4S,5S)-41 was bis-silylated using TIPSOTf 
to form the bis-triisopropyl ether SS-42a in 100% yield.  The quasienantiomers RR-42b (see 
Section 2.2.1) and SS-42a were mixed in approximately equimolar ratio to form the first mixture 
of two compounds M-42ab.  The PMB ether of M-42ab was cleaved with DDQ
64
 and the crude 
alcohol product was directly subjected to a Swern oxidation
59
 to yield aldehyde M-53ab in 61% 
yield over two steps.  The yields of these and other reactions executed on fluorous mixtures were 
calculated based on the average molecular weight of the components in the mixture, assuming 
equimolar ratio of the constituent components.   
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Scheme 3.1.  Early mixture synthesis stages 
MeO2C OPMB
MeO2C OPMB
OTIPSF5
OTIPSF5
OTIPS
OTIPS
1. DDQ
2. Swern
MeO2C
O
OTIPSF0,F5
OTIPSF0,F5
M-53ab,
61%, 2 steps
RR-42b, 79%
SS-42a, 100%
(4S,5S)-41
TIPSOTf,
2,6-lutidine
M-42ab
 
 
The aldehyde mixture M-53ab was subjected to the critical diastereoselective allylboration step 
as shown in Scheme 3.2.  The sample of M-53ab was split and each half treated with 
commercially available solutions of (+)- and ()-32.  After flash chromatography of the crude 
product, the (R)-alcohol from the allylboration with (+)-32 was silylated with TIPSOTf to yield 
(R)-M-54ab in 41% yield over two steps.  Likewise, the (S)-alcohol product after flash 
chromatography from the allylboration with ()-32 was silylated with TIPSF5OTf to form (S)-M-
54ab in 30% yield over two steps.  Based on the 4:1 diastereoselectivity that we observed for the 
allylboration during the single isomer pilot synthesis (see Section 2.2.1), each two-compound 
mixture (R)- and (S)-M-54ab was expected to contain a maximum of four possible products (two 
major and two minor).  Indeed, 
1
H NMR and fluorous HPLC analysis of each of these mixtures 
indicated a complex isomeric composition.  Because isomer separation of (R)- and (S)-M-54ab 
was not successful, we decided to change our FMS strategy to avoid performing the allylboration 
on fluorous mixtures. 
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Scheme 3.2.  Diastereoselective allylations of aldehyde M-53ab 
1. (+)Ipc2B(allyl)
2. TIPSOTf,
2,6-lutidine
1. (-)Ipc2B(allyl)
2. TIPSF5OTf,
2,6-lutidine
MeO2C
OTIPSF0,5
O OTIPS
TIPSF0,5
MeO2C
OTIPSF0,5
O OTIPSF5
TIPSF0,5
(R)-M-54ab + isomers
41%, 2 steps
(S)-M-54ab + isomers
30%, 2 steps
M-53ab
(R)
(S)
 
3.2 REVISED MULTI-TAG FMS STRATEGY 
To avoid the isomer purification problem with the FMS plan in Section 3.1, we shifted the 
mixture synthesis stage of the FMS to after the critical asymmetric allylation reaction.  Scheme 
3.3 shows the synthesis of isomerically pure homoallylic alcohols 44.  Diastereomers RRR-44 
and RRS-44 were already available as single isomer samples from allylboration of RR-43 with 
the allylboranes 32 during the single isomer synthesis (see Section 2.2.1).  Compound SS-42a 
(see Section 3.1) was subjected to a two-step sequence of PMB ether cleavage with DDQ,
64
 
followed by Swern oxidation
59
 to produce the aldehyde SS-43 in 78% yield over two steps.   The 
sample of quasienantiomer SS-43 was split and each half was treated with commercially 
available solutions of (+) and ()-32 at 78 °C as reported for 31c (Section 2.1.1).  Consistent 
with prior results, the diastereoselectivities of these two asymmetric allylborations were 
estimated as 4:1 dr by 
1
H NMR spectroscopy of the crude products.  Careful flash 
 33 
chromatography of the crude product from both allylations furnished multigram quantities of the 
homoallylic alcohols SSR-44 and SSS-44 as essentially single diastereomers in 59% and 67% 
yields, respectively.  
 
Scheme 3.3.  Synthesis of the new premixing precursors 
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3.2.1 New Minimalist Tagging Strategy 
With four isomerically pure alcohols 44 in hand, we were ready to initiate the mixture synthesis 
stage of FMS.  Scheme 3.4 shows the tagging reactions that were executed to encode the C7 
stereocenters of alcohols 44.  To be consistent, we encoded the 7R configuration using the non-
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fluorous TIPS tag, while the 7S configuration was encoded by the TIPS
F5
 tag.  Accordingly, 
reaction of SSR and RRR-44 with TIPSOTf and 2,6-lutidine provided the quasiisomers SSR-46a 
and RRR-46c in 99% and 84% yields, respectively.  Likewise, reaction of SSS-44 and RRS-44 
with TIPS
F5
OTf and 2,6-lutidine provided the quasiisomers SSS-46b and RRS-46d (from Section 
2.1.3) in 99% and 84% yields, respectively.  Each of the four quasiisomers 46 was fully 
characterized by by 
1
H, 
13
C and 
19
F NMR spectroscopy, IR, HRMS, and optical rotation.  The 
four quasiisomers 46 were mixed in approximately equimolar ratio to form the first fluorous 
mixture M-46abcd. 
 
Scheme 3.4.  Tagging schedule of the quasiisomers 46 
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   Mixture M-46abcd was analyzed by a fluorous analytical HPLC column (PF-C8) under 
gradient elution (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min).  Figure 2 shows 
the analytical HPLC trace of M-46abcd.  Pleasingly, M-46abcd exhibited four well-spaced 
peaks eluting at 14.4, 21.5, 27.4, and 35.0 min.  The four quasiisomers comprising M-46abcd 
were encoded using two tags (TIPS, and TIPS
F5
), only one of which is fluorous.  This is 
noteworthy because in all previous FMS work, three or four tags were needed to encode a four-
quasiisomer mixture.  This new minimalist tagging strategy arises from double usage of two tags 
– once from bis-silylation of enantiomeric diols 41 and once again after introducing the C7 
stereoecenter in both possible configurations.  The tagging schedule developed herein allows us 
to maintain the throughput and efficiency of FMS, while economizing the available fluorous 
tags. 
 
SSR-46a
3 TIPSF0
RRS-46d
3 TIPSF5
SSS-46b
2 TIPSF0
1 TIPSF5
RRR-46c
1 TIPSF0
2 TIPSF5
 
Figure 2:  Fluorous analytical HPLC trace of M-46abcd 
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3.2.2 Mixture synthesis stage 
With a convenient tagging strategy secured, we proceeded with the FMS of the 4,5-trans-
dihydroxy family of Sch725674.  The steps of the mixture synthesis were executed in the same 
manner as during the single isomer pilot synthesis (see Section 2.2.1).  Scheme 3.5 shows the 
cleavage of methyl ester M-46abcd.  Treatment of M-46abcd with TMSOK furnished M-
55abcd in 94% yield.  The product mixtures after this and all other FMS reaction steps were 
carefully monitored by 
1
H and 
19
F NMR spectroscopy, MS, and fluorous analytical HPLC. 
 
Scheme 3.5.  Cleavage of methyl ester M-46abcd 
MeO2C
OTIPSF0,F5
O OTIPSF0,F5
TIPSF0,F5
M-46abcd
HO2C
OTIPSF0,F5
O OTIPSF0,F5
TIPSF0,F5
M-55abcd, 94%
TMSOK
Et2O, rt
 
 
 The rest of the mixture synthesis stage is shown in Scheme 3.6.  The sample of free acid 
M-55abcd was split and each half was esterified under the Yamaguchi conditions with both 
enantiomers of the chiral alcohol 18 to afford (R)- and (S)-M-56abcd in 95% and 100% yields, 
respectively.  Parallel treatment of (R)- and (S)-M-56abcd with the optimized conditions for the 
ring-closing metathesis followed by partial hydrogenation with Pd/SrCO3 provided the final 
mixtures (R)- and (S)-M-57abcd in 88% and 87% yields, respectively.     
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Scheme 3.6.  Completion of the mixture synthesis phase of the 4,5-trans isomer family 
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EtOH
O
O
OTIPSF0,F5
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OTIPSF0,F5
C5H11
O
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(R)
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3.2.3 Post-Mix Stage  
After careful analysis of the final mixtures (R)- and (S)-M-57abcd (
1
H and 
19
F NMR 
spectroscopy, MS, and fluorous HPLC), each mixture was demixed using gradient elution with a 
fluorous semi-preparative PF-C8 HPLC column (90:10 MeCN/H2O to 100% MeCN in 15 min, 
then 100% MeCN for 90 min) with a constant flow rate of 10 mL/min.   Interestingly, the two 
final mixtures M-57abcd did not show identical separation with the semipreparative fluorous 
HPLC column (Figure 3).  The four components in (R)-M-57abcd (left trace) resolved into four 
well-separated peaks, while the four components of (S)-M-57abcd (right trace) showed 
significant overlap between the second and third-eluting compounds at 70-100 min.       
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Figure 3:  Fluorous HPLC demix traces of (R)- M-57abcd (left) and (S)-M-57abcd (right) 
 
Scheme 3.6 shows the quasiisomers resulting from the demixing of (R)- and (S)-M-
57abcd.  The sample comprising (R)-M-57abcd (584 mg) was demixed in ~90 mg/mL aliquots 
to obtain, eluting in order of increasing fluorine content, the following quasiisomers:  SSRR-57a 
(82.4 mg), SSSR-57b (80.5 mg), RRRR-57c (66.8 mg), and RRSR-57d (52.3 mg).  Likewise, the 
sample comprising (S)-M-57abcd (524 mg) was also demixed in ~90 mg/mL aliquots to obtain, 
eluting in order of increasing fluorine content, the following quasiisomers:  SSRS-57a (89.1 mg), 
SSSS-57b (69.6 mg), RRRS-57c (69.9 mg), and RRSS-57d (87.4 mg).  Careful cutting of fractions 
in the demixing of (S)-M-57abcd furnished SSSS-57b as a single quasiisomer, but RRRS-57c was 
isolated as a cross-contamined mixture of quasiisomers (~3:1 RRRS-57c/SSSS-57b) as 
determined by 
1
H NMR spectroscopy.  Collection of the cross-contaminated mixture and 
resubmission to the fluorous semipreparative HPLC column did not improve the purity of 
quasiisomer RRRS-57c, so this impure product was taken to the detagging step.  The overall 
mass recoveries for the demixing of (R)- and (S)-M-57abcd were 48% and 60%, respectively.  
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Each of the demixed products 57 were fully characterized by 
1
H, 
13
C and 
19
F NMR, IR, HRMS, 
and optical rotation measurement. 
 
Scheme 3.7.  Demixing of two final mixtures M-57abcd into individual quasiisomers 
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 The remaining task in the synthesis of the first eight-compound Sch725674 isomer family 
was the global detagging.  The typical reaction conditions with TBAF (6 equiv) in THF 
optimized during the single isomer pilot synthesis (see Section 2.2.1) were used for the eight 
quasiisomers 57 to afford final triols 5 (Figure 4).  Five of the eight triols were sufficiently pure 
after standard flash chromatography of the crude products.  To eliminate non-isomeric 
impurities, triols (4S,5S,7R,13R)-5 and (4S,5S,7R,13S)-5 were purified by injection onto the 
(S,S)-Whelk-O-1 column with gradient elution (90:10 hexanes/isopropanol for 15 min, then 
80:20 hexanes/isopropanol for 30 min, at 10.0 mL/min) and obtained in 19 and 15% isolated 
yields, respectively.   
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 Only one of the final triols in this series (4R,5R,7R,13S)-5 required additional isomer 
purification due to cross-contamination from demixing of (S)-M-57abcd.  Analysis of the cross-
contaminated sample of (4R,5R,7R,13S)-5 by HPLC with the Chiralcel OD column and isocratic 
elution (92:8 hexanes/isopropanol for 75 min) showed two peaks in approximately 4:1 ratio (see 
HPLC trace in Figure 4).  The identity of the minor peak in Figure 4 as the (4S,5S,7S,13S)-5 triol 
was confirmed by HPLC analysis of the isomerically pure sample of (4S,5S,7S,13S)-5 isolated by 
FMS.  Final purification of pure (4R,5R,7R,13S)-5 was achieved by semipreparative HPLC with 
the Chiralcel OD column and isocratic elution (92:8 hexanes/isopropanol for 75 min) at 4.5 
mL/min.  The overall yield of this isomer is low (3.2 mg, 14%) due to conservative fraction 
cutting during semipreparative HPLC.  This was necessary since emphasis was placed on 
obtaining an isomerically pure sample of (4R,5R,7R,13S)-5.   
 Each enantiomeric pair in the 4,5-trans-dihydroxy family of Sch725674 was fully 
characterized by 
1
H, 
13
C NMR and IR spectroscopy, HRMS, and optical rotation.  Copies of 
1
H 
and 
13
C NMR spectra for all (4,5-trans-dihydroxy-13R)-5 triols are included in the Appendix.  
Assignment of the 
1
H and 
13
C NMR signals was assisted by 2D NMR experiments, including 
1
H-
1
H COSY, 
1
H-
13
C HMQC, and 
1
H-
13
C HMBC.  In accordance with the results obtained by Dr. 
Wang’s FMS, no compound in the 4,5-trans-dihydoxy family of Sch725674 matched the NMR 
spectra of the natural isomer.  As expected, the NMR spectra for the sample of (4R,5R,7R,13R)-5 
isolated by FMS matched those obtained from the single isomer pilot synthesis (see Section 
2.2.1).  This lends proof to the principle of stereocenter encoding with fluorous tags in FMS.  
Also noteworthy is the ample quantity of final triols that can be isolated along this FMS route (3-
17 mg).   
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C5H11
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557
 
Figure 4:  Global detagging results for 4,5-trans-dihydroxy isomer family and HPLC trace for 
(4R,5R,7R,13S)-5 
3.2.4 Synthesis of 4,5-syn Ring-Open Sch725674 Analogs  
We next synthesized an eight-membered family of ring-open Sch725674 analogs.  The purpose 
of this exercise was to compare the properties of the macrocyclic Sch725674 stereoisomer 
library to those of a ring-open stereoisomer library.  Accordingly, the RCM-precursor mixtures 
(R)- and (S)-M-56abcd were demixed using the same HPLC method as for the macrocyclic 
mixtures M-57abcd (see Section 3.2.3).  Unlike what we observed upon demixing of mixtures 
M-57abcd, the ring-open mixtures (R)- and (S)-M-56abcd exhibited adequate separation on the 
fluorous semi-preparative HPLC column (Figure 5).  No isomer cross-contamination occurred 
during demixing of either mixture M-56abcd as shown by the presence of four well-separated 
peaks in each demix trace.   
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Figure 5:  Fluorous HPLC demix traces of (R)-56abcd (left) and (S)-56abcd (right) 
 
 Scheme 3.8 shows the amounts of each quasiisomer demixed from mixtures (R)- and (S)-
M-56abcd.  Aliquots of the sample comprising (R)-M-56abcd (50 mg/mL) were injected to 
obtain, in order of increasing fluorine content, the following acyclic quasiisomers:  SSRR-56a 
(58.8 mg), SSSR-56b (68.2 mg), RRRR-56c (111.6 mg), and RRSR-56d (60.0 mg).  Likewise, 
aliquots of the sample comprising (S)-M-56abcd (50 mg/mL) were injected to obtain, in order of 
increasing fluorine content, the following acyclic quasiisomers:  SSRS-56a (83.0 mg), SSSS-56b 
(92.4 mg), RRRS-56c (90.4 mg), and RRSS-56d (105.7 mg).  The mass recoveries for the 
demixing of mixtures (R)- and (S)-56abcd were 93% and 80%, respectively.  All eight 
quasiisomers 56 were fully characterized by 
1
H, 
13
C, 
19
F and IR spectroscopy, HRMS, and 
optical rotation.  
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Scheme 3.8.  Demixing of mixtures (R)-M-56abcd and (S)-M-56abcd 
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Figure 6 shows expansions of the CF2 region of the 
19
F NMR spectra for macrocyclic 
epimers RRSR-57 (top left) and RRSS-57 (bottom left) alongside ring-open epimers RRSR-56 
(top right) and RRSS-56 (bottom right).  All four spectra were recorded at 282 MHz using 
chloroform as solvent.  The CF2 resonances from the TIPS
F5
 tags (see Scheme 2.10 in Section 
2.2.1 for the structure of the TIPS
F5
 tag) are triplets due to coupling with the adjacent CH2 
groups and each spectrum shows three more-or-less overlapping triplets.  Figure 6 shows that the 
CF2 resonances are clearly different for the macrocyclic epimers 57, but are substantially 
identical for the ring-open epimers 56.  We propose that the different configurations of the 
remote C13 stereocenter in epimers 57 change the general conformation of the macrocycle.  
Consequently, the CF2 substituent from the fluorous tag is placed in different environments, as 
evidenced by the distinct CF2 resonances in epimers 57.  The detection of this interaction by 
19
F 
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NMR spectroscopy therefore provides an added benefit to the use of fluorous tags in mixture 
synthesis. 
 
 
Figure 6:  Comparison of the CF2 resonances of SSSR-57 and SSSS-57 (left) to SSSR-56 and SSSS-56 (right) 
 
The final task in the synthesis of the ring-open analog library was the global detagging.  
The typical reaction conditions with TBAF in THF optimized during the single isomer pilot 
synthesis in Section 2.2.1 were used for the eight ring-open quasiisomers 56 to afford the final 
triols 58 (Table 3-1).  All eight ring-open triols 58 in this library had sufficient purity after 
conventional flash chromatography of the crude product.  The detagging reactions provided 
ample amounts of the triols 58 (15-30 mg) in 60-88% yield.  Copies of 
1
H and 
13
C NMR spectra 
for (4,5-trans-dihydroxy,15S)-58 series are included in the Appendix. 
 
-120.0 -120.5 ppm -120.4 -120.6 ppm
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Table 3-1:  Detagging of the ring-open Sch725674 analogs 
O
O
OH
OH
OH
C5H11
O
O
OTIPSFn
OTIPSFn
OTIPSFn
C5H11
TBAF
THF
(4S,5S,7R,15R)-58 3TIPS 16.5 65
(4S,5S,7S,15R)-58 2TIPS + TIPSF5 15.6 60
(4R,5R,7R,15R)-58 TIPS + 2TIPSF5 26.4 69
(4R,5R,7S,15R)-58 3TIPSF5 11.0 63
(4S,5S,7R,15S)-58 3TIPS 23.9 67
(4S,5S,7S,15S)-58 2TIPS + TIPSF5 30.1 85
(4R,5R,7R,15S)-58 TIPS + 2TIPSF5 23.8 77
(4R,5R,7S,15S)-58 3TIPSF5 29.0 88
a Isolated yields af ter flash chromatography
Isomer tag, TIPSFn amount (mg) yield (%)a
5856
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4.0  FMS OF THE 4,5-CIS-DIHYDROXY FAMILY OF SCH725674 
We next sought to prepare the eight stereoisomers comprising the 4,5-cis-dihydroxy Sch725674 
isomer family.  Once all sixteen stereoisomers of Sch725674 were characterized, the absolute 
configuration of Sch725674 could be positively identified upon comparison to the literature 
NMR data.  To prepare the new isomer family, we needed to develop a concise route to 
enantiomeric 1,2-anti-diols as the key starting material. 
4.1 MITSUNOBU APPROACH  
The initial approach to prepare the requisite enantiomeric (R,S)- and (S,R)-diols was inspired by 
a Mitsunobu inversion strategy employed in the Smith-Omura
88
 synthesis of macrosphelides A 
and B.  Monosilylation of (4S,5S)-41 followed by Mitsunobu inversion of the free allylic alcohol 
59a would deliver the key anti-diol building block (Scheme 4.1).  Initially, (4S,5S)-41 was 
treated with TBSCl, DMAP, and imidazole at room temperature.  An alternate set of procedures 
to produce 59a was tried with syringe-pump addition of TBSOTf to a solution of (4S,5S)-41 and 
2,6-lutidine at 78 °C.89  Each set of conditions, however, resulted in an inseparable mixture of 
C4 (59b) and C5 (59a) O-monosilylated isomers as the predominant products.  As a result, the 
Mitsunobu strategy was not pursued further. 
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Scheme 4.1.  Attempted monosilylation of diol 41 
OPMB
MeO2C
OH
OH
OPMB
MeO2C
OR1
OR2conditions
conditions
1. TBSCl, DMAP, Im
2. TBSOTf, 2,6-lutidine,78 °C
(4S,5S)-41 59a: R1 = H, R2 = TBS
59b: R1 = TBS, R2 = H  
4.2 EPOXIDE-OPENING APPROACH 
We next adapted an epoxide-opening strategy from a synthesis of aigialomycin D by Winssinger 
and coworkers.
90
  Reduction of the aldehyde 40 to the known allylic alcohol 60 set the stage for a 
Sharpless asymmetric epoxidation (SAE)
91,92
 with L-(+)-diisopropyl tartrate (DIPT) to form the 
known epoxy alcohol
93
 61 in 69% yield (Scheme 4.2).  Upon Parikh-Doering oxidation
94
 of the 
primary alcohol, the crude aldehyde product was directly subjected to an HWE olefination under 
the Masamune-Roush conditions.
54
  The vinyl epoxide E-62 was formed in 64% yield over two 
steps and no Z-isomer was detected.  Treatment of 62 with HClO4
95
 or Sc(OTf)3,
96
 however, did 
not provide the target diol 41.  The electron-withdrawing ester subsitutent on the double bond in 
62 presumably deactivated the epoxide for SN2 opening.   
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Scheme 4.2.  Attempted epoxide-opening sequence 
OHC
OPMB OPMBHO
DIBAL-H
DCM
40 60, 87%
OPMBHO
Ti(OiPr)4, TBHP
L-(+)-DIPT, DCM
61, 69%
O
OPMB
O
MeO2C
E -62, 64%,
over 2 steps
1. SO3-py
2. HWE
OPMB
MeO2C
OH
OH
4:1 THF/H2O
(4R,5S)-41
Sc(OTf)3
 
4.3 CHIRAL POOL APPROACH FROM 2-DEOXYRIBOSE 
We then accessed the chiral pool in a strategy adapted from a recent synthesis of aigialomycin D 
by Danishefsky and coworkers.
97
  Protection of the 1,2-diol unit in 2-deoxy-D-ribose using 2-
methoxypropene (2.0 equiv), p-toluenesulfonic acid (PTSA) (20 mol %) in N,N′-
dimethylformamide (DMF) led to the acetonide (4R,5S)-63, in 27% yield (Scheme 4.3).
98
  Many 
conditions were tried to improve the yield for this transformation, including acid
99
- and iodine
100
-
catalyzed solvolysis with acetone.  However, these reactions either failed or gave 63 in even 
lower yield.  The masked aldehyde character of the sugar lactol (4R,5S)-63 was exploited by a 
Wittig chain extension with butyllithium (2.8 equiv) and methyltriphenylphosphonium iodide
97
 
(3 equiv) in THF to form the primary alcohol (4R,5S)-64 in 85% yield.  After oxidation of 
(4R,5S)-64 under the Parikh-Doering conditions,
94
 the crude aldehyde product was directly 
subjected to HWE olefination with the Masamune-Roush conditions
54
 to form a separable 4:1 
E/Z mixture of 65 (estimated by 
1
H NMR analysis of crude product).  The isolated yield of pure 
(2E,4R,5S)-65 was 57% over two steps.  Acid-catalyzed cleavage of the acetonide
101
 furnished 
the requisite anti-diol (4R,5S)-66 in 97% yield and excellent purity.  The enantiomer (4S,5R)-66 
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was also prepared using 2-deoxy-L-ribose as the starting material by this five step sequence 
(steps not shown).  This sequence was scaled up to provide >2 g of each enantiomer of 66.  
 
Scheme 4.3.  Sugar-based syntheses of diols 66 
O
O
O
OH
O
OH
OH
OH
2-Deoxy-D-ribose
2-methoxy-
propene
PTSA, DMF
(4R,5S)-63, 27%
HO
O
O
(4R,5S)-64, 85%
PPh3Me,
n-BuLi, THF
O
O
CO2Me
1. SO3-py
2. LiCl, DBU,
TPA, 4:1 E:Z
CO2Me
OH
OH
HCl, MeOH
(2E ,4R,5S)-65, 57%,
over 2 steps
CO2Me
OH
OH
(4S,5R)-66(4R,5S)-66, 97%
From 2-Deoxy-L-ribose
(steps not shown)  
4.3.1 Pre-mix Stage 
We next adopted the same minimalist tagging strategy (see Section 3.2.1) used in the FMS of the 
4,5-trans-dihydroxy Sch725674 isomer family (Scheme 4.4).  Accordingly, (4S,4R)-66 was bis-
silylated using TIPSOTf (2.5 equiv) and 2,6-lutidine to form SR-67 in 93% yield (Scheme 4.4).  
Likewise, (4R,5S)-66 was bis-silylated with TIPS
F5
OTf (2.5 equiv) to form RS-67 in 90% yield.  
Oxidative cleavage of the terminal olefins present in SR-67 and RS-67 was achieved with 
catalytic OsO4 (2 mol %), NaIO4 (4 equiv), and 2,6-lutidine
102
 (2 equiv) at room temperature to 
furnish the quasienantiomers, SR-43 and RS-43 in 79% and 68% yields, respectively.  
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Conveniently, this FMS route to the 4,5-cis-dihydroxy family directly intersects that of the 4,5-
trans-dihydroxy family with the preparation of quasienantiomers 43. 
 
Scheme 4.4.  Synthesis of quasienantiomers 43 
(4S,5R)-66
(4R,5S)-66
TIPSOTf
2,6-lutidine
MeO2C
OTIPS
OTIPS
OsO4 (cat.),
NaIO4
2,6-lutidine,
4:1 t-BuOH/H2O
MeO2C
OTIPS
O
OTIPS
TIPSF5OTf
2,6-lutidine
MeO2C
OTIPSF5
OTIPSF5
OsO4 (cat.),
NaIO4
2,6-lutidine,
4:1 t-BuOH/H2O
MeO2C
OTIPSF5
O
OTIPSF5
SR-67, 93% SR-43, 79%
RS-67, 90% RS-43, 68%  
 
 The asymmetric allylboration was the next critical step in the premixing stage.  As shown 
in Scheme 4.5, the sample of aldehyde SR-43 was split and one half was initially treated with 
(+)-32 (prepared in situ, see Section 2.2.1).  
1
H NMR analysis of the crude product indicated a 
6:1 mixture of diastereomers.  In contrast to the FMS of the 4,5-trans series, these diastereomers 
were not as easily separable by conventional flash chromatography or HPLC.  The 
diastereomeric mixture after flash chromatography was advanced to the next silylation step with 
TIPSOTf to afford quasiisomer SRR-46e in 54% yield and approximately 8:1 dr over two steps.  
Likewise, the allylboration of SR-43 with ()-32 (prepared in situ) produced an inseparable 6:1 
mixture of diastereomers as determined by 
1
H NMR analysis of the crude product.  Silylation of 
this mixture with TIPS
F5
OTf gave quasiisomer SRS-46f in 61% yield and approximately 6:1 dr 
over two steps.   
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 Similarly, the allylboration reactions of RS-43 with (+) and ()-32 gave comparable 
diastereoselectivities (~6:1 in each case) and the resulting diastereomeric mixtures were difficult 
to separate.  Flash chromatography followed by protection of the (R)-alcohol product from the 
(+)-allylboration with TIPSOTf gave quasiisomer RSR-46g in 65% yield and 4:1 dr over two 
steps.  Likewise, flash chromatography and tagging of the (S)-alcohol from the ()-allylboration 
with TIPS
F5
OTf gave quasiisomer RSS-46h in 80% yield and 8:1 dr over two steps.  Unlike the 
FMS of the 4,5-trans-dihydroxy-5 series, quasiisomers SRR-46e, SRS-46f, RSR-46g, and RSS-
46h were advanced to the mixture synthesis stage as diastereomeric mixtures and combined in 
approximately equimolar fashion to form mixture M-46efgh.  Ultimately, we would have to find 
an HPLC method for purifying the final triols after the detagging stage. 
 
Scheme 4.5.  Synthesis of the tagged FMS precursors 
SR-43
RS-43
MeO2C
OTIPS
O
MeO2C
OTIPS
O
OTIPS
OTIPSF5
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MeO2C
OTIPSF5
O
MeO2C
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O
OTIPS
OTIPSF5
TIPSF5
TIPSF5
1. (+)-Ipc2B(allyl), 78
oC
2. TIPSOTf, 2,6-lutidine
SRR-46e, 54%
two steps, dr 8:1
RSS-46h, 80%
two steps, dr 8:1
RSR-46g, 65%
two steps, dr 4:1
SRS-46f, 61%
two steps, dr 6:1
1. ()-Ipc2B(allyl), 78
oC
2. TIPSF5OTf, 2,6-lutidine
split
1. (+)-Ipc2B(allyl), 78
oC
2. TIPSOTf, 2,6-lutidine
1. ()-Ipc2B(allyl), 78
oC
2. TIPSF5OTf, 2,6-lutidine
split
M-46efgh
 
 52 
4.3.2 Mixture synthesis stage 
The mixture synthesis sequence was executed in the same manner as for the FMS of the 4,5-
trans-dihydroxy-5 series (see Section 3.2.2) and the first step is shown in Scheme 4.6.  
Treatment of methyl ester M-46efgh with TMSOK furnished the acid M-55efgh in 90% yield.  
The product mixtures after every reaction step were analyzed by 
1
H and 
19
F NMR spectroscopy, 
LRMS, and fluorous HPLC. 
 
Scheme 4.6.  Cleavage of methyl ester M-46efgh with TMSOK 
HO2C
OTIPSF0,F5
O OTIPSF0,F5
TIPSF0,F5
M-55efgh, 80%
M-46efgh TMSOK
Et2O
 
 
 The rest of the mixture synthesis stage is shown in Scheme 4.7.  Splitting the sample of 
M-55efgh and coupling each half with both enantiomers of the chiral alcohol 18 gave mixtures 
(R)- and (S)-M-56efgh in 90% and 89% yields, respectively.  Macrocyclization of (R)- and (S)-
M-56efgh with Grubbs II catalyst (20 mol %), followed by partial hydrogenation with Pd/SrCO3 
(1 equiv) provided the final mixtures (R)- and (S)-M-57efgh in 84% and 94% two step yields, 
respectively.   
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Scheme 4.7.  Mixture synthesis stage 
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O
O
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trichlorobenzoyl
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(S)-18, NEt3,
DMAP, 2,4,6-
trichlorobenzoyl
chloride
1. Grubbs 2nd
2. Pd/SrCO3, H2,
EtOH
1. Grubbs 2nd
2. Pd/SrCO3, H2,
EtOH
O
O
OTIPSF0,F5
OTIPSF0,F5
OTIPSF0,F5
C5H11
O
O
OTIPSF0,F5
OTIPSF0,F5
OTIPSF0,F5
C5H11
(R)-M-57efgh, 84%,
over 2 steps
(S)-M-57efgh, 94%,
over 2 steps
(S)-M-56efgh, 89%
(R)-M-56efgh, 90%
(R)(R)
(S) (S)
 
4.3.3 Post-Mix Stage 
After careful analysis of the final mixtures (R)- and (S)-M-57efgh, each mixture was demixed 
using the same HPLC method as for M-57abcd (see Section 3.2.3).  Similar to what was 
observed during the demixing of (R)- and (S)-M-57abcd, the final mixtures (R)- and (S)-M-
57efgh did not show identical separation with the semipreparative fluorous HPLC column 
(Figure 7).  The demix trace of (R)-M-57efgh (left trace) exhibits four well-separated peaks.  The 
demix trace of (S)-M-57efgh (right trace) exhibits tighter separation between the second and 
third-eluting components (35-50 min), but still better separation than (S)-M-57abcd (see Section 
3.2.4) which overlapped.    
 
 54 
SRRR-57e
3 TIPSF0
RSSR-57h
3 TIPSF5
SRSR-57f
2 TIPSF0
1 TIPSF5
RSRR-57g
1 TIPSF0
2 TIPSF5
RSSS-57h
3 TIPSF5
RSRS-57g
1 TIPSF0
2 TIPSF5
SRSS-57f
2 TIPSF0
1 TIPSF5
SRRS-57e
3 TIPSF0
 
Figure 7:  Fluorous HPLC demix traces of (R)-M-57efgh (left) and (S)-M-57efgh (right) 
 
 Scheme 4.8 shows the quasiisomers resulting from the demixing of (R)- and (S)-M-
57efgh.  The sample comprising (R)-M-57efgh (463 mg) was demixed in ~90 mg/mL aliquots to 
obtain, eluting in order of increasing fluorine content, the following quasiisomers:  SRRR-57e 
(59.2 mg), SRSR-57f (94.1 mg), RSRR-57g (114 mg), and RSSR-57h (41.5 mg).  Likewise, the 
sample comprising (S)-M-57efgh (547 mg) was demixed in ~50 mg/mL aliquots to obtain, 
eluting in order of increasing fluorine content, the following quasiisomers:  SRRS-57e (73.4 mg), 
SRSS-57f (52.0 mg), RSRS-57g (60.3 mg), and RSSS-57h (65.8 mg).  The tight separation in (S)-
M-57efgh resulted in cross-contamination in some fractions between the second and third-
eluting compounds at 35-50 min.  Combination of the cross-contaminated fractions and re-
subjecting this mixture, however, furnished SRSS-57f and RSRS-57g as individually pure 
quasiisomers.  The overall mass recoveries for the demixing of (R)- and (S)-M-57efgh were 69% 
and 56%, respectively.   
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 Once the eight quasiisomers 57 were obtained in good purity based on the tags, each one 
was subjected to a full battery of characterization including:  
1
H, 
13
C, 
19
F NMR and IR 
spectroscopy, HRMS, and optical rotation measurement.  As expected from the allylboration 
stage (see Section 4.3.1), each demixed quasiisomer 57 was isolated with its residual C7 
diastereomer as an inseparable mixture.  The isomer content of each quasiisomer 57 is listed in 
Scheme 4.7 and ranges from 3:1 to 10:1 dr as evaluated by 
1
H NMR spectroscopy.  Each 
quasiisomer was submitted to the detagging stage as a mixture of diastereomers and a method for 
isomer purification of the final triols 5 was developed. 
 
Scheme 4.8.  Demixing of the final mixtures M-57efgh into quasiisomers 
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 Figure 8 shows the results from the global detagging of quasiisomers 57 to triols 5.  
Detagging of SRSR-57f with the usual conditions (TBAF, 6 equiv) proved sluggish and 
incomplete by TLC.  Alternatively, treatment of the remaining seven quasiisomers 57 in this 
 56 
series with HF/MeCN
103
 over 16 h improved the conversion of the detagging reactions as 
analyzed by TLC.  The crude mixture of each global detagging reaction was initially purified by 
conventional flash chromatography to afford the eight final triols 5, each isolated as a mixture of 
diastereomers in various ratios (not shown).   
The two true C7 diastereomers comprising the sample of (4R,5S,7R,13R)-5 after flash 
chromatography were separated by HPLC with the (S,S)-Whelk-O-1 column and gradient elution 
(90:10 hexanes/isopropanol for 15 min, then 80:20 hexanes/isopropanol for 30 min).  Figure 8 
shows an analytical HPLC trace with excellent separation between (4R,5S,7R,13R)-5 (tR = 18.2 
min) and its C7 epimer, (4R,5S,7S,13R)-5 (tR = 12.0 min).  The retention times of each of these 
isomers match the retention times of the corresponding minor/major isomers in two other 
products, as expected.  Application of this HPLC method to all eight 4,5-cis-dihydroxy-5 triols in 
this series allowed for the enhancement of diastereomeric mixtures to single isomer samples, 
with the only exception being (4S,5R,7S,13R)-5 which was isolated as a 14:1 isomeric 
composition.  As we observed in the preparation of the 4,5-trans-dihydroxy isomer family, the 
quantity of final 4,5-cis-dihydroxy triols that was isolated along this FMS route (4-14 mg) was 
plentiful for full characterization by 
1
H, 
13
C NMR and IR spectroscopy, HRMS, and optical 
rotation.  Copies of 
1
H and 
13
C NMR spectra for all (4,5-cis-dihydroxy-13R)-5 triols are included 
in the Appendix. 
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O
O
OH
OH
OH
C5H11
O
O
OTIPSFn
OTIPSFn
OTIPSFn
C5H11
HF/MeCN
Isomer tags, TIPSFn amount (mg) yield (%)a
(4S,5R,7R,13R)-5 3TIPS 11.0 29
(4S,5R,7S,13R)-5b 2TIPS + TIPSF5 12.4 37
(4R,5S,7R,13R)-5 TIPS + 2TIPSF5 11.4 32
(4R,5S,7S,13R)-5 3TIPSF5 4.7 40
(4S,5R,7R,13S)-5 3TIPS 13.4 45
(4S,5R,7S,13S)-5 2TIPS + TIPSF5 5.5 17
(4R,5S,7R,13S)-5 TIPS + 2TIPSF5 14.0 73
(4R,5S,7S,13S)-5 3TIPSF5 6.9 36
a Isolated yield af ter HPLC purification by Whelk-O-1 column
b TBAF/THF for detagging this isomer
57 5
(4R,5S,7S,13R)-
5
(4R,5S,7R,13R)-
5
 
Figure 8:  Global detagging results for 4,5-cis-dihydroxy isomer family and HPLC trace for 
(4R,5S,7R,13R)-5 
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5.0  CHARACTERIZATION OF THE SCH725674 STEREOISOMER LIBRARY 
MEMBERS  
5.1.1 Ring-Closed Sch725674 Stereoisomer Library, Macrocyles 5  
Once all sixteen macrocycles 5 comprising the full ring-closed stereoisomer library of 
Sch725674 were purified, the eight 13R enantiomers (Scheme 5.1) were carefully characterized 
by 
1
H and 
13
C NMR, IR, HRMS, and optical rotation measurement.  The members of the 13S 
series were characterized only by 
1
H NMR and optical rotation.  The assignment of 
1
H and 
13
C 
signals was assisted by 2D NMR spectroscopy, particularly the 
1
H-
1
H COSY, 
1
H-
13
C HMQC, 
and 
1
H-
13
C HMBC experiments.  As expected, the 
1
H NMR spectra of corresponding 
enantiomeric pairs 5 were identical.  This shows that stereocenter encoding by fluorous tags and 
the demixing both succeeded. 
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Scheme 5.1.  3D structures of the ring-closed 13R-5 enantioseries 
O
O
OH
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
(4S,5S,7R,13R)-5 (4S,5S,7S,13R)-5 (4R,5R,7R,13R)-5 (4R,5R,7S,13R)-5
(4S,5R,7R,13R)-5 (4S,5R,7S,13R)-5 (4R,5S,7R,13R)-5 (4R,5S,7S,13R)-5
1
4
5
7
13
O
O
C5H11
OH
OH
OH
 
 
 The 
1
H NMR spectral data of the 4,5-trans-dihydroxy-13R-5 series and 4,5-cis-
dihydroxy-13R-5 series are listed in Tables 5-1 and 5-2, respectively.  All eight 
1
H NMR spectra 
were recorded in d4-MeOD at 700 MHz.  Due to overlap in the aliphatic region, the 
1
H signals of 
C9-C11 could not be assigned for the ring-closed compounds, even with the aid of 2D NMR 
experiments.  Throughout all eight sets of data, the 
1
H NMR resonances of the C15-C18 
sidechain remain unchanged regardless of absolute configuration.  Also, the vinyl protons at C2 
and C3 show only slight differences in chemical shift based on absolute configuration.  The most 
notable differences between the eight 
1
H NMR spectra, however, exist at the C4, C5, and C7 
carbinol proton resonances.     
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Table 5-1:  
1
H NMR data (700 MHz) of the ring-closed (4,5-trans-dihydroxy-13R)-5 series in d4-MeOD 
C no. (4S,5S,7R,13R)-5 (4S ,5S,7S,13R)-5 (4R,5R,7R,13R)-5 (4R,5R,7S,13R)-5
2 6.11 (dd, 15.8, 1.5, 1H) 6.10 (dd, 15.8, 1.3, 1H) 6.11 (d, 15.8, 1H) 6.12 (dd, 15.8, 1.5, 1H)
3 7.04 (dd, 15.8, 5.3, 1H) 6.96 (dd, 15.8, 5.9, 1H) 6.91 (dd, 15.8, 6.4, 1H) 7.07 (dd, 15.8, 5.4, 1H)
4 4.95 (dddd, 12.5, 7.6, 5.0, 2.3, 1H) 4.03 (ddd, 7.6, 6.0, 1.5, 1H) 4.16 (t, 6.0, 1H) 4.26 (td, 6.5, 1.5, 1H)
5 3.77 (dt, 7.4, 4.5, 1H) 3.54 (td, 8.5, 1.5, 1H) 3.82 (ddd, 9.2, 6.0, 3.8, 1H) 3.90 (td, 6.5, 2.8, 1H)
6 1.70 (dd, 5.4, 4.5, 2H) 1.76 (ddd, 14.6, 8.5, 2.7, 1H) 1.63 (m, 1H) 1.70 (m, 2H)
1.67 (m, 1H) 1.45 (m, 1H)
7 3.92 (m, 1H) 3.47 (m, 1H) 3.79 (m, 1H) 3.78 (sept, 4.20, 1H)
8 1.43 (m, 1H) 1.55 (m, 1H) 1.45 (m, 2H) 1.31 (m, 2H)
1.33 (m, 1H) 1.34 (m, 1H)
9 1.19 (m, 2H) nd* nd nd
10 nd nd nd nd
11 nd nd nd nd
12 1.62 (m, 1H) 1.67 (m, 2H) 1.78 (m, 1H) 1.70 (m, 2H)
1.54 (m, 1H) 1.56 (m, 1H)
13 4.95 (dddd, 12.5, 7.6, 5.0, 2.3, 1H) 4.93 (m, 1H) 5.03 (m, 1H) 4.97 (m, 1H)
14 1.62 (m, 1H) 1.67 (m, 1H) 1.56 (m, 1H) 1.63 (m, 2H)
1.54 (m, 1H) 1.64 (m, 1H) 1.45 (m, 1H)
15 1.33 (m, 2H) 1.34 (m, 2H) 1.33 (m, 2H) 1.31 (m, 2H)
16 1.33 (m, 2H) 1.34 (m, 2H) 1.33 (m, 2H) 1.31 (m, 2H)
17 1.33 (m, 2H) 1.34 (m, 2H) 1.33 (m, 2H) 1.31 (m, 2H)
18 0.91 (t, 6.9, 3H) 0.91 (t, 6.9, 3H) 0.90 (t, 6.9, 3H) 0.91 (t, 6.9, 3H)
* nd = not determined  
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Table 5-2:  
1
H NMR data (700 MHz) of the ring-closed (4,5-cis-dihydroxy-13R)-5 series in d4-MeOD 
C no. (4S,5R,7R,13R)-5 (4S,5R,7S,13R)-5 (4R,5S ,7R,13R)-5 (4R,5S,7S,13R)-5
2 6.09 (dd, 15.8, 1.8, 1H) 6.06 (dd, 15.8, 2.2, 1H) 6.08 (dd, 15.8, 1.5, 1H) 6.14 (dd, 15.8, 1.4, 1H)
3 6.94 (dd, 15.8, 4.7, 1H) 7.00 (dd, 15.8, 3.6, 1H) 6.87 (dd, 15.8, 6.1, 1H) 6.95 (dd, 15.8, 4.2, 1H)
4 4.47 (ddd, 4.7, 3.0, 1.8, 1H) 4.46 (m, 1H) 4.49 (ddd, 5.8, 2.7, 1.5, 1H) 4.54 (m, 1H)
5 3.89 (ddd, 7.2, 4.7, 3.0, 1H) 3.95 (ddd, 7.6, 4.5, 2.2, 1H) 3.85 (m, 1H) 3.89 (dt, 8.8, 2.1, 1H)
6 1.71 (ddd, 14.6, 7.2, 4.7, 1H) 2.02 (ddd, 14.1, 8.1, 4.5, 1H) 1.83 (dt, 14.7, 6.1, 1H) 1.32 (m, 2H)
1.33 (m, 1H) 1.54 (m, 1H) 1.65 (dt, 14.7, 5.0,1H)
7 3.71 (m, 1H) 3.68 (sept, 4.5, 1H) 3.99 (quint, 6.2, 1H) 3.38 (m, 1H)
8 1.45 (m, 2H) 1.28 (m, 2H) 1.34 (m, 2H) 1.32 (m, 2H)
9 nd* nd nd nd
10 nd nd nd nd
11 nd nd nd nd
12 1.76 (m, 1H) 1.69 (m, 2H) 1.65 (m, 2H)
1.63 (m, 1H) 1.71 (dddd, 14.2, 6.7, 4.6, 2.0, 1H)
13 5.01 (m, 1H) 4.95 (m, 1H) 4.95 (dddd, 10.4, 7.9, 5.4, 2.9, 1H) 4.93 (m, 1H)
14 1.56 (m, 1H) 1.61 (m, 2H) 1.55 (m, 1H) 1.65 (m, 1H)
1.45 (m, 1H) 1.61 (m, 1H) 1.54 (m, 1H)
15 1.33 (m, 2H) 1.34 (m, 2H) 1.34 (m, 2H) 1.32 (m, 2H)
16 1.33 (m, 2H) 1.34 (m, 2H) 1.34 (m, 2H) 1.32 (m, 2H)
17 1.33 (m, 2H) 1.34 (m, 2H) 1.34 (m, 2H) 1.32 (m, 2H)
18 0.90 (t, 6.9, 3H) 0.90 (t, 6.9, 3H) 0.90 (t, 6.9, 3H) 0.90 (t, 6.9, 3H)
* nd = not determined  
 
 Figure 9 shows 
1
H NMR expansions of the sensitive carbinol region (4.80 - 3.30 ppm) for 
the 13R-5 series.  The carbinol protons at C4, C5, and C7 are labeled directly on the expansions 
and follow the general left-to-right order H4-H5-H7, as confirmed by the 2D 
1
H-
1
H COSY 
experiment.  For (4S,5S,7R,13R)-5 (top spectrum) and (4R,5S,7R,13R)-5 (second spectrum from 
bottom), however, the H5 and H7 carbinol proton resonances are reversed and follow the left-to-
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right order H4-H7-H5.  The H5 and H7 resonances for (4R,5R,7R,13R)-5 (third spectrum from 
top) partially overlap, but still follow the left-to-right H4-H5-H7 order.   
 
 
Figure 9:  
1
H NMR expansion (700 MHz) of the carbinol region for the 13R-5 enantioseries in d4-MeOD 
 
 The 
13
C NMR spectral data of the full 13R-5 enantioseries are listed in Table 5-3.  As 
observed with the 
1
H NMR spectra, the carbon signals pertaining to the C15-C18 sidechain were 
3.63.73.83.94.04.14.24.34.44.54.6 ppm
H4
H5
H7
H7
H5
H4 H5
H7
H5,H7H4
H4
H7
H5
H4
H4
H5 H7
H7 H5
H4
H4 H5
H7
(4S ,5S ,7R ,13R ) -5
(4S ,5S ,7S ,13R ) -5
(4R ,5R ,7R ,1 3R )-5
(4R ,5R ,7S ,1 3R )-5
(4S ,5R ,7R ,1 3R )-5
(4S ,5R ,7S ,13R ) -5
(4R ,5S ,7R ,1 3R )-5
(4R ,5S ,7S ,13R ) -5
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substantially identical for all eight recorded 
13
C NMR spectra.  The vinyl carbon resonances at 
C2 and C3 show only modest differences based on absolute configuration.  As expected, the 
carbinol region (78-74 ppm) was most sensitive to absolute configuration.  In conclusion, all 
eight members of the 13R-5 series have unique 
1
H and 
13
C NMR spectra and only one member 
should match the spectral data of the natural product. 
 
Table 5-3:  
13
C NMR data (175 MHz) for the 13R-5 enantioseries in d4-MeOD 
C no. (4S,5S,7R,13R)-5 (4S,5S,7S,13R)-5a (4R,5R,7R,13,R)-5a (4R,5R,7S,13R)-5 (4S,5R,7R,13R)-5 (4S,5R,7S,13R)-5 (4R,5S,7R,13R)-5 (4R,5S,7S,13R)-5
1 168.0 168.1 168.2 168.9 168.0 168.0 168.4 169.0
2 123.5 123.1 124.3 123.3 123.4 122.3 123.1 121.8
3 148.7 149.4 148.4 149.8 148.6 150.2 149.3 150.0
4 75.8 77.8 77.5 75.3 74.6 75.7 76.0 75.0
5 74.4 74.6 73.4 73.9 72.3 72.1 72.9 72.1
6 37.9 43.8 42.0 ndb 39.1 39.5 38.3 40.5
7 69.2 68.3 67.6 69.9 68.8 68.8 69.5 68.8
8 nd nd nd nd 36.4 39.5 nd nd
9 nd nd nd nd nd nd nd nd
10 nd nd nd nd nd nd nd nd
11 nd nd nd nd nd nd nd nd
12 36.4 35.8 34.5 nd 34.4 34.9 34.1 33.9
13 77.6 75.9 77.6 75.8 77.4 76.1 77.6 75.5
14 36.8 33.3 36.0 nd 35.7 32.8 36.5 36.2
15 26.4 26.4 26.6 26.5 26.6 26.6 26.4 23.8
16 33.0 33.0 32.9 33.0 33.0 33.0 33.0 33.0
17 23.8 23.8 23.8 23.8 23.8 23.8 23.8 23.8
18 14.5 14.5 14.5 14.5 14.5 14.5 14.5 14.5
a Measured at 125 MHz
b nd = not determined  
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 The optical rotation measurements of the sixteen macrocycles 5 are listed pairwise in 
Table 5-4.  All measurements were made in absolute MeOH at room temperature.  
Corresponding enantiomers have optical rotation measurements that are about equal in 
magnitude but opposite in sign.  Interestingly, the magnitude of the optical rotation values for 
macrocycles 5 varies widely from 2 to almost 40.  Also, each isomer has a unique optical 
rotation value except for (4S,5R,7S,13R)-5, (4R,5S,7R,13S)-5, (4R,5S,7R,13R)-5, and 
(4S,5R,7S,13S)-5, all four of which are close to zero in magnitude. 
 
Table 5-4:  Optical rotation measurements of macrocyclic triols 5 
Isomer c (g/100 mL) []D
a
(4S,5S,7R,13R)-5 0.54 9.43
(4R,5R,7S,13S)-5 0.89 +11.3
(4S,5S,7S,13R)-5 0.77 18.8
(4R,5R,7R,13S)-5 0.32 +16.5
(4R,5R,7R,13R)-5 1.25 +24.8
(4S,5S,7S,13S)-5 0.83 25.9
(4R,5R,7S,13R)-5 0.38 +7.66
(4S,5S,7R,13S)-5 0.27 4.04
(4S,5R,7R,13R)-5 0.55 +15.5
(4R,5S,7S,13S)-5 0.35 13.8
(4S,5R,7S,13R)-5 0.54 +1.66
(4R,5S,7R,13S)-5 0.70 2.14
(4R,5S,7R,13R)-5 0.27 +5.15
(4S,5R,7S,13S)-5 0.21 2.93
(4S,5R,7S,13R)-5 0.24 38.6
(4S,5R,7R,13S)-5 0.67 +38.7
a Measured at room temperature in absolute MeOH
5
O
O
OH
OH
OH
C5H11
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5.1.2 Ring-Open Stereoisomer Library, Esters 58 
Once the eight ring-open triols 58 were isolated, the 15S-58 enantioseries (Scheme 5.2) was 
carefully characterized by 
1
H and 
13
C NMR, IR, HRMS, and optical rotation measurement.  The 
15R-58 enantiomers were characterized by only 
1
H NMR and optical rotation.  In addition, the 
assignment of all 1D 
1
H and 
13
C signals in this enantioseries was assisted by 2D NMR 
spectroscopy, particularly the 
1
H-
1
H COSY, 
1
H-
13
C HMQC, and 
1
H-
13
C HMBC experiments.  
Lastly, the matching spectra of all four enantiomeric pairs 58 were further proof to the principle 
of stereocenter encoding by multiple tags in FMS. 
 
Scheme 5.2.  3D structures of the ring-open 15S-58 triols 
O
O
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
O
O
OH
OH
OH
C5H11
OH
(4S,5S,7R,15S)-58 (4S,5S,7S,15S)-58 (4R,5R,7R,15S)-58 (4R,5R,7S,15S)-58
1
4
5
7
10
11
15
 
 
Interestingly, all four triols in the ring-open 15S-58 series exhibited very similar 
1
H NMR 
spectra.  The 
1
H NMR spectral data of the 15S-58 series are tabulated in Table 5-6.  All four 
1
H 
NMR spectra were recorded in d4-MeOD at 600 MHz.  As expected, the 
1
H NMR signals of the 
C17-C19 sidechain remain unchanged regardless of absolute configuration.  The vinyl protons at 
C2 and C3 likewise show only slight differences based on absolute configuration.  The most 
notable differences between the four 
1
H NMR spectra, however, exist at the more sensitive C4, 
C5, and C7 carbinol stereogenic atoms.     
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Table 5-5:  
1
H NMR data (600 MHz) for the full ring-open 15S-58 enantioseries in d4-MeOD 
C no. (4S,5S,7R ,15S )-58 (4S,5S,7S ,15S )-58 (4R ,5R,7R,15S)-58 (4R,5R ,7S,15S)-58
2 6.10 (dd, 15.7, 1.7, 1H) 6.11 (dd, 15.7, 1.8, 1H) 6.11 (dd, 15.7, 1.7, 1H) 6.11 (dd, 15.7, 1.7, 1H)
3 7.05 (dd, 15.7, 4.7, 1H) 7.05 (dd, 15.7, 4.6, 1H) 7.05 (dd, 15.7, 4.6, 1H) 7.05 (dd, 15.7, 4.7, 1H)
4 4.19 (td, 4.7, 1.7, 1H) 4.22 (td, 4.5, 1.8, 1H) 4.22 (td, 4.4, 1.8, 1H) 4.19 (td, 4.7, 1.7, 1H)
5 3.87 (m, 2H) 3.82 (quint, 4.3, 1H) 3.82 (quint, 4.4 Hz, 1H) 3.88 (m, 2H)
6 1.54 (m, 2H) 1.74 (dt, 14.2, 4.4, 1H) 1.74 (dt, 14.1, 4.4, 1H) 1.55 (m, 2H)
1.55 (dt, 17.2, 8.7, 1H) 1.54 (dt, 14.1, 8.7, 1H)
7 3.87 (m, 2H) 3.87 (m, 1H) 3.87 (m, 1H) 3.88 (m, 2H)
8 2.24 (m, 2H) 2.25 (m, 2H) 2.25 (m, 2H) 2.24 (m, 2H)
9 5.87 (ddt,17.2,10.2,7.0,1H) 5.87 (ddt,17.2,10.2,7.0,1H) 5.87 (ddt,17.2,10.2,7.0,1H) 5.87 (ddt,17.2,10.2,7.0,1H)
10 5.02 (m, 2H) 5.00 (m, 2H) 5.01 (m, 2H) 5.00 (m, 2H)
11 5.02 (m, 2H) 5.00 (m, 2H) 5.01 (m, 2H) 5.00 (m, 2H)
12 5.82 (ddt,16.9,10.2,6.7,1H) 5.82 (ddt,16.9,10.2,6.7,1H) 5.82 (ddt,16.9,10.2,6.7,1H) 5.82 (ddt,16.9,10.2,6.7,1H)
13 2.07 (m, 2H) 2.08 (m, 2H) 2.08 (m, 2H) 2.08 (m, 2H)
14 1.68 (m, 2H) 1.67 (m, 2H) 1.68 (m, 2H) 1.68 (m, 2H)
15 5.02 (m, 1H) 5.00 (m, 1H) 5.01 (m, 1H) 5.00 (m, 1H)
16 1.58 (m, 2H) 1.59 (m, 2H) 1.59 (m, 2H) 1.58 (m, 2H)
17 1.32 (m, 2H) 1.32 (m, 2H) 1.32 (m, 2H) 1.32 (m, 2H)
18 1.32 (m, 2H) 1.32 (m, 2H) 1.32 (m, 2H) 1.32 (m, 2H)
19 1.32 (m, 2H) 1.32 (m, 2H) 1.32 (m, 2H) 1.32 (m, 2H)
20 0.90 (t, 6.9, 3H) 0.90 (t, 6.9, 3H) 0.90 (t, 6.9, 3H) 0.90 (t, 6.9, 3H)
 
  
 Figure 10 shows expansions of the sensitive carbinol region of the 
1
H NMR spectra for 
the 13S-58 triols.  The proton resonances of the stereogenic C4, C5, and C7 atoms were assigned 
by the 2D 
1
H-
1
H COSY experiment and are labeled directly on each spectrum.  The carbinol 
proton resonances at C5 and C7 overlap in (4S,5S,7R,15S)-58 and (4R,5R,7S,15S)-58 (top two 
spectra, respectively).  The carbinol proton resonances of (4S,5S,7S,15S)-58 and (4R,5R,7R,15S)-
58 (bottom two spectra, respectively), however, follow the left-to-right order H4-H7-H5.   
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Figure 10:  
1
H NMR expansions (600 MHz) of the carbinol region for the ring-open 15S-58 triols in d4-MeOD 
 
 The 
13
C NMR spectral data of the 15S-58 series are tabulated in Table 5-6.  The chemical 
shifts of C17-C19 sidechain and vinyl C2-C3 carbon atoms indicate no dependence on absolute 
configuration.  As expected, the chemical shifts of carbon signals pertaining to the carbinol (C4, 
C5, and C7) atoms are most sensitive to absolute configuration.  Overall, the appearance of the 
NMR spectra for the ring-open series 58 show little dependence on absolute stereochemistry. 
 
H4
3.63.84.04.24.4 ppm
H4
H4
H4
H5,H7
H5,H7
H7
H7
H5
H5
(4S ,5S ,7R ,15S ) -5 8
(4R ,5R ,7S ,1 5S ) -58
(4R ,5R ,7R ,1 5S )-58
(4S ,5S ,7S ,15S )-5 8
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Table 5-6:  
13
C NMR data (125 MHz) for the full ring-open 15S-58 enantioseries in d4-MeOD 
C no. (4S,5S,7R,15S)-58 (4S,5S,7S,15S)-58 (4R,5R,7R,15S)-58 (4R,5R,7S,15S)-58
1 168.1 168.1 168.1 168.1
2 122.8 122.8 122.8 122.8
3 149.8 149.9 149.9 149.8
4 75.5 74.7 74.7 75.5
5 71.8 70.9 70.9 71.8
6 40.6 39.8 39.8 40.6
7 68.8 73.8 73.8 68.8
8 43.9 43.1 43.1 44.0
9 136.5 136.2 136.2 136.5
10 117.5 117.7 117.7 117.5
11 115.6 115.6 115.6 115.6
12 139.2 139.2 139.2 139.2
13 30.9 30.9 31.0 31.0
14 34.8 34.8 34.8 34.8
15 75.2 75.2 75.2 75.2
16 35.4 35.4 35.4 35.4
17 26.2 26.2 26.2 26.2
18 32.9 32.9 32.9 32.9
19 23.8 23.7 23.8 23.8
20 14.5 14.5 14.5 14.5
 
 
 The optical rotation measurements of all eight ring-open triols 58 are listed pairwise in 
Table 5-7.  Corresponding enantiomers have optical rotation measurements that are about equal 
in magnitiude but opposite in sign.  Because of the amount of isolated material of the ring-open 
triols (up to ~30 mg), the mass of each triol 58 was measured with greater accuracy than 
macrocyles 5.  All measurements were made in absolute MeOH at room temperature.  
Interestingly, (4S,5S,7S,15R)-58 and (4R,5R,7R,15S)-58 are indistinguishable by 
1
H NMR 
 69 
spectroscopy but can be easily identified by their unique optical rotation values of 13.3 and 
+15.2, respectively. 
 
Table 5-7:  Optical rotation measurements of the ring-open triols 58 
O
O
OH
OH
OH
C5H11
Isomer c (g/100 mL) []D
a
(4S,5S,7R,15R)-58 1.08 30.7
(4R,5R,7S,15S)-58 1.45 +33.2
(4S,5S,7S,15R)-58 0.83 15.1
(4R,5R,7R,15S)-58 1.19 +15.2
(4R,5R,7R,15R)-58 1.02 +17.9
(4S,5S,7S,15S)-58 1.51 13.3
(4R,5R,7S,15R)-58 1.02 +34.6
(4S,5S,7R,15S)-58 1.20 23.0
a Measured at room temperature in absolute MeOH
58
 
5.1.3 Spectral Comparison of the Ring-Open and Ring-Closed Libraries 
The NMR spectroscopic data of the ring-open and macrocyclic triols were compared.  Figure 10 
shows 
1
H NMR expansions (4.60–3.35 ppm) of the carbinol region for the macrocyclic C13-
epimers (4R,5R,7R,13R)-5 and (4R,5R,7R,13S)-5 (top two spectra, respectively), and ring-open 
C15-epimers (4R,5R,7R,15R)-58 and (4R,5R,7R,15S)-58 (bottom two spectra, respectively).  All 
four compounds have the (4R,5R,7R) configuration and were recorded in d4-MeOH with high-
field NMR instruments (500-700 MHz).  There is substantial similarity between the three 
1
H 
NMR carbinol resonances of the 15R and 15S ring-open triols 58.  The drastically different 
 70 
spectra of the 13R and 13S ring-closed macrocycles 5, however, indicate communication 
between the remote C13 stereocenter and the carbinol stereogenic atoms along the carbon 
skeleton of 5.  Indeed, the different 
1
H NMR spectra of epimers (4R,5R,7R,13R)-5 and 
(4R,5R,7R,13S)-5 suggest that the configuration at the remote C13 stereocenter has a clear effect 
on the ring conformation of the natural product.      
 
 
Figure 11:  Spectral comparison of the carbinol protons in ring-open vs. ring-closed triols 
5.1.4 Assignment of Absolute Configuration to Sch725674 
The spectral data from the 13R-5 enantioseries was compared to the NMR spectral data reported 
for the natural product.  As shown in Table 5-8, the synthetic sample (4R,5S,7R,13R)-5 matched 
3.84.04.24.4 ppm
H4
H4
H4
H4
H5
H5
H5
H5,H7
H7
H7
H7
(4R ,5R ,7R ,13R)-5
(4R ,5R ,7R ,13S)-5
(4R ,5R ,7R ,15R)-58
(4R ,5R ,7R ,15S)-58
 71 
the 
1
H and 
13
C NMR spectra of the natural product.  Supported by the Celmer guideline of 
macrolide stereochemistry (see Section 1.2.2), we can confidently assign (4R,5S,7R,13R)-5 as 
the natural configuration of Sch725674.   
  
Table 5-8:  Comparison of 
1
H and 
13
C NMR data between natural Sch725674 and (4R,5S,7R,13R)-5 
Sch725674a (4R,5S,7R,13R)-5b Sch725674c (4R,5S,7R,13R)-5d
1 168.4 168.4
2 6.07 (dd, 15.8, 1.6, 1H) 6.08 (dd, 15.8, 1.5, 1H) 123.1 123.1
3 6.86 (dd, 15.8, 6.0, 1H) 6.87 (dd, 15.8, 6.1, 1H) 149.3 149.3
4 4.48 (ddd, 6.0, 3.0, 1.6, 1H) 4.49 (ddd, 5.8, 2.7, 1.5, 1H) 76.0 76.0
5 3.84 (ddd, 6.0, 4.7, 3.0, 1H) 3.85 (m, 1H) 72.9 72.9
6 1.82 (ddd, 14.7, 6.5, 6.0, 1H) 1.83 (dt, 14.7, 6.1, 1H) 38.3 38.3
1.65 (m, 1H) 1.65 (dt, 14.7, 5.0, 1H)
7 3.98 (quart, 6.5, 1H) 3.99 (quint, 6.2, 1H) 69.5 69.5
8 1.36 (m, 2H) 1.34 (m, 2H) 36.8 nd
9 1.19 (m, 1H) nde 25.8 nd
1.37 (m, 1H)
10 1.15 (m, 1H) nd 29.5 nd
1.40 (m, 1H)
11 1.19 (m, 1H) nd 27.0 nd
12 1.54 (m, 1H) 1.55 (m, 1H) 34.1 34.1
1.70 (m, 1H) 1.71 (dddd, 14.2, 6.7, 4.6, 2.0, 1H)
13 4.94 (dddd, 9.8, 7.5, 5.0, 2.2, 1H) 4.95 (dddd, 10.4, 7.9, 5.4, 2.9, 1H) 77.6 77.6
14 1.57 (m, 1H) 1.55 (m, 1H) 36.5 36.5
1.61 (m, 1H) 1.61 (m, 1H)
15 1.32 (m, 2H) 1.34 (m, 2H) 26.4 26.4
16 1.30 (m, 2H) 1.34 (m, 2H) 32.9 33.0
17 1.30 (m, 2H) 1.34 (m, 2H) 23.8 23.8
18 0.89 (t, 6.8, 3H ) 0.90 (t, 6.9, 3H) 14.5 14.5
a Measured at 500 MHz
b Measured at 700 MHz
c Measured at 125 MHz
d Measured at 175 MHz
e nd = not determined
C/H no. 1H () 13C ()
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5.2 CONCLUSION 
The technique of fluorous mixture synthesis was applied to obtain all sixteen candidate 
stereoisomers of the macrolactone natural product Sch725674.  Initially, the synthesis of a single 
stereoisomer of Sch725674 was performed as a pilot study to secure a stereoselective route to the 
natural product stereoisomer library and to confirm the 2D connectivity of Sch725674.  The 
synthetic sequence established in the pilot study was then applied to an eight-member isomer 
family of Sch725674, with each member of the family having a trans relationship between the 
C4 and C5 stereocenters.  An eight-member library of ring-open Sch725674 analogs was also 
synthesized by FMS.  A second eight-member family of macrocycles was then synthesized, with 
each member of this family having a cis relationship between the C4 and C5 stereocenters.  All 
three of these libraries employed a novel tagging strategy which used two sorting tags, only one 
of which is fluorous.  Finally, we confidently assigned the configuration of natural Sch725674 as 
(4R,5S,7R,13R) by comparing the NMR spectral data of our synthetic samples to those of the 
natural isomer. 
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6.0  EXPERIMENTAL 
General:  Proton nuclear magnetic resonance (
1
H NMR) spectra and carbon nuclear magnetic 
resonance (
13
C NMR) spectra were recorded on a Bruker WH-300 MHz, IBM AF-300, Bruker 
Avance
TM
 500 NMR, Bruker Avance
TM
 600 NMR, or a Bruker Avance
TM
 700 NMR 
spectrometer using deuterated chloroform as solvent, unless otherwise indicated.  Signal 
positions are given as part per million (δ) and were determined relative to the residual proton 
resonance of CDCl3 (7.27 ppm) or central CDCl3 carbon peak carbon peak (77.03 ppm) as the 
internal standards.  Coupling constants (J values) are in Hz.  Spectral content is listed in the 
following order:  chemical shift (δ), multiplicity, coupling constants (Hz), number of nuclei.  All 
spectra were acquired at room temperature.  In the case of 
19
F NMR spectral data, an internal 
standard (-trifluorotoluene) was used only for Mosher ester analyses.   
 Infrared (IR) spectra were recorded on a Mattson Genesis series FTIR spectrometer as 
thin films on NaCl plates and peaks are reported in wave numbers (cm
1
).  Optical rotations were 
measured on a Perkin-Elmer 241 polarimeter at a Na D-line (λ = 589 nm) using a 1 dm cell.  
Low-resolution mass spectra were obtained on a V/G 70/70 double focusing machine and were 
reported in units of m/z.  HPLC analyses and separations were performed on a Waters 600E 
system with a Waters 2487 dual λ absorption detector.  Compound names were obtained from 
ChemDraw Ultra 12.0 (Cambridge Soft Corp.). 
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 All reactions were monitored by either thin layer chromatography or 
1
H NMR 
spectroscopy.  Visualization of the thin layer chromatography plates was achieved with 
ultraviolet light (254 nm), followed by development in a staining solution of anisaldehyde in 
ethanol, or 5% aqueous potassium permanganate.  Conventional flash chromatography was 
performed with 230-400 mesh silica gel (E. Merck, Silica gel 60).  All dry solvents were 
obtained by passing over activated alumina.  Unless water was a cosolvent or reagent, all 
reactions were carried out under inert an atmosphere of dry argon.  Deionized water was used for 
all workup operations.  Standard syringe/septa techniques were employed throughout all 
reactions.  
6.1 EXPERIMENTAL DATA FOR THE 2ND GENERATION PILOT SYNTHESIS 
O OPMB  
 
3-(4-Methoxybenzyloxy)propanal (26).
60
  CAS registry number: [128461-65-4].  Solid NaH 
(60% in mineral oil, 5.78 g, 144.55 mmol) was added to anhydrous dimethylformamide (200 
mL).  The resultant suspension was quickly cooled to 0 °C and a catalytic amount of 
tetrabutylammonium iodide (4.85 g, 13.14 mmol) was added.  Then, 1,3-propanediol (9.50 mL, 
131.41 mmol) was slowly added dropwise by syringe.  After 30 min at 0 °C, 4-methoxybenzyl 
chloride (18.63 mL, 137.98 mmol) was added dropwise by syringe.  The suspension was stirred 
for 30 min at 0 °C, then at room temperature for 16 h.  The reaction was quenched by addition of 
saturated aqueous NH4Cl (100 mL).  The resultant bilayer was transferred to a separatory funnel 
and Et2O (250 mL) was added.  The layers were separated and the aqueous layer was extracted 
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with Et2O (3 x 200 mL).  The combined organic extracts were washed with water (150 mL) and 
brine (150 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the PMB ether as a pale yellow 
oil (12.48 g, 48%):  
1
H NMR (300 MHz, CDCl3) δ 7.25 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.7 Hz, 
2H), 4.44 (s, 2H), 3.79 (s, 3H), 3.74 (t, J = 5.7 Hz, 2H), 3.62 (t, J = 5.8 Hz, 2H), 2.56 (broad s, 
1H), 1.84 (quintet, J = 5.8 Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 159.2, 130.1, 129.2, 113.8, 
72.8, 68.8, 61.6, 55.2, 32.1.   
General Procedure for Swern oxidations.
59
  
 Swern Oxidation of 3-(4-methoxybenzyloxy)-1-propanol: 
 A solution of DMSO (18.2 mL, 255.6 mmol) in CH2Cl2 (100 mL) was slowly added by 
syringe to a solution of oxalyl chloride (1.65 mL, 19.18 mmol) in CH2Cl2 (600 mL) at 78 °C.  
After 15 min, the above alcohol (12.48 g, 63.3 mmol) in CH2Cl2 (125 mL) was added dropwise 
by cannula transfer.  The flask containing the alcohol was rinsed with CH2Cl2 (25 mL) and the 
rinse was also transferred by cannula.  The resulting mixture was stirred at 78 °C for 15 min, 
then Et3N (6.68 mL, 47.95 mmol) was added slowly dropwise by syringe.  The reaction mixture 
was maintained at 78 °C for 15 min then warmed to 0 °C, and the stirring continued for 30 
min.  Water was then added and the mixture was diluted with Et2O.  The organic layer was 
separated and washed with brine.  The combined aqueous layers were extracted with Et2O. The 
organic layers were combined, dried over MgSO4, filtered, and then concentrated by rotary 
evaporation.  The crude product was then purified by flash chromatography (3:1 hexanes:EtOAc) 
to afford the title compound as a pale yellow oil (13.03 g, 79%):  
1
H NMR (300 MHz, CDCl3) δ 
9.79 (t, J = 1.8 Hz, 1H), 7.26 (d, J = 8.3 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 3.79 (t, J = 6.1 Hz, 
2H), 4.47 (s, 2H), 3.81 (s, 3H), 2.69 (td, J1 = 1.8 Hz, J2 = 6.1 Hz, 2H). 
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OPMB
MeO2C  
 
(2E)-Methyl-5-(4-methoxybenzyloxy)pent-2-enoate (E-25). CAS registry number: [201667-
72-3]. 
General Procedure for the HWE (Masamune-Roush) olefination:
54
  
 Trimethylphosphonoacetate (11.64 mL, 80.51 mmol) was added dropwise by syringe to a 
stirring slurry of LiCl (3.41 g, 80.51 mmol) in anhydrous MeCN (650 mL).  1,8-Diazabicyclo-
[5.4.0]-undec-7-ene (11.03 mL, 73.80 mmol) was added dropwise by syringe at room 
temperature.  The resultant suspension was cooled to 0 °C, and a solution of the propanal 26 in 
acetonitrile (125 mL) was added dropwise by cannula transfer.  The flask containing the 
propanal was rinsed with acetonitrile (25 mL) and the rinse was transferred to the reaction 
mixture by cannula.  The resultant suspension was stirred at 0 °C for 5 min, then at room 
temperature for 45 min.  Deionized water (300 mL) was then added to the suspension to dissolve 
the phosphonic acid byproduct, and the mixture was transferred to a separatory funnel.  The 
layers were separated and the aqueous layer was extracted with Et2O (2 x 500 mL).  The 
combined organic extracts were washed with brine (200 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  
1
H NMR analysis of the crude product revealed a 12.5:1 
ratio of E/Z isomers.  Flash chromatography of the crude product gave the title compound as a 
pale yellow oil (13.8 g, 82%):  
1
H NMR (300 MHz, CDCl3) δ 7.26 (d, J = 8.6 Hz, 2H), 6.99 (dt, 
J1 = 15.7 Hz, J2 = 6.9 Hz, 1H), 6.91 (d, J = 8.7 Hz, 2H), 5.90 (dt, J1 = 15.6 Hz, J2 = 1.6 Hz, 1H), 
4.46 (s, 2H), 3.81 (s, 3H), 3.74 (s, 3H), 3.56 (t, J = 6.4 Hz, 2H), 2.51 (qd, J1 = 6.6 Hz, J2 = 1.6 
Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 166.9, 159.3, 146.0, 130.2, 129.3, 122.5, 113.8, 72.7, 
68.0, 55.3, 51.4, 32.7.   
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OPMB
MeO2C
OH
OH
 
 
(2R,3S)-Methyl 2,3-dihydroxy-5-(4-methoxybenzyloxy)pentanoate ((2R,3S)-27).  AD-mix-
α58 (22.37 g) and methanesulfonamide (3.04 g, 31.96 mmol) were added to 1:1 tBuOH/H2O (145 
mL) at room temperature.  The orange suspension was stirred at room temperature for 30 min, 
then cooled to 0 °C by Cryocooler.  A solution of the ester 25 (4.00 g, 15.98 mmol) in 1:1 
tBuOH/H2O (15 mL) was added to the cooled suspension dropwise by syringe.  The reaction 
mixture was stirred at 0 °C for 24 h.  The reaction was quenched by addition of saturated 
aqueous sodium thiosulfate (75 mL) and the mixture was stirred for 1 h at room temperature.  
The layers were separated and the aqueous layer was extracted with Et2O (3 x 150 mL).  The 
combined organic extracts were washed with brine (80 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  Flash chromatography of the crude product (1:2 
hexanes/EtOAc) gave the title compound as a highly viscous solid that solidified upon freezing 
(3.71 g, 82%):  
1
H NMR (300 MHz, CDCl3) δ 7.26 (d, J = 9.0 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 
4.47 (s, 2H), 4.18 (dtd, J1 = 11.2 Hz, J2 = 3.7 Hz, J3 = 2.0 Hz, 1H), 4.10 (dd, J1 = 6.9 Hz, J2 = 2.0 
Hz,1H), 3.83 (s, 3H), 3.82 (s, 3H), 3.70 (m, 2H), 3.12 (d, J = 7.0 Hz, 1H), 2.99 (d, J = 5.5 Hz, 
1H), 2.04 (m, 1H), 1.83 (ddt, J1 = 16.3 Hz, J2 = 8.7 Hz, J3 = 3.8 Hz, 1H); 
13
C NMR (75 MHz, 
CDCl3) δ 173.6, 159.4, 129.9, 129.4, 113.9, 73.7, 73.1, 71.7, 67.9, 55.3, 52.7, 33.2; FTIR (thin 
film)  νmax 3315, 2946, 1463, 1227, 1180, 1118 cm
1; HRMS calcd (ESI) for C14H20O6Na [M + 
Na]
+
:  307.1158, found 307.1141;   78.225 D  (c 0.87, CHCl3).  
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MeO2C
OH
OH
 
 
(2S,3R)-Methyl-2,3-di-hydroxy-5-(4-methoxy-benzy-loxy)-pentanoate ((2S,3R)-27). The 
procedure
58
 used for the preparation of (2R,3S)-27 was repeated using AD-mix-β (2.29 g), 
methanesulfonamide (312 mg, 3.28 mmol), and the ester 25 (410 mg, 1.64 mmol) in 1:1 
tBuOH/H2O (16 mL).  Flash chromatography of the crude product (1:2 hexanes/EtOAc) gave the 
title compound as a white amorphous solid that solidified upon freezing (299 mg, 62%).  The 
1
H 
and 
13
C NMR spectra matched those of (2R,3S)-27 (see above); HRMS calcd (ESI) for 
C14H20O6Na [M + Na]
+
:  307.1158, found 307.1152;   3.425 D (c 1.04, CHCl3). 
 
OPMB
MeO2C
OMTPS-S
OMTPS-S
 
 
RSSS-28.  General procedure for Mosher ester derivatization:
63
 Commercially available (R)-
MTPA-Cl (120 μl, 0.633 mmol) was added in portion to a solution of the diol (2S,3R)-27 (60.0 
mg, 0.211 mmol) in pyridine (2.00 mL) at 0 °C.  The reaction mixture was stirred at this 
temperature for 15 min, then at room temperature for 3 h.  The reaction was quenched by 
addition of water (3 mL) and transferred to a separatory funnel by pipette.  The contents were 
then diluted with Et2O (10 mL) and the layers were separated.  The aqueous layer was extracted 
with Et2O (3 x 10 mL).  The combined organic extracts were washed with 20% aqueous CuSO4 
(3 x 5 mL), water (5 mL), and brine (5 mL).  The organic solution was dried over MgSO4, 
filtered and concentrated by rotary evaporation.  The crude product was analyzed without 
 79 
purification: 
1
H NMR (300 MHz, CDCl3) δ 7.57 (d, J = 7.9 Hz, 2H), 7.48 (d, J = 7.1 Hz, 2H), 
7.37 (m, 6H), 7.22 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 5.80 (td, J1 = 8.2 Hz, J2 = 1.7 
Hz, 1H), 5.40 (d, J = 1.8 Hz, 1H), 4.35 (d, J = 11.5 Hz, 1H), 4.28 (d, J = 11.5 Hz, 1H), 3.82 (s, 
3H), 3.74 (s, 3H), 3.48 (s, 3H), 3.38 (m, 1H), 3.34 (s, 3H), 3.25 (m, 1H), 1.96 (m, 2H); 
19
F NMR 
(282 MHz, CDCl3) δ 72.2, 72.8.  The minor peaks in the 
19
F NMR spectrum of (RSSS)-28 
match the major peaks of (SRSS)-28 (see below). 
 
OPMB
MeO2C
OMTPA-S
OMTPA-S
 
 
SRSS-28.  The general procedure for Mosher ester derivatization
63
 was followed using the diol 
(2R,3S)-27 (47.0 mg, 0.165 mmol) and (R)-MTPA-Cl (100 μl, .496 mmol) in pyridine (2 mL).  
The crude product was analyzed without purification:   
1
H NMR (300 MHz, CDCl3) δ 7.63 (d, J 
= 6.9 Hz, 2H), 7.47 (d, J = 6.4 Hz, 2H), 7.35 (m, 6H), 7.22 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.6 
Hz, 2H), 5.72 (td, J1 = 7.9 Hz, J2 = 1.6 Hz, 1H), 5.44 (d, J = 1.8 Hz, 1H), 4.40 (d, J = 11.6 Hz, 
1H), 4.31 (d, J = 11.6 Hz, 1H), 3.79 (s, 3H), 3.63 (s, 3H), 3.54 (s, 3H), 3.39 (s, 3H), 3.34 (m, 
2H), 1.93 (m, 1H), 1.78 (m, 1H); 
19
F NMR (282 MHz, CDCl3) δ 72.3, 72.5.  The minor peaks 
in the 
19
F NMR spectrum of SRSS-28 match the major peaks of RSSS-28 (see above). 
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MeO2C
OTIPS
OTIPS
 
 
(2R,3S)-Methyl-5-(4-methoxy-benzyloxy)-2,3-bis-(tri-isopropyl-silyl-oxy)-pentanoate (29). 
Triisopropyl trifluoromethanesulfonate (7.30 mL, 27.08 mmol) was added dropwise to a solution 
of the diol (2R,3S)-27 (3.50 g, 12.31 mmol) and 2,6-lutidine (3.14 mL, 27.08 mmol) in CH2Cl2 
(80 mL) at 0 °C.  The reaction mixture was stirred at 0 °C for 15 min, then at room temperature 
for 4 h.  The reaction was quenched by addition of saturated aqueous NH4Cl (30 mL).  The 
layers were separated and the aqueous layer was extracted with ether (3 x 75 mL).  The 
combined organic extracts were washed with water (25 mL) and brine (25 mL), dried over 
MgSO4, filtered, and concentrated by rotary evaporation.  Flash chromatography of the crude 
product (10:1 hexanes/EtOAc) gave the title compound as a colorless oil (5.96 g, 81%):  
1
H 
NMR (300 MHz, CDCl3) δ 7.25 (d, 8.6 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 4.42 (m, 3H), 4.23 (td, 
J1 = 6.2 Hz, J = 4.3 Hz, 1H), 3.81 (s 3H), 3.69 (s, 3H), 3.55 (m, 2H), 2.28 (sextet, J = 7.1 Hz, 
1H), 1.74 (J = 6.5 Hz, 1H) 1.05 (broad s, 42H); 
13
C NMR (75 MHz, CDCl3) δ 172.3, 159.0, 
130.8, 129.1, 113.6, 75.1, 72.3, 72.0, 66.7, 55.2, 51.2, 33.1, 18.0, 17.9, 17.9, 12.8, 12.4; FTIR 
(thin film)  νmax  2944, 2866, 1754, 1513, 1464, 1248 cm
1; HRMS calcd (ESI) for 
C32H60O6Si2Na [M + Na]
+
:  619.3826, found 617.3799;   6.1525 D (c 1.09, CHCl3). 
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O
MeO2C
OTIPS
OTIPS
 
 
(2R,3S)-Methyl 5-oxo-2,3-bis(triisopropylsilyloxy)pentanoate (30).  The PMB ether 29 (2.77 
g, 4.65 mmol) was dissolved in 18:1 CH2Cl2/H2O (38 mL).  The mixture was cooled to 0 °C and 
DDQ
64
 (1.16 g, 5.12 mmol) was added in one portion.  The green suspension was stirred at 0 °C 
for 5 min, then at room temperature for 2 h.  The reaction was quenched by addition of saturated 
aqueous NaHCO3 (15 mL).  The resulting emulsion was broken in the separatory funnel by 
addition of chloroform (20 mL).  The layers were separated and the aqueous layer was extracted 
with chloroform (3 x 50 mL).  The combined organic extracts were washed with brine (15 mL), 
dried over MgSO4, filtered, and concentrated by rotary evaporation.  The crude product was 
taken to the next step as an inseparable mixture of the free alcohol and anisaldehyde. 
 The general procedure for Swern oxidation
59
 was followed with DMSO (0.86 mL, 12.12 
mmol), oxalyl chloride (0.70 mL, 8.08 mmol), and NEt3 (2.82 mL, 20.20 mmol).  Flash 
chromatography gave the title compound as a pale yellow oil (1.62 g, 79% over two steps): 
1
H 
NMR (300 MHz, CDCl3) δ 9.85 (t, J = 2.0 Hz, 1H), 4.62 (q, J = 5.5 Hz, 1H), 4.52 (d, J = 5.3 Hz, 
1H), 3.72 (s, 3H), 3.19 (ddd, J1 = 16.6 Hz, J2 = 6.1 Hz, J3 = 1.6 Hz, 1H), 2.61 (ddd, J1 = 16.4 Hz, 
J2 = 5.5 Hz, J3 = 2.1 Hz, 1H), 1.04 (broad s, 42H); 
13
C NMR (75 MHz, CDCl3) δ 200.4, 171.6, 
76.4, 73.9, 69.6, 51.2, 46.6, 17.7, 17.6, 17.5, 12.1, 11.9; FTIR (thin film)  νmax  2945, 2867, 1751, 
1130 cm1; HRMS calcd (ESI) for C24H50O5Si2Na [M + Na]
+
:  497.3095, found 497.3119; 
  4.1525 D (c 1.02, CHCl3). 
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OTIPS
O OTIPS
TIPS
 
 
(2R,3S,5R)-Methyl-5-hydroxy-2,3-bis(triisopropylsilyloxy)oct-7-enoate (31c).  Commercially 
available (+)-Ipc2B(allyl) (1.0 M solution in pentane, 3.82 mL, 3.82 mmol) was added to a 
solution of aldehyde 30 (1.30 g, 2.73 mmol) in Et2O (20 mL) at 78 °C.  The reaction mixture 
was stirred at this temperature for 3 h, and warmed to room temperature.  The reaction was 
quenched by the addition of 1:2:1 30% aq. H2O2/MeOH/pH 7 buffer (60 mL), and the resulting 
suspension was stirred for 16 h.  The layers were separated and the aqueous layer extracted with 
ether (3 x 80 mL).  The combined organic extracts were washed with water (50 mL), sat. aq. 
NaHCO3 (50 mL), more water (50 mL), brine (50 mL), then dried over MgSO4.  Flash 
chromatography of the crude product (10:1 hexanes/EtOAc) gave a mixture of the major and 
minor alcohol epimers along with 3-pinanol byproduct.  The mixture was dissolved in CH2Cl2 
(30 mL) then silylated as reported for compound 29 using 2,6-lutidine (1.20 mL, 10.04 mmol) 
and TIPSOTf (2.71 mL, 10.04 mmol).  Flash chromatography of the crude product (40:1 
hexanes/EtOAc) afforded the title compound as a colorless oil (1.10 g, 60% over two steps, 4:1 
mixture of diastereomers):  
1
H NMR (300 MHz, CDCl3) δ 5.92 (m, 1H), 5.06 (dd, J1 = 15.9 Hz, 
J2 = 11.6 Hz, 2H), 4.47 (d, J = 3.9 Hz, 1H), 4.28 (m, 1H), 4.17 (ddd, J1 = 7.7 Hz, J2 = 5.6 Hz, J3 
= 1.9 Hz, 1H), 2.39 (m, 2H), 1.97 (ddd, J1 = 13.9 Hz, J2 = 7.7 Hz, J3 = 6.1 Hz, 1H), 1.71 (ddd, J1 
= 14.2 Hz, J2 = 7.9 Hz, J3 = 5.7 Hz, 1H), 1.08 (broad s, 63 H); 
13
C NMR (75 MHz, CDCl3) δ 
172.5, 172.2, 135.0, 134.5, 117.2, 116.2, 72.5, 72.1, 69.2, 68.9, 42.0, 41.7, 18.1, 13.1; FTIR (thin 
film)  νmax 2944, 2893, 2866, 1752, 1463 cm
1;   6.1125 D (c 1.02, CHCl3). 
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OPMB  
 
1-((But-3-enyloxy)methyl)-4-methoxybenzene (38).
104
  CAS registry number: [142860-83-1].  
The general procedure for 4-methoxy-benzyl protection for compound 26 was followed
 
using 
buten-1-ol (5.00 mL, 58.45 mmol), NaH (95%, 1.92 g, 75.99 mmol), and 4-methoxybenzyl 
chloride (9.52 mL, 70.14 mmol) in dimethylformamide (200 mL).  Flash chromatography of the 
crude product (1:1 hexanes/EtOAc) gave the title compound as a yellow oil (9.52 g, 85%):  
1
H 
NMR (300 MHz, CDCl3) δ 7.27 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 5.84 (ddt, J1 = 17.0 
Hz, J2 = 10.2 Hz, J3 = 6.7 Hz, 1H), 5.10 (ddd, J1 = 17.5 Hz, J2 = 10.2 Hz, J3= 1.7 Hz, 2H), 4.46 
(s, 2H), 3.82 (s, 3H), 3.53 (t, J = 6.8 Hz, 2H), 2.38 (ddd, J1 = 14.8 Hz, J2 = 6.7 Hz, J3 = 1.4 Hz, 
2H); 
13
C NMR (75 MHz, CDCl3) δ 159.1, 135.5, 130.5, 129.1, 115.7, 113.2, 72.4, 69.2, 55.1, 
34.2.   
 
OPMB
OHC
 
 
(E)-5-(4-Methoxybenzyloxy)pent-2-enal (40).
85
 CAS registry number: [671232-57-8].  Alkene 
38 (10.25 g, 53.1 mmol) was dissolved in anhydrous, degassed CH2Cl2 (100 mL).  
Crotonaldehyde (22.0 mL, 266 mmol) was then added by syringe at room temperature.  The 
Grubbs-Hoveyda 2
nd
 generation catalyst (333 mg, 0.53 mmol) was then added at room 
temperature in one portion.  The flask was then fitted with a reflux condenser and the reaction 
mixture was stirred at reflux for 16 h (~50 °C, bath temperature).  The reaction mixture was then 
cooled to room temperature and concentrated by rotary evaporation.  Flash chromatography of 
the crude product (3:1 hexanes/EtOAc) gave the title compound as a pale brown oil (11.21 g, 
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95%, E/Z>20:1):  
1
H NMR (300 MHz, CDCl3) δ 7.26 (d, J = 8.5 Hz, 2H), 6.90 (d, J = 6.8 Hz, 
2H), 6.88 (dt, J1 = 15.7 Hz, J2 = 6.7 Hz, 1H), 6.18 (ddt, J1 = 15.8 Hz, J2 = 7.9 Hz, J3 = 1.4 Hz, 
1H), 4.47 (s, 2H), 3.82 (s, 3H), 3.62 (t, J = 6.2 Hz, 2H), 2.63 (qd, J1 = 6.5 Hz, J2 = 1.4 Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 193.7, 159.2, 133.9, 129.8, 129.1, 113.7, 72.6, 67.4, 55.1, 32.9.   
 
OPMB
MeO2C  
 
(2E,4E)-Methyl-7-(4-methoxybenzyloxy)hepta-2,4-dienoate (37). The general procedures for 
the Masamune-Roush conditions
54 
were employed with aldehyde 40 (11.21 g, 50.66 mmol), 
trimethylphosphonoacetate (8.79 mL, 60.79 mmol), LiCl (2.58 g, 60.79), and 1,8-diazabicyclo-
[5.4.0]-undec-7-ene (8.33 mL, 55.73 mmol).  Filtration of the crude product over a silica plug 
afforded the title compound as a pale yellow oil (12.49 g, 89%, E/Z>20:1):   
1
H NMR (300 MHz, 
CDCl3) δ 7.27 (dd, J1= 15.4 Hz, J2 = 10.2 Hz, 1H), 7.26 (d, J = 8.2 Hz, 2H), 6.89 (d, J = 8.7 Hz, 
2H), 6.19 (m, 2H), 8.81 (d, J = 15.4 Hz, 1H), 4.46 (s, 2H), 3.82 (s, 3H), 3.75 (s, 3H), 3.53 (t, J = 
6.5 Hz, 2H), 2.48 (q, J = 6.4 Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 167.6, 159.3, 150.0, 140.7, 
129.9, 129.3, 119.4, 113.8, 72.7, 67.8, 55.3, 51.5, 33.4. 
 
OPMB
MeO2C
OH
OH
 
 
(4S,5S,2E)-Methyl-4,5-dihydroxy-7-(4-methoxybenzyloxy)hept-2-enoate ((4S,5S)-41): The 
same procedure
58
 used for the preparation of (2R,3S)-27 was followed with K2Os(OH)2 (84.5 
mg, 0.230 mmol), (DHQ)2PHAL (376 mg, 0.459 mmol), K3Fe(CN)6 (22.7 g, 68.82 mmol), 
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K2CO3 (9.51 g, 68.82 mmol), methanesulfonamide (4.36 g, 45.88 mmol), and dienoate 37 (6.34 
g, 22.94 mmol).  Flash chromatography of the crude product (1:2 hexanes/EtOAc) afforded the 
title compound as a highly viscous, pale yellow syrup (4.89 g, 67%, 92% ee):  
1
H NMR (300 
MHz, CDCl3) δ 7.24 (d, J = 8.6 Hz, 2H), 6.96 (dd, J1 = 15.3 Hz, J2 = 4.7 Hz, 1H), 6.89 (d, J = 
8.6 Hz, 2H), 6.15 (dd, J1 = 15.7 Hz, J2 = 1.8 Hz, 1H), 4.46 (s, 2H), 4.17 (qd, J1= 4.9 Hz, J2 = 1.8 
Hz, 1H), 3.82 (s, 3H), 3.75 (s, 3H), 3.68 (m, 2H), 3.39 (d, J = 3.4 Hz, 1H), 2.97 (d, J = 5.3 Hz, 
1H), 1.87 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 166.8, 159.1, 147.4, 129.6, 129.2, 121.4, 113.7, 
73.6, 72.7, 72.5, 67.4, 55.0, 51.5, 32.5; FTIR (thin film) νmax 3455, 2915, 1723, 1586, 1249 cm
-1; 
HRMS (ESI) calcd for C16H22O6Na [M + Na]
+
: 333.1314, found 333.1287;   2.425 D (c 1.08, 
CHCl3). 
 
OPMB
MeO2C
OH
OH
 
 
(4R,5R,2E)-Methyl-4,5-dihydroxy-7-(4-methoxy-benzyloxy)-heptenoate ((4R,5R-41)).  The 
same procedure used for the preparation of (2R,3S)-27 was followed with commercially 
available AD-mix-β58 (93.0 g), (DHQD)2PHAL (55 mg, 0.67 mmol), methanesulfonamide (4.23 
g, 44.5 mmol), and dienoate 37 (6.15 g, 22.26 mmol) in 1:1 tBuOH/H2O (225 mL).  Flash 
chromatography of the crude product (1:2 hexanes/EtOAc) afforded the title compound as a 
highly viscous, pale yellow syrup (4.33 g, 61%).  The 
1
H and 
13
C NMR spectra matched those of 
(4S,5S)-41 (above); HRMS calcd (EI) for C16H22O6 [M + H]
+
:  310.1416, found 310.1421; 
  50.525 D (c 1.01, CHCl3). 
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MeO2C
OPMB
OMTPA-S
OMTPA-S
 
 
SSSS-42.  The general procedure for Mosher ester derivatization
63
 was followed using the diol 
(2S,3S)-41 (12.8 mg, 0.040 mmol) and (R)-MTPA (31 μl, 0.162 mmol) in pyridine (1 mL).  The 
crude product was then analyzed without purification:  
1
H NMR (300 MHz, CDCl3) δ 7.42 (m, 
10H), 7.24 (d, J = 6.7 Hz, 2H), 6.89 (d, J1 = 6.7 Hz, 2H), 6.74 (dd, J2 = 15.8 Hz, J = 5.0 Hz, 1H), 
5.81 (ddd, J1 = 4.8 Hz, J2 = 3.0 Hz, J3 = 1.6 Hz, 1H), 5.77 (dd, J1 = 15.9 Hz, J2 = 1.6 Hz, 1H), 
5.55 (ddd, J1 = 8.0 Hz, J2 = 5.2 Hz, J3 = 3.1 Hz, 1H), 4.34 (d, J = 3.4 Hz, 2H), 3.81 (s, 3H), 3.72 
(s, 3H), 3.49 (s, 3H), 3.44 (s, 3H), 3.38 (m, 1H), 3.25 (m, 1H), 1.84 (m, 2H); 
19
F NMR (282 
MHz, CDCl3) δ 71.7 (s, 3F), 71.9 (s, 3F).  The minor peaks in the 
19
F NMR spectrum of SSSS-
42 matched the major peaks of SSRR-42 (below). 
 
MeO2C
OPMB
OMTPA-R
OMTPA-R
 
 
SSRR-42.  The general procedure for Mosher ester derivatization
63
 was followed using the diol 
(2S,3S)-41 (21.6 mg, 0.068 mmol) and (S)-MTPA (51 μl, 0.273 mmol) in pyridine (2 mL).  The 
crude product was then analyzed without purification:   
1
H NMR (300 MHz, CDCl3) δ 7.39 (m, 
10H), 7.23 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 6.67 (dd, J1 = 15.8 Hz, J2 = 5.6 Hz, 1H), 
5.80 (dd, J1 = 15.8 Hz, J2 = 1.5 Hz, 1H), 5.74 (ddd, J1 = 7.1 Hz, J2 = 2.6 Hz, J3 = 1.6 Hz, 1H), 
5.49 (td, J1 = 6.6 Hz, J2 = 2.7 Hz, 1H), 4.36 (s, 2H), 3.81 (s, 3H), 3.72 (s 3H), 3.47 (s, 3H), 3.40 
(s, 3H), 3.35 (m, 2H), 1.82 (m, 2H); 
19
F NMR (282 MHz, CDCl3) δ 71.8 (s, 3F), 72.0 (s, 3F).  
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The minor peaks in the 
19
F NMR spectrum of SSRR-49 matched the major peaks of SSSS-49 
(above). 
 
OPMB
MeO2C
OTIPSF5
OTIPSF5
 
 
(4R,5R,2E)-Methyl-4,5-bis(diisopropyl(3,3,4,4,4-pentafluorobutyl)silyloxy)-7-(4-methoxy-
benzyloxy)-hept-2-enoate (RR-42b).   
General Procedure for Fluorous tagging
105
:  
 Freshly distilled CF3SO3H (2.34 mL, 26.36 mmol) was added dropwise by syringe to 
neat, stirring (3,3,4,4,4-pentafluorobutyl)diisopropylsilane (7.41 g, 28.24 mmol) at 0 °C.  The 
turbid, orange reaction mixture was allowed to stir at 0 °C for 15 min, and then at room 
temperature for 45 min.  The reaction mixture was then diluted with CH2Cl2 (25 mL) and the 
resulting solution was transferred by cannula into a separate flask (cooled to 0 °C) containing a 
solution of the (4R,5R)-41 (3.97 g, 12.55 mmol) and 2,6-lutidine (4.37 mL, 37.65 mmol) in 
CH2Cl2 (100 mL).  The reaction mixture was stirred at 0 °C for 15 min, then warmed to room 
temperature.  After 1 h, the reaction was quenched at 0 °C with saturated aqueous NH4Cl (50 
mL).  The mixture was stirred at 0 °C for 15 min, after which the contents of the flask were 
transferred to a separatory funnel.  The layers were separated and the aqueous layer was 
extracted with diethyl ether (3 x 75 mL).  The combined organic layers were washed with water 
(50 mL) and brine (50 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  
Flash chromatography of the crude product (10:1 hexanes/EtOAc) afforded the title compound as 
a pale yellow oil (8.37 g, 86%):  
1
H NMR (300 MHz, CDCl3) δ 7.21 (d, J = 8.42 Hz, 2H), 7.07 
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(dd, J1 = 15.8 Hz, J2 = 4.0 Hz, 1H), 6.86 (d, J = 8.3 Hz, 2H), 6.05 (dd, J1 = 15.7 Hz, J2 = 1.1 Hz, 
1H), 4.44 (m, 1H), 4.38 (d, J = 2.4 Hz, 2H), 4.03 (quintet, J = 3.9 Hz, 1H), 3.81 (s, 3H), 3.75 (s, 
3H), 3.46 (m, 2H), 2.02 (m, 5H), 1.45 (m, 1H), 1.03 (broad s, 28H), 0.86 (m, 4H);   
13
C NMR (75 
MHz, CDCl3) δ 166.4, 159.2, 146.8, 130.5, 129.2, 121.9, 113.7, 74.7, 72.6, 72.5, 65.9, 55.1, 
51.5, 32.3, 27.6, 25.3, 17.5, 17.4, 17.4, 18.5, 17.1, 12.9, 12.8, 12.7, 12.6, 1.1, 0.8; FTIR (thin 
film)  νmax 3389, 2949, 1729, 1199 cm
1; HRMS calcd (EI) for C36H56O6F10Si2Na [M + Na]
+
:  
853.3353, found 853.3400;   1.2725 D (c 1.08, CHCl3). 
 
O
MeO2C
OTIPSF5
OTIPSF5
 
 
(4R,5R,2E)-Methyl-4,5-bis(diisopropyl(3,3,4,4,4-pentafluorobutyl)silyloxy)-7-oxohept-2-
enoate (RR-43)).  The same deprotection conditions used in the preparation of aldehyde 30 were 
used with RR-42b (7.43 g, 9.59 mmol), DDQ
64
 (2.83 g, 12.5 mmol), and 18:1 CH2Cl2/H2O (100 
mL).  The crude product was taken to the next step without further purification as a mixture of 
the free alcohol and anisaldehyde byproduct. 
 This mixture was then subjected to the general procedure for Swern oxidation
59
 was 
followed with DMSO (2.04 mL, 28.77 mmol), oxalyl chloride (1.65 mL, 19.18 mmol), NEt3 
(6.68 mL, 47.95 mmol).  Flash chromatography of the crude product gave the title compound as 
a pale yellow oil (5.56 g, 82%): 
1
H NMR (300 MHz, CDCl3) δ 9.78 (s, 1H), 7.06 (dd, J1 = 15.6 
Hz, J2 = 3.5 Hz, 1H), 6.09 (d, J = 15.8 Hz, 1H), 4.49 (m, 2H), 3.78 (s, 3H), 2.72 (dd, J1 = 16.8 
Hz, J2 = 2.9 Hz, 1H), 2.45 (dd, J1 = 17.1 Hz, J2 = 6.4 Hz, 1H), 2.02 (m, 4H), 1.04 (broad s, 28H), 
0.86 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ 192.3, 166.1, 145.6, 122.8, 74.0, 70.3, 51.5, 46.4; 
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FTIR (thin film)  νmax  3376, 2359, 2339, 1728, 1199 cm
 1; HRMS calcd (ESI) for 
C28H46O5Si2F10Na [M + Na]
+
:  731.2622, found 731.2675;   5.4725 D (c 1.16, CHCl3). 
 
MeO2C
OTIPSF5
O OH
TIPSF5
 
 
(4R,5R,7R,2E)-Methyl-4,5-bis(diisopropyl(3,3,4,4,4-pentafluorobutyl)silyloxy)-7-hydroxy-
deca-2,9-dienoate (RRR-44).  The same procedure employed in the preparation of 31c was 
followed using commercially available (+)-Ipc2B(allyl) (4.35 mL, 4.35 mmol, 1.0 M in pentane) 
and aldehyde RR-43 (2.57 g, 3.63 mmol) in Et2O (45 mL).  
1
H NMR analysis of the crude 
product indicated an approximately 4:1 mixture of diastereomers.  Flash chromatography of the 
crude product (10:1 hexanes/EtOAc) afforded the title compound as a single diastereomer 
(colorless oil), with minor impurities (1.91 g, 73%).  The compound was taken to the next step 
for fuller characterization.  Selected 
1
H NMR data (300 MHz, CDCl3) δ 7.08 (dd, J1 = 15.8 Hz, 
J2 = 4.3 Hz, 1H), 6.07 (dd, J1 = 15.8 Hz, J2 = 1.7 Hz, 1H), 5.76 (m, 1H), 5.12 (dd, J1 = 18.3 Hz, 
J2 = 10.7 Hz, 4.50 (td, J1 = 4.4 Hz, J2 = 1.8 Hz, 1H), 4.13 (m, 1H), 3.77 (s, 3H). 
 
MeO2C
OTIPSF5
O OH
TIPSF5
 
 
(4R,5R,7S,2E)-Methyl-4,5-bis(diisopropyl(3,3,4,4,4-pentafluorobutyl)silyloxy)-7-hydroxy-
deca-2,9-dienoate (RRS-44).  The in situ preparation of the Brown reagent was followed 
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according to the literature precedent.
79
  A solution of commercially available ()-DIP-Cl (2.15 g, 
6.71 mmol) in Et2O (20 mL) was treated with allyl magnesium bromide (5.50 mL, 5.50 mmol, 
1.0 M in Et2O) at 78 °C.  The reaction was warmed to 0 °C and stirred at this temperature for 1 
h.  The stirring was turned off to allow the magnesium mixed halide salt to settle to the bottom of 
the flask.  The supernatant fluid was transferred dropwise by cannula to a solution of the 
aldehyde RR-43 (2.93 g, 4.14 mmol) in Et2O (40 mL) at 78 °C.  The reaction was stirred at this 
temperature for 3 h and quenched by addition of 1:2:1 pH 7 buffer/methanol/30% aq. H2O2 (160 
mL).  The mixture was stirred for 20 h at room temperature, diluted with Et2O (150 mL) and 
transferred to a separatory funnel.   The layers were separated and the aqueous layer was 
extracted with Et2O (3 x 125 mL).  The combined organic extracts were washed with water (75 
mL), saturated aqueous NaHCO3 (75 mL), then again with water (75 mL), and brine (75 mL).  
The organic solution was then dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  
1
H NMR analysis of the crude product indicated an approximately 4:1 mixture of 
diastereomers.  Flash chromatography of the crude product (10:1 hexanes/EtOAc) afforded the 
title compound as a single diastereomer (colorless oil), with minor impurities (2.23 g, 77%).  The 
compound was taken to the next step for fuller characterization.  Selected 
1
H NMR data (300 
MHz, CDCl3) δ 7.11 (dd, J1 = 15.7 Hz, J2 = 3.8 Hz, 1H), 6.09 (dd, J1 =15.8 Hz, J2 = 1.8 Hz, 1H), 
5.77 (m, 1H), 5.14 (dd, J1 = 18.4 Hz, J2 = 10.0 Hz, 2H), 4.50 (m, 1H), 4.16 (m, 1H), 3.77 (s, 3H), 
3.73 (m, 1H), 1.07 (broad s, 28H). 
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MeO2C
OTIPSF5
O OTIPSF5
TIPSF5
 
 
(4R,5R,7R,2E)-Methyl-4,5,7-tris(diisopropyl(3,3,4,4,4-pentafluorobutyl)silyloxy)deca-2,9-
dienoate (RRR-45d).  The same procedure employed in the preparation of 31c was followed 
using commercially available (+)-Ipc2B(allyl) (1.0 M solution in pentane, 6.83 mL, 6.83 mmol) 
and aldehyde RR-43 (3.87 g, 5.46 mmol) in Et2O (55 mL) at 78 °C.  
1
H NMR of the crude 
product indicated a 4:1 mixture of diastereomers, along with 3-pinanol byproduct.  Flash 
chromatography of the crude product (10:1 hexanes/EtOAc) gave a mixture of the major alcohol 
along with 3-pinanol, which was then taken to the next protection step without further 
purification. 
 The general procedure for fluorous tagging
105
 was then followed using 
diisopropyl(3,3,4,4,4-pentafluorobutyl)silane (3.29 g, 12.56 mmol), CF3SO3H (1.02 mL, 11.47 
mmol), and 2,6-lutidine (1.90 mL, 16.38 mmol) in CH2Cl2 (50 mL).  Flash chromatography of 
the crude product (40:1 hexanes/EtOAc) afforded the title compound as a colorless oil (2.69 g, 
49% over two steps):  
1
H NMR (300 MHz, CDCl3) δ 7.05 (dd, J1 = 15.8 Hz, J2 = 4.4 Hz, 1H), 
6.04 (dd, J1 = 15.8 Hz, J2 = 1.6 Hz, 1H), 5.83 (ddt, J1 = 17.1 Hz, J2 = 10.6 Hz, J3 = 7.3 Hz, 1H), 
5.06 (dd, J1 = 17.7 Hz, J2 = 10.2 Hz, 2H), 4.44 (ddd, J1 = 5.9 Hz, J2 = 4.4 Hz, J3 = 1.7 Hz, 1H), 
3.99 (ddt, J1 = 10.1 Hz, J2 = 5.8 Hz, J3 = 4.2 Hz, 1H), 3.90 (J = 9.4 Hz, J = 3.2 Hz, 1H), 3.75 (s, 
3H), 2.34 (m, 1H), 2.07 (m, 6H), 1.84 (ddd, J1 = 13.7 Hz, J2 = 9.6 Hz, J3 = 3.0 Hz, 1H), 1.47 
(ddd, J1 = 13.9 Hz, J2 = 9.1 Hz, J3 = 4.2 Hz, 1H), 1.05 (broad s, 42H), 0.85 (m, 6H); 
13
C NMR 
(75 MHz, CDCl3) δ 166.1, 146.3, 134.0, 120.8, 117.0, 74.3, 73.1, 69.1, 51.6, 40.9, 39.3, 25.3, 
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17.5, 13.0, 12.9, 12.9, 12.8, 12.6, 1.5, 0.9, 0.8; FTIR (thin film) νmax  3343, 2949, 2870, 1731, 
1197 cm1;   2.3025 D (c 1.12, CHCl3). 
 
MeO2C
OTIPSF5
O OTIPSF5
TIPSF5
 
 
(4R,5R,7S)-Methyl-4,5,7-tris-(diiso-propyl-(3,3,4,4,4-penta-fluoro-butyl)-silyloxy)-deca-2,9-
dienoate (RRS-46d).  The general procedure for fluorous tagging
105
 was employed using the 
alcohol RRS-44 (2.38 g, 3.170 mmol), (3,3,4,4,4-pentafluorobutyl)diisopropylsilane (1.83 g, 
6.980 mmol), trifluoromethanesulfonic acid (0.46 mL, 5.160 mmol), 2,6-lutidine (1.10 mL, 
9.520 mmol) in CH2Cl2 (32.0 mL).  Flash chromatography of the crude product (40:1 
hexanes/EtOAc) afforded the title compound as a colorless oil (2.68 g, 84%):  
1
H NMR (300 
MHz, CDCl3) δ 7.08 (dd, J1 = 15.8 Hz, J2 = 4.3 Hz, 1H), 6.07 (dd, J1 = 15.8 Hz, J2 = 1.7 Hz, 
1H), 5.82 (m, 1H), 5.07 (ddd, J1 = 17.1 Hz, J2 = 10.2 Hz J3 = 3.5 Hz, 2H), 4.46 (td, J1 = 4.2 Hz, 
J2 = 1.6 Hz, 1H), 4.06 (m, 1H), 4.00 (m, 1H), 3.78 (s, 3H), 2.32 (m, 2H), 2.05 (m, 6H), 1.73 (m, 
1H), 1.59 (m, 1H), 1.04 (broad s, 42H), 0.89 (m, 4H), 0.81 (m, 2H); 
13
C NMR (75 MHz, CDCl3) 
δ 166.1, 146.5, 133.9, 122.3, 117.8, 76.1, 72.7, 68.9, 51.6, 41.5, 41.2, 25.7, 25.6, 25.4, 25.3, 25.2, 
25.1, 25.0, 24.9, 17.7, 17.6, 17.5, 13.0, 12.9, 12.8, 12.6, 12.5, 1.1, 0.8; 
19
F NMR (282 MHz, 
CDCl3) 85.12 (s, 3F), 85.15 (s, 3F), 85.17 (s, 3F), 120.48 (t, 
3
JHF = 17.7 Hz, 2F), 120.58 
(t, 
3
JHF = 17.5 Hz, 4F); FTIR (thin film) νmax  2949, 2870, 1731, 1464, 1440, 1196, 885 cm
 1; 
HRMS calcd (ESI, positive mode) for C41H69O5F15Si3Na [M + Na]
+
:  1,033.4111, found 
1,033.4192;   8.1025 D  (c 1.09, CHCl3). 
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O  
 
(R)-2-(But-3-enyl)oxirane ((R)-17).
52
  CAS registry number: [137688-20-1].  A 100-mL round 
bottom flask was charged with (R,R)-()-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminocobalt(II) catalyst (289 mg, 0.479 mmol), followed by racemic 1,2-epoxy-5-
hexene (10.8 mL, 95.73 mmol) and acetic acid (110 μL).  The resultant red suspension was then 
cooled to 0 °C and deionized water (0.95 mL) was slowly added over 5 min.  The reaction 
mixture was stirred at 0 °C for 3 h, then at room temperature for 20 h.  The mixture was 
concentrated by rotary evaporation and the crude product was purified by Kügelrohr distillation 
(60 °C, 40 torr) to afford the title compound as a colorless liquid (4.68 g, 49%):  
1
H NMR (300 
MHz, CDCl3) δ 5.86 (ddt, J1 = 16.9 Hz, J2 = 10.2 Hz, J3 = 6.7 Hz, 1H), 5.05 (ddd, J1 = 17.1 Hz, 
J2 = 10.2 Hz, J3 = 1.6 Hz, 2H), 2.95 (m, 1H), 2.77 (dd, J1 = 4.9 Hz, J2 = 4.2 Hz, 1H), 2.50 (dd, J1 
= 5.0 Hz, J2 = 2.7 Hz, 1H), 2.24 (m, 2H).   
 
O  
 
(S)-2-(But-3-enyl)oxirane ((S)-17).
52
  CAS registry number: [137688-21-2].  The literature 
procedure for (R)-17 was followed using 1,2-epoxy-5-hexene (11.00 mL, 97.50 mmol), acetic 
acid (120 μL, 2.10 mmol), THF (1.00 mL), and (S,S)-(+)-N,N′-bis(3,5-di-tert-butylsalicylidene)-
1,2-cyclohexanediaminocobalt(II) (319 mg, 0.528 mmol).  Kügelrohr distillation of the crude 
product (60 °C, 25 torr) gave the title compound as a colorless liquid (2.01 g, 21%).  The 
1
H 
NMR spectrum matched that of (R)-17. 
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C5H11
OH  
 
(5S)-Dec-1-en-5-ol ((S)-18).
53
  A solution of butyllithium (1.6 M in hexanes, 34.2 mL, 54.7 
mmol) was added dropwise to a stirred suspension of CuCN (269 g, 30.0 mmol) in THF (80 mL) 
at 78 °C.  The reaction mixture was warmed to 20 °C and the epoxide (R)-17 (3.57 g, 36.4 
mmol) in THF (35 mL) was slowly added by cannula.  The original flask containing the epoxide 
was then washed with THF (10 mL) and the rinse was also added to the reaction mixture by 
cannula at 20 °C.  The resultant yellow suspension was stirred for 3 h at room temperature.  
The reaction was quenched by addition of 90:10 saturated aqueous NH4Cl/ NH4OH at 0°C and 
the mixture was stirred for 1 h at room temperature.  The quenched mixture was then filtered 
through a Büchner funnel and the filtrate was transferred to a separatory funnel.  The layers were 
separated and the aqueous layer was extracted with Et2O (3 x 100 mL).  The combined organic 
extracts were washed with water (75 mL) and brine (75 mL), dried with MgSO4, filtered, and 
concentrated by rotary evaporation.  Flash chromatography of the crude product (1:1 pentanes/ 
Et2O) gave the title compound as a colorless liquid (5.12 g, 90%):  
1
H NMR (300 MHz, CDCl3) 
δ 5.85 (ddt, J1 = 17.0 Hz, J2 = 10.2 Hz, J3 = 6.7 Hz, 1H), 5.02 (dd, J1 = 17.0 Hz, J2 = 10.2 Hz, 
2H), 3.63 (m, 1H), 2.18 (m, 2H), 1.57 (m, 2H), 1.42 (m, 4H), 1.32 (broad s, 4H), 0.90 (t, J = 6.6 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 138.7, 114.7, 71.6, 37.5, 36.5, 31.9, 30.1, 25.3, 22.7, 
14.1; FTIR (thin film) νmax 3350, 2929, 2858 cm
1; HRMS calcd (EI) for C10H20O [M]
+
:  
156.1514, found 156.1510;   0.1625 D  (c 1.01, CHCl3). 
 
 
 95 
C5H11
OH  
 
(5R)-Dec-1-en-5-ol ((R)-18).  The literature precedent
53
 for (S)-18 (above) was followed using 
the epoxide (S)-17 (1.73 g, 17.63 mmol), CuCN (2.32 g, 25.92 mmol), and a solution of 
butyllithium (1.6 M in pentane, 29.42 mL, 47.07 mmol) in THF (75 mL).  Flash chromatography 
(1:1 pentane/ Et2O) of the crude product gave the title compound as a colorless liquid (1.76 g, 
64%).  The 
1
H and 
13
C NMR match those of (S)-18 (see above); HRMS calcd (EI) for C10H20O 
[M]
+
:  156.1514, found 156.1512;   6.1725 D  (c 1.17, CHCl3). 
 
C5H11
OMTPA-R  
 
SR-47.  The general procedure for Mosher ester derivatization
63
 was followed using the alcohol 
(S)-18 (12.8 mg, 0.078 mmol) and (S)-MTPA-Cl (29 μl, 0.155 mmol) in pyridine (3 mL).  The 
crude product was then analyzed without purification:   
1
H NMR (300 MHz, CDCl3) δ 7.56 (m, 
2H), 7.41 (m, 3H), 5.74 (ddt, J1 = 16.4 Hz, J2 = 9.7 Hz, J3 = 6.6 Hz, 1H), 5.12 (m, 1H), 4.96 (m, 
2H), 3.57 (s, 3H), 1.95 (m, 2H), 1.66 (m, 4H), 1.31 (m, 6H), 0.89 (t, J = 6.6 Hz, 3H); 
19
F NMR 
(300 MHz, CDCl3) δ 71.8 (s, 3F).  No minor peaks were observed in the 
19
F NMR spectrum of 
SR-47. 
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C5H11
OMTPA-R  
 
RR-47.  The general procedure for Mosher ester derivatization
63
 was followed using the diol (R)-
18 (11.6 mg, 0.074 mmol) and (S)-MTPA-Cl (28 μl, 0.149 mmol) in pyridine (2 mL).  The crude 
product was then analyzed without purification:   
1
H NMR (300 MHz, CDCl3) δ 7.57 (m, 2H), 
7.41 (m, 3H), 5.81 (ddt, J1 = 16.9 Hz, J2 = 10.2 Hz, J3 = 6.6 Hz, 1H), 5.12 (m, 1H), 5.02 (m, 2H), 
3.57 (s, 3H), 2.09 (m, 2H), 1.75 (m, 2H), 1.59 (m, 2H), 1.22 (m, 6H), 0.85 (t, J = 6.8 Hz, 3H); 
19
F NMR (300 MHz, CDCl3) δ 71.6 (s, 3F).  No minor peaks were observed in the 
19
F NMR 
spectrum of RR-47. 
 
HO2C
OTIPSF5
O OTIPSF5
TIPSF5
 
 
(4R,5R,7R)-4,5,7-Tris-(di-isopropyl-(3,3,4,4,4-penta-fluoro-butyl)-silyloxy)-deca-2,9-dienoic 
acid (48).  Potassium trimethylsilanolate
82
 (90%, 3.67 g, 25.8 mmol) was added in one portion to 
a solution of the methyl ester RRR-45d (2.61 g, 2.58 mmol) in Et2O (26 mL) at 0 °C.  The 
reaction mixture was stirred at 0 °C for 15 min then at room temperature for 16 h.  The reaction 
was quenched by addition of 0.5 M citric acid (25 mL) at 0 °C.  After 10 minutes, the quenched 
mixture was transferred to a separatory funnel and the layers were separated.  The aqueous layer 
was extracted with Et2O (3 x 40 mL).  The combined organic extracts were washed with water 
(30 mL and brine (30 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  
Flash chromatography of the crude product (10:1 hexanes/EtOAc) gave the title compound as a 
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colorless, viscous oil (2.23 g, 87%):  
1
H NMR (300 MHz, CDCl3) δ 7.18 (dd, J1 = 15.7 Hz, J2 = 
4.3 Hz, 1H), 6.05 (dd, J1 = 15.8 Hz, J2 = 1.4 Hz, 1H), 5.83 (ddt, J1 = 17.0 Hz, J2 = 10.0 Hz, J3 = 
6.8 Hz, 1H), 5.07 (dd, J1 = 10.1 Hz, J2 = 17.7 Hz, 2H), 4.48 (td, J1 = 4.3 Hz, J2 = 1.6 Hz, 1H), 
4.01 (m, 1H), 3.93 (m, 1H), 2.35 (m, 1H), 2.08 (m, 7H), 1.86 (ddd, J1 = 13.6 Hz, J2 = 9.6 Hz, J3 
= 2.9 Hz, 1H), 1.48 (ddd, J1 = 13.8 Hz, J2 = 9.7 Hz, J3 = 4.2 Hz, 1H), 1.06 (broad s, 42H), 1.02 
(broad s, 6H); 
13
C NMR (75 MHz, CDCl3) δ 171.1, 149.0, 134.0, 121.9, 117.7, 74.3, 73.1, 69.1, 
40.9, 39.4, 25.3, 17.5, 13.0, 12.9, 12.9, 12.8, 12.6, 1.5, 0.8; FTIR (thin film) νmax  29.48, 2870, 
1702, 1198, 759 cm1; HRMS calcd (ESI) for C40H67O5F15Si3Na [M + Na]
+
:  1019.3955, found 
1019.3895;   8.3325 D  (c 0.93, CHCl3). 
 
O
O
C5H11
OTIPSF5
OTIPSF5
OTIPSF5  
 
(4R,5R,7R,2E)-((R)-Dec-1-en-5-yl)-4,5,7-tris-(di-isopropyl-(3,3,4,4,4-pentafluorobutyl)-silyl-
oxy)-deca-2,9-dienoate (49).
82
  Triethylamine (0.59 mL, 4.26 mmol) was added to a solution of 
the acid 48 (2.13 g, 2.13 mmol) in toluene (21.0 mL) at room temperature.  2,4,6-
trichlorobenzoyl chloride (0.35 mL, 2.24 mmol) was then added by syringe and the resulting 
white slurry was stirred at room temperature for 1 h.  A solution of the alcohol (R)-18 (401 mg, 
2.56 mmol) and DMAP (678 mg, 5.55 mmol) in toluene (3 mL) was then slowly added to the 
reaction mixture by cannula transfer.  The milky emulsion was stirred at room temperature for 3 
h.  Toluene (50 mL) and saturated aqueous NaHCO3 (50 mL) were added and the emulsion 
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became a clear bilayer.  The layers were separated and the aqueous layer was extracted with 
Et2O (3 x 75 mL).  The combined organic extracts were washed with water (50 mL) and brine 
(50 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash 
chromatography of the crude product (40:1 hexanes/EtOAc) gave the title compound as a pale 
yellow oil (2.31 g, 95%):  
1
H NMR (500 MHz, CDCl3) δ 7.03 (dd, J1 = 15.7 Hz, J2 = 4.7 Hz, 
1H), 6.01 (dd, J1 = 15.8 Hz, J2 = 1.6 Hz, 1H), 5.83 (m, 2H), 5.00 (m, 5H), 4.43 (td, J1 = 4.6 Hz, 
J2 = 1.6 Hz, 1H), 3.99 (sextet, J = 4.5 Hz, 1H), 3.92 (dt, J1 = 3.6 Hz, J2 = 7.7 Hz, 1H), 2.34 (m, 
1H), 2.16 (quintet, J = 6.8 Hz, 1H), 2.05 (m, 6H), 1.87 (ddd, J1 = 12.7 Hz, J2 = 9.3 Hz, J3 = 3.3 
Hz, 1H), 1.67 (m, 2H), 1.50 (ddd, J1 = 13.9 Hz, J2 = 9.4 Hz, J3 = 4.4 Hz, 1H), 1.29 (broad s, 6H), 
1.09 (broad s, 46H), 0.87 (broad s, 7H), 0.79 (m, 2H); 
13
C NMR (125 MHz, CDCl3) δ 165.4, 
145.8, 137.9, 133.9, 123.1, 117.7, 114.8, 74.3, 74.0, 73.2, 69.2, 41.0, 39.3, 34.1, 33.3, 31.7, 29.6, 
25.3, 24.9, 25.3, 22.5, 17.6, 17.5, 13.9, 12.9, 12.9, 12.7, 1.6, 0.8; HRMS calcd (ESI) for 
C50H85O5Si3F15Na [M + Na]
+
:  1157.5363, found 1157.5317;   8.2525 D  (c 1.17, CHCl3). 
 
O
O
OTIPSF5
OTIPSF5
OTIPSF5
C5H11
 
 
(2E,4R,5R,7R,10E,13R,)-4,5,7-Tris-(di-isopropyl-(3,3,4,4,4-penta-fluoro-butyl)-silyloxy)-14-
pentyl-oxacyclotetradeca-3,10-dien-2-one (51).
85
  Grubbs 2
nd
 generation catalyst (41 mg, 48.3 
μmol) was added in portion to a stirring solution of the ester 49 (550 mg, 0.484 mmol) in CH2Cl2 
(240 mL, degassed).  The reaction flask was fitted with a reflux condenser, heated to a steady 
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reflux (50 °C, external bath temperature), and stirred for 1 day.  The reaction mixture was cooled 
to room temperature and an additional loading of the catalyst (42 mg, 49.8 μmol) was added in 
one portion.  The reaction mixture was heated again to reflux (50 °C, external bath temperature) 
and stirred for an additional 24 h.  The reaction mixture was again cooled to room temperature 
and concentrated by rotary evaporation.  Flash chromatography of the crude product gave the 
title compound as a highly viscous, colorless oil (410 mg, 5:1 E:Z, 76%).  The compound was 
taken to the next step for fuller characterization.  Selected 
1
H NMR spectral data (500 MHz, 
CDCl3) δ 6.88 (dd, J1 = 16.0 Hz, J2 = 5.0 Hz, 1H), 5.91 (dd, J1 = 16.0 Hz, J2 = 3.5 Hz, 1H), 5.38 
(dt, J1 = 15.0 Hz, J2 = 6.5 Hz, 1H), 5.29 (dt, J1 = 15.0 Hz, J2 = 7.0 Hz, 1H).     
 
O
O
OTIPSF5
OTIPSF5
OTIPSF5
C5H11
 
 
(5R,6R,8R,14R,E)-5,6,8-Tris-(di-isopropyl-(3,3,4,4,4-pentafluoro-butyl)-silyloxy)-14-pentyl-
oxacyclotetradec-3-en-2-one (52).
55
  A 25-mL flask was charged with the diene 51 (193 mg, 
0.174 mmol) in ethanol (8.72 mL), treated with Pd/SrCO3 (927 mg, 0.172 mmol).  The flask was 
fitted with a three-junction vacuum adaptor, connected to a vacuum line and a balloon full of 
hydrogen gas.  The flask was purged of air through the vacuum line and the flask was entrained 
with hydrogen gas.  This “vac-fill” cycle was repeated three times to completely purge the flask 
with dihydrogen.  The reaction mixture was stirred for exactly 80 min, at which point the 
vacuum adaptor/balloon assembly was removed and the catalyst was filtered.  The supernatant 
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liquid was concentrated by rotary evaporation.  Flash chromatography of the crude product (40:1 
hexanes/EtOAc) gave the title compound as a viscous, colorless oil (140 mg, 75%): 
1
H NMR 
(500 MHz, CDCl3) δ 6.82 (dd, J1 = 15.9 Hz, J2 = 6.4 Hz, 1H), 5.96 (dd, J1 = 15.9 Hz, J2 = 1.2 
Hz, 1H), 5.00 (m, 1H), 4.45 (dt, J1 = 5.9 Hz, J2 = 1.1 Hz, 1H), 4.13 (q, J = 5.3 Hz, 1H), 4.04 
(quintet, J = 6.2 Hz, 1H), 2.05 (m, 8H), 1.78 (t, J = 6.0 Hz, 2H), 1.70 (m, 1H), 1.64 (m, 1H), 1.55 
(m, 4H), 1.42 (m, 2H), 1.30 (broad s, 6H), 1.23 (m, 2H), 1.05 (broad s, 42H), 0.89 (m, 7H), 0.82 
(m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 165.6, 146.4, 123.9, 76.7, 73.4, 70.5, 41.9, 37.3, 34.1, 
31.7, 31.2, 28.2, 25.3, 25.1, 24.5, 24.2, 22.5, 17.9, 17.8, 17.8, 17.7, 17.6, 17.5, 17.5, 17.4, 14.1, 
13.3, 13.1, 12.7, 12.6, 12.5, 12.4, 1.5, 0.8, 0.7; FTIR (thin film) νmax (thin film, cm
-1
) 2943, 2868, 
1721, 1198 cm1;   5.4825 D  (c 0.79, CHCl3). 
 
O
O
OH
OH
OH
C5H11
 
 
(4R,5R,7R,13R)-4,5,7-Tri-hydroxy-13-pentyl-oxa-cyclotetradecenone ((4R,5R,7R,13R)-5).
87
  
Tetrabutylammonium fluoride (0.60 mL, 0.60 mmol, 6 equiv) was added dropwise to a solution 
of the macrolactone 52 (111 mg, 0.10 mmol) in THF (2.0 mL) at 0 °C.  The reaction mixture was 
stirred at 0 °C for 5 min, and then warmed to room temperature.  After stirring at room 
temperature for 4 h, the reaction was quenched by addition of sat. aq. NH4Cl (3.0 mL) at 0 °C.  
After stirring at 0 °C for 15 minutes, the white suspension was diluted with water (1.0 mL) and 
ether (3.0 mL) and transferred to a separatory funnel.  The aqueous layer was separated and 
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extracted with ether (3 x 10 mL).  The combined organic extracts were then washed with brine, 
dried over MgSO4, filtered, and concentrated in vacuo.  Flash chromatography (3:1 
hexanes/EtOAc, then 100% EtOAc) of the crude product gave the title compound as an 
amorphous white solid (24.8 mg, 79%):  
1
H NMR (700 MHz, CD3OD) 6.91 (dd, J1 = 15.8 Hz, 
J2 = 6.4 Hz, 1H), 6.11 (d, J = 15.8 Hz, 1H), 5.03 (m, 1H), 4.16 (t, J = 6.0 Hz, 1H), 3.82 (ddd, J1 
= 9.2 Hz, J2 = 6.0 Hz, J3 = 3.8 Hz, 1H), 3.79 (m, 1H), 1.78 (m, 1H), 1.63 (m, 2H), 1.56 (m, 1H), 
1.45 (m, 4H) 1.39 (m, 2H), 1.33 (m, 7H), 1.18 (m, 2H), 1.11 (m, 1H) 0.90 (t, J = 6.9 Hz, 3H); 
13
C NMR (125 MHz, CD3OD) 168.2, 148.4, 124.3, 77.6, 77.5, 73.4, 67.6, 42.0, 37.0, 36.0, 
34.5, 32.9, 30.1, 26.6, 26.5, 25.2, 23.8, 14.5 FTIR (thin film)  νmax  3384, 2927, 2858, 1716, 
1650, 1267 cm1; HRMS calcd (EI) for C18H33O5 [M + H]
+
:  329.2338, found 329.2328; 
  8.2425 D  (c 1.25, MeOH). 
6.2 EXPERIMENTAL DATA FOR THE FMS OF THE 4,5-TRANS-DIHYDROXY 
FAMILY OF SCH725674 
OPMB
MeO2C
OTIPS
OTIPS
 
 
(4S,5S,E)-Methyl-7-(4-methoxy-benzyloxy)-4,5-bis(triisopropyl-silyloxy)hept-2-enoate (SS-
42a).  TIPSOTf (10.2 mL, 37.71 mmol) was added dropwise to a solution of the diol (4S,5S)-41 
(4.77 g, 15.08 mmol) and 2,6-lutidine (5.25 mL, 45.25 mmol) in CH2Cl2 (150 mL) at 0 °C.  The 
reaction mixture was stirred at 0 °C for 15 min, then at room temperature for 4 h.  The reaction 
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was quenched by addition of saturated aqueous NH4Cl (60 mL).  The layers were separated and 
the aqueous layer was extracted with ether (3 x 175 mL).  The combined organic extracts were 
washed with water (50 mL) and brine (50 mL), dried over MgSO4, filtered, and concentrated by 
rotary evaporation.  Flash chromatography of the crude product (10:1 hexanes/EtOAc) gave the 
title compound as a colorless oil (9.68 g, 100%):  
1
H NMR (300 MHz, CDCl3) δ 7.23 (d, J = 8.8 
Hz, 2H), 7.19 (dd, J1 = 15.6 Hz, J2 = 3.4 Hz, 1H), 6.86 (d, J = 8.7 Hz, 2H), 6.14 (dd, J1 = 15.7 
Hz, J2 = 1.9 Hz, 1H), 4.59 (ddd, J1 = 5.1 Hz, J2 = 3.4 Hz, J3 = 2.0 Hz, 1H), 4.391 (s, 2H), 4.12 
(dt, J1 = 8.1 Hz, J2 = 4.4 Hz, 1H), 3.81 (s, 3H), 3.75 (s, 3H), 3.53 (m, 2H), 2.00 (tdd, J1 = 11.8 
Hz, J2 = 8.0 Hz, J3 = 3.9 Hz, 1H), 1.50 (m, 1H), 1.06 (broad s, 42H); 
13
C NMR (75 MHz, CDCl3) 
δ 166.8, 159.0, 148.2, 130.7, 129.0, 121.1, 113.5, 74.7, 72.3, 66.6, 55.1, 51.3, 32.4, 18.1, 18.0, 
12.6, 12.3; FTIR (thin film)  νmax 3398, 2944, 2867, 1464, 1110 cm
1; HRMS calcd (ESI) for 
C34H62O6Si2Na [M + Na]
+
:  645.3983, found 645.4012;   1.3725 D (c 0.98, CHCl3). 
 
MeO2C
O
OTIPS
OTIPS
MeO2C
O
OTIPSF5
OTIPSF5
+
 
 
(4S,5S,E)-Methyl-7-oxo-4,5-bis(triisopropylsilyloxy)hept-2-enoate, (4R,5R,E)-Methyl-7-oxo-
4,5-bis(1,1,1,2,2-pentafluorobutyldiisopropylsilyloxy)hept-2-enoate (M-53ab).  DDQ
64
 (857 
mg, 3.776 mmol) was added in portion to a solution of M-42ab (2.03 g, 2.904 mmol) in 19:1 
CH2Cl2/H2O (29 mL) at 0 °C.  The green reaction mixture was then stirred at room temperature 
for 3 h, at which time a brown suspension had formed.  The reaction was quenched by addition 
saturated aqueous NaHCO3 (20 mL) which caused a thick dark emulsion to form.  The contents 
of the reaction flask were transferred to a separatory funnel where the emulsion was broken by 
 103 
the addition of chloroform (15 mL).  The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (3 x 40 mL).  The combined organic extracts were washed with water (15 
mL), brine (15 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  The 
crude product was taken to the next oxidation step and used without further purification. 
The general procedure for Swern oxidation
59
 was then employed using the crude alcohol, 
DMSO (0.62 mL, 8.712 mmol), oxalyl chloride (0.50 mL, 5.808 mmol), NEt3 (2.02 mL, 14.52 
mmol) in CH2Cl2 (30 mL).  Flash chromatography of the crude product (10:1 hexanes/EtOAc) 
afforded the title compound as a pale yellow oil (1.06 g, 61% based on average molecular 
weight).   
 
MeO2C
OTIPS
O OTIPS
TIPS
MeO2C
OTIPSF5
O OTIPS
TIPSF5
+
 
 
(4S,5S,7R,E)-Methyl-4,5,7-tris(triisopropylsilyloxy)deca-2,9-dienoate, (4R,5R,7R,E)-Methyl 
4,5-(bis-(1,1,1,2,2,-penta-fluoro-butyldi-isopropyl-silyoxy)-7-tri-isopropyl-silyloxy-deca-2,9-
dienoate ((R)-M-54ab).  A solution of (+)-Ipc2B(allyl) (1.15 ml, 1.15 mmol, 1.0 M in pentane) 
was added dropwise by syringe to a solution of the aldehyde mixture M-53ab (532 mg, 0.880 
mmol) in Et2O (9 mL) at 78 °C.  The reaction was stirred at this temperature for 3 h and was 
quenched by addition of 1:2:1 pH 7 buffer/methanol/30% aq. H2O2 (32 mL).  The reaction was 
quenched for 20 h at room temperature, diluted with Et2O (25 mL) and was then transferred to a 
separatory funnel.   The layers were separated and the aqueous layer was extracted with Et2O (3 
x 50 mL).  The combined organic extracts were washed with water (25 mL), saturated aqueous 
NaHCO3 (25 mL), then again with water (25 mL), and brine (25 mL).  The organic solution was 
 104 
then dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash chromatography 
of the crude product (10:1 hexanes/EtOAc) afforded an enriched mixture of quasiisomers as a 
colorless oil.  This mixture was then taken to the next silylation step and used without further 
purification. 
TIPSOTf (0.83 mL, 3.08 mmol) was added dropwise by syringe to a solution of the 
purified homoallyl alcohol mixture and 2,6-lutidine (0.33 mL, 2.86 mmol) in CH2Cl2 (7 mL) at 0 
°C.  The reaction mixture was then stirred for 2 h at room temperature, then quenched by 
addition of saturated aqueous NH4Cl (4 mL).  The layers were separated and the aqueous layer 
was extracted with CH2Cl2 (3 x 10 mL).  The combined organic extracts were then washed with 
water (5 mL), brine (5 ml), dried over MgSO4, filtered, and then concentrated by rotary 
evaporation.  Flash chromatography of the crude product (40:1 hexanes/EtOAc) afforded the title 
mixture as a colorless oil (240 mg, 41% based on average molecular weight).   
 
MeO2C
OTIPS
O OTIPSF5
TIPS
MeO2C
OTIPSF5
O OTIPSF5
TIPSF5
+
 
 
(4S,5S,7S,E)-Methyl-4,5,7-tris(triisopropylsilyloxy)deca-2,9-dienoate, (4R,5R,7S,E)-Methyl 
4,5-(tris(1,1,1,2,2,-pentafluorobutyldiisopropylsilyoxy)-deca-2,9-dienoate ((S)-M-54ab).  A 
solution of ()-Ipc2B(allyl) (1.15 ml, 1.15 mmol, 1.0 M in pentane) was added dropwise by 
syringe to a solution of the aldehyde mixture M-53ab (532 mg, 0.880 mmol) in Et2O (9 mL) at 
78 °C.  The reaction was stirred at this temperature for 3 h and was quenched by addition of 
1:2:1 pH 7 buffer/methanol/30% aq. H2O2 (32 mL).  The reaction was quenched for 20 h at room 
temperature, diluted with Et2O (25 mL) and was then transferred to a separatory funnel.   The 
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layers were separated and the aqueous layer was extracted with Et2O (3 x 50 mL).  The 
combined organic extracts were washed with water (25 mL), saturated aqueous NaHCO3 (25 
mL), then again with water (25 mL), and brine (25 mL).  The organic solution was then dried 
over MgSO4, filtered, and concentrated by rotary evaporation.  After flash chromatography of the 
crude product (10:1 hexanes/EtOAc) the mixture of quasiisomers was taken to the next silylation 
step and used without further purification. 
The general procedure for fluorous tagging was followed
105
 with (3,3,4,4,4-
pentafluorobutyl)diisopropylsilane (807 mg, 3.08 mmol), CF3SO3H (0.25 mL, 2.77 mmol), 2,6-
lutidine (0.34 mL, 2.86 mmol) and the purified homoallyl alcohol mixture and in CH2Cl2 (5 mL).  
Flash chromatography of the crude product (40:1 hexanes/EtOAc) afforded the title mixture as a 
colorless oil (120 mg, 30% based on average molecular weight).   
 
O
MeO2C
OTIPS
OTIPS
 
 
(4S,5S,2E)-Methyl-7-oxo-4,5-bis(triisopropylsilyloxy)hept-2-enoate (SS-43).  The ester SS-
42a (5.83 g, 9.35 mmol) was dissolved in 19:1 CH2Cl2/H2O (100 mL).  The mixture was cooled 
to 0 °C and DDQ
64
 (2.76 g, 12.16 mmol) was added in one portion.  The green suspension was 
stirred at 0 °C for 5 min, then at room temperature for 2 h.  The reaction was quenched by 
addition of saturated aqueous NaHCO3 (40 mL).  The emulsion was broken in the separatory 
funnel by addition of chloroform (50 mL).  The layers were then separated and the aqueous layer 
was extracted with CH2Cl2 (3 x 150 mL).  The combined organic extracts were washed with 
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brine (60 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  The crude 
product was taken to the next step as a mixture of the free alcohol and anisaldehyde. 
 The general procedure for Swern oxidation
59
 was followed using DMSO (2.00 mL, 28.06 
mmol), oxalyl chloride (1.61 mL, 18.71 mmol), NEt3 (6.52 mL, 46.77 mmol).  Flash 
chromatography of the crude product gave the title compound as a pale yellow oil (3.67 g, 78%): 
1
H NMR (300 MHz, CDCl3) δ 9.79 (t, J = 1.2 Hz, 1H), 7.18 (dd, J1 = 15.8 Hz, J2 = 3.6 Hz, 1H), 
6.16 (dd, J1 = 15.6 Hz, J2 = 1.8 Hz, 1H), 4.67 (m, 1H), 6.90 (dd, J1 = 11.4 Hz, J2 = 5.5 Hz), 3.77 
(s, 3H), 2.68 (ddd, J1 = 16.0 Hz, J2 = 5.6 Hz, J3 = 2.2 Hz, 1H), 2.45 (ddd, J1 = 16.1 Hz, J2 = 6.0 
Hz, J3 = 2.2 Hz, 1H), 1.07 (broad s, 42H); 
13
C NMR (75 MHz, CDCl3) δ 200.2, 166.6, 147.1, 
122.2, 74.1, 70.8, 51.6, 46.7, 18.0, 12.3; FTIR (thin film)  νmax  3889, 2946, 2866, 1730, 1464, 
1113 cm1; HRMS calcd (ESI) for C26H52O5Si2Na [M + Na]
+
:  523.3251, found 523.3234; 
  9.5625 D (c 1.01, CHCl3). 
 
MeO2C
OTIPS
O OH
TIPS
 
 
(4S,5S,7R,2E)-Methyl-7-hydroxy-4,5-bis(tri-isopropyl-silyl-oxy)deca-2,9-dienoate (SSR-44).  
The same procedure employed in the preparation of 31c was followed using commercially 
available (+)-Ipc2B(allyl) (5.00 mL, 5.00 mmol, 1.0 M in pentane) and the aldehyde SS-43 (2.26 
g, 4.51 mmol) in Et2O (45 mL) at 78 °C.  
1
H NMR analysis of the crude product indicated an 
approximately 4:1 mixture of diastereomers.  Flash chromatography of the crude product (10:1 
hexanes/EtOAc) afforded the title compound as a single diastereomer (colorless oil), 
contaminated with 3-pinanol (1.45 g, 59%).  The compound was taken to the next step for fuller 
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characterization.  Selected 
1
H NMR data (300 MHz, CDCl3) δ 7.20 (dd, J1 = 15.8 Hz, J2 = 3.7 
Hz, 1H), 6.14 (dd, J1 = 15.8 Hz, J2 = 1.9 Hz, 1H), 5.78 (m, 1H), 5.11 (dd, J1 = 16.0 Hz, J2 = 11.2 
Hz, 2H), 4.64 (m, 1H), 4.21 (m, 1H). 
 
MeO2C
OTIPS
O OH
TIPS
 
 
(4S,5S,7S,2E)-Methyl-7-hydroxy-4,5-bis(triisopropylsilyloxy)deca-2,9-dienoate (SSS-44).  
The same procedure employed in the preparation of 31c was followed using commercially 
available ()-Ipc2B(allyl) (4.72 mL, 4.72 mmol, 1.0 M in pentane) and aldehyde SS-43 (2.15 g, 
4.29 mmol) in Et2O (45 mL).  
1
H NMR analysis of the crude product indicated an approximately 
4:1 mixture of diastereomers.  Flash chromatography of the crude product (10:1 hexanes/EtOAc) 
afforded the title compound as a single diastereomer (colorless oil), with minor impurities (1.51 
g, 67%).  The compound was taken to the next step for fuller characterization.  Selected 
1
H NMR 
data (300 MHz, CDCl3) δ7.18 (dd, J1 = 15.9 Hz, J2 = 3.6 Hz, 1H), 6.14 (dd, J1 = 15.9 Hz, J2 = 
1.8 Hz, 1H), 5.80 (ddt, J1 = 17.4 Hz, J2 = 10.5 Hz, J3 = 6.9 Hz, 1H), 5.10 (dd, J1 = 16.8 Hz, J2 = 
10.8 Hz, 2H), 4.63 (td, J1 = 4.8 Hz, J2 = 2.1 Hz, 1H), 4.25 (m, 1H), 3.91 (m, 1H), 3.77 (s, 3H). 
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MeO2C
OTIPS
O OTIPS
TIPS
 
 
(4S,5S,7R,2E)-Methyl-4,5,7-tris-(tri-isopropyl-silyloxy)-deca-2,9-dienoate (SSR-46a):  The 
same silylation procedure used in the preparation of SS-42a was followed using the homoallylic 
alcohol SSR-44 (1.22 g, 2.250 mmol), TIPSOTf (64 μL, 0.235 mmol), and 2,6-lutidine (0.55 mL, 
0.282 mmol) in CH2Cl2 (25 mL).  Flash chromatography of the crude product (40:1 
hexanes/EtOAc) afforded the title compound as a colorless oil (1.56 g, 99%):  
1
H NMR (300 
MHz, CDCl3) δ 7.21 (dd, J1 = 15.8 Hz, J2 = 3.8 Hz, 1H), 6.15 (dd, J1 = 15.8 Hz, J2 = 1.8 Hz, 
1H), 5.95 (m, 1H), 5.06 (d, J = 13.1 Hz, 2H), 2.30 (m, 1H), 4.17 (m, 1H), 4.08 (m, 1H), 1.082 
(broad s, 42H), 1.05 (broad s, 21H); 
13
C NMR (75 MHz, CDCl3) δ 166.6, 148.5, 135.0, 121.4, 
116.9, 72.6, 67.8, 51.5, 42.0, 40.9, 18.3, 18.2, 18.1, 12.7, 12.6, 12.4; FTIR (thin film)  νmax  2945, 
2893, 2867, 1731, 1463, 1267, 1109, 1062, 883 cm1; HRMS calcd (ESI, positive mode) for 
C38H78O5Si3Na [M + Na]
+
:  721.5055, found 721.5074;   8.2625 D  (c 1.26, CHCl3). 
 
MeO2C
OTIPS
O OTIPSF5
TIPS
 
 
(4S,5S,7S,)-Methyl-7-(diisopropyl(3,3,4,4,4-pentafluorobutyl)silyloxy)-4,5-bis(triisopropyl-
silyloxy)deca-2,9-dienoate (SSS-46b).  The general procedure for fluorous tagging was 
employed
105
 with alcohol SSS-44 (1.40 g, 2.580 mmol), (3,3,4,4,4-
pentafluorobutyl)diisopropylsilane (1.49 g, 5.680 mmol), trifluoromethanesulfonic acid (0.46 
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mL, 5.160 mmol), 2,6-lutidine (0.90 mL, 7.740 mmol) in CH2Cl2 (2.0 mL).  Flash 
chromatography of the crude product (40:1 hexanes/EtOAc) afforded the title compound as a 
colorless oil (1.38 g, 67%):  
1
H NMR (300 MHz, CDCl3) δ 7.20 (dd, J1 = 15.8 Hz, J2 = 3.4 Hz, 
1H), 6.14 (dd, J1 = 15.8 Hz, J2 = 1.8 Hz, 1H), 5.87 (ddt, J1 = 16.7 Hz, J2 = 9.5 Hz, J3 = 7.1 Hz, 
1H), 5.06 (d, J = 14.1 Hz, 2H), 2.31 (m, 1H), 4.01 (m, 2H), 3.75 (s, 3H), 2.39 (m, 1H), 2.06 (m, 
3H), 1.84 (ddd, J1 = 13.4 Hz, J2 = 10.6 Hz, J3 = 2.0 Hz, 1H), 1.51 (m, 1H), 1.10 (broad s, 21H), 
1.07 (broad s, 21H), 1.01 (broad s, 14H), 0.79 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 166.6, 
148.0, 134.8, 121.6, 117.3, 74.2, 73.0, 69.5, 51.4, 40.8, 39.8, 25.7, 25.4, 25.1, 18.2, 18.1, 17.7, 
17.6, 17.5, 13.1, 12.9, 12.5, 0.83; 
19
F NMR (282 MHz, CDCl3) 85.03 (s, 3F), 120.45 (t, 
3
JHF = 
18.0 Hz, 2F); FTIR (thin film) νmax  1069, 2924, 2361, 2340, 1069 cm
1; HRMS calcd (ESI, 
positive mode) for C39H75O5F5Si3Na [M + Na]
+
:  825.4740, found 825.4769;   78.525 D  (c 
1.05, CHCl3). 
 
MeO2C
OTIPSF5
O OTIPS
TIPSF5
 
 
(4R,5R,7S)-Methyl-4,5-bis-(di-iso-propyl-(3,3,4,4,4-penta-fluoro-butyl)-silyloxy)-7-(tri-iso-
propyl-silyloxy)deca-2,9-dienoate (RRR-46c).  The same silylation procedure used in the 
preparation of SS-42a was followed using the homoallylic alcohol RRR)-44 (1.85 g, 2.46 mmol), 
TIPSOTf (1.00 mL, 3.690 mmol), and 2,6-lutidine (0.60 mL, 5.166 mmol) in CH2Cl2 (25 mL).  
Flash chromatography of the crude product (40:1 hexanes/EtOAc) afforded the title compound as 
a colorless oil (1.88 g, 84%):  
1
H NMR (300 MHz, CDCl3) δ 7.07 (dd, J1 = 15.8 Hz, J2 = 4.7 Hz, 
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1H), 6.03 (dd, J1 = 15.8 Hz, J2 = 1.4 Hz, 1H), 5.90 (ddt, J1 = 16.6 Hz, J2 = 11.2 Hz, J3 = 6.9 Hz, 
1H), 5.05 (dd, J1 = 16.8 Hz, J2 = 10.2 Hz, 2H), 4.45 (m, 1H), 4.04 (sextet, J = 4.6 Hz, 1H), 3.94 
(m, 1H), 3.76 (s, 3H), 2.40 (m, 1H), 2.38 (m, 1H), 2.19 (m, 1H), 2.05 (m, 4H), 1.86 (ddd, J1 = 
13.1 Hz, J2 = 9.0 Hz, J3 = 3.6 Hz, 1H), 1.51 (ddd, J1 = 13.9 Hz, J2 = 9.3 Hz, J3 = 4.7 Hz, 1H), 
1.04 (broad s, 49H), 0.87 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ 166.2, 146.9, 134.3, 122.1, 
117.2, 74.3, 73.3, 68.6, 51.6, 41.0, 39.1, 25.3 (m), 18.1, 17.6, 17.5, 17.5, 13.0, 12.7, 12.6, 1.5, 
0.8; 
19
F NMR (282 MHz, CDCl3) δ 85.03 (s, 3F), 85.08 (s, 3F), 120.52 (
3
JHF = 17.4 Hz, 4F); 
FTIR (thin film) νmax  2947, 2869, 1732, 1464, 1439, 1333, 1270, 1198 cm
1; HRMS calcd (ESI, 
positive mode) for C40H72O5F10Si3Na [M + Na]
+
:  929.4426, found 929.4509;   1.2425 D (c 
1.32, CHCl3). 
 
MeO2C
OTIPSF5
O OTIPSF5
TIPSF5
 
 
(4R,5R,7S,E)-Methyl-4,5,7-tris-(di-isopropyl-(3,3,4,4,4-penta-fluorobutyl)-silyloxy)deca-2,9-
dienoate (RRS-46d).  The general procedure for fluorous tagging
105
 was employed using the 
alcohol RRS-44 (2.38 g, 3.170 mmol), (3,3,4,4,4-pentafluorobutyl)diisopropylsilane (1.83 g, 
6.980 mmol), CF3SO3H (0.46 mL, 5.160 mmol), and 2,6-lutidine (1.10 mL, 9.520 mmol) in 
CH2Cl2 (32.0 mL).  Flash chromatography of the crude product (40:1 hexanes/EtOAc) afforded 
the title compound as a colorless oil (2.68 g, 84%):  
1
H NMR (300 MHz, CDCl3) δ 7.08 (dd, J1 = 
15.8 Hz, J2 = 4.3 Hz, 1H), 6.07 (dd, J1 = 15.8 Hz, J2 = 1.7 Hz, 1H), 5.82 (m, 1H), 5.07 (ddd, J1 = 
17.1 Hz, J2 = 10.2 Hz J3 = 3.5 Hz, 2H), 4.46 (td, J1 = 4.2 Hz, J2 = 1.6 Hz, 1H), 4.06 (m, 1H), 
4.00 (m, 1H), 3.78 (s, 3H), 2.32 (m, 2H), 2.05 (m, 6H), 1.73 (m, 1H), 1.59 (m, 1H), 1.04 (broad 
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s, 42H), 0.89 (m, 4H), 0.81 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 166.1, 146.5, 133.9, 122.3, 
117.8, 76.1, 72.7, 68.9, 51.6, 41.5, 41.2, 25.7, 25.6, 25.4, 25.3, 25.2, 25.1, 25.0, 24.9, 17.7, 17.6, 
17.5, 13.0, 12.9, 12.8, 12.6, 12.5, 1.1, 0.8; 
19
F NMR (282 MHz, CDCl3) 85.12 (s, 3F), 85.15 
(s, 3F), 85.17 (s, 3F), 120.48 (t, 3JHF = 17.7 Hz, 2F), 120.58 (t, 
3
JHF = 17.5 Hz, 4F); FTIR 
(thin film) νmax  2949, 2870, 1731, 1464, 1440, 1196, 885 cm
1; HRMS calcd (ESI, positive 
mode) for C41H69O5F15Si3Na [M + Na]
+
:  1,033.4111, found 1,033.4192;   8.1025 D , (c 1.09, 
CHCl3). 
 
HO
O
OTIPSF5
OTIPSF5
OTIPS
HO
O
OTIPSF5
OTIPSF5
OTIPSF5
HO
O
OTIPS
OTIPS
OTIPS
HO
O
OTIPS
OTIPS
OTIPSF5
+ + +
 
 
(4S,5S,7R,E)-4,5,7-Tris(triisopropylsilyloxy)deca-2,9-dienoic acid, (4S,5S,7S,E)-4,5-Bis(tri-
iso-propyl-silyloxy)-7-((1,1,1,2,2)-penta-fluoro-butyl-di-isopropyl-silyloxy)-deca-2,9-dienoic 
acid, (4R,5R,7R,E)-4,5-Bis((1,1,1,2,2)-penta-fluorobutyl(diisopropylsilyloxy))-7-(triiso-
propyl-silyloxy)-deca-2,9-dienoic acid, (4R,5R,7S,E)-4,5,7-Tris((1,1,1,2,2)-pentafluorobutyl-
(diisopropylsilyloxy))deca-2,9-dienoic acid (M-55abcd).  The same procedure employed for 
compound 48 was repeated using SSR-46a (250 mg, 0.36 mmol), SSS-46b (287 mg, 0.36 mmol), 
RRR-46c (324 mg, 0.36 mmol), RRS-46d (362 mg, 0.36 mmol), and TMSOK (3.05 g, 21.41 
mmol) in Et2O (13.0 mL).  Flash chromatography of the crude product (3:1 hexanes/EtOAc) 
gave the title compound as a colorless oil (1.01 g, 84% based on average molecular weight):  
LRMS (ESI, positive mode) (SSR-55a) m/z 709 (M + Na)
+
; (SSS-55b) m/z 813 (M + Na)
+
; (RRR-
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55c) m/z 915 (M + Na)
+
; (RRS-55d) m/z 1019 (M + Na)
+
; fluorous analytical HPLC (90:10 
MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 mL/min):  tR = 9.0 min (SSR-55a), 
14.9 min (SSS-55b), 20.3 min (RRR-55c), 28.6 min (RRS-55d). 
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(4S,5S,7R)-((R)-Dec-1-en-5-yl)-4,5,7-tris(triisopropylsilyloxy)-deca-2,9-dienoate, (4S,5S,7S)-
((R)-Dec-1-en-5-yl)-4,5-bis-(triisopropyl-silyloxy)-7-diisopropyl-(1,1,1,2,2-pentafluorobutyl-
silyl-oxy)deca-2,9-dienoate, (4R,5R,7R)-((R)-Dec-1-en-5-yl)-4,5-bis-(di-iso-propyl-(1,1,1,2,2-
pentafluorobutylsilyloxy))-7-triisopropylsilyloxy-deca-2,9-dienoate, (4R,5R,7S,E)-((R)-Dec-
1-en-5-yl)-4,5,7-tris(diisopropyl(1,1,1,2,2-pentafluorobutylsilyloxy)) deca-2,9-dienoate ((R)-
M-56abcd):  The same method employed in the preparation of 49 was repeated using mixture 
M-55abcd (1.16 g, 1.38 mmol based on average molecular weight), alcohol (R)-18 (237 mg, 
1.52 mmol), NEt3 (385 L), DMAP (338 mg, 2.76 mmol), and 2,4,6-trichlorobenzoyl chloride 
(227 L, 1.45 mmol) in toluene (28.0 mL).  Flash chromatography of the crude product (40:1 
hexanes/EtOAc) gave the title compound as a colorless oil (1.29 g, 95% based on average 
molecular weight).  HRMS (ESI, positive mode): calcd for C47H9405Si3Na [M + Na]
+
 845.6307, 
found 845.6340 for SSRR-56a;  calcd for C48H91O5F5Si3Na [M + Na]
+
 949.5992, found 949.6046 
for SSSR-56b; calcd for C49H88O5F10Si3Na [M + Na]
+
 1,053.5678, found 1,053.5725 for RRRR-
56c; calcd for C50H85O5F15Si3Na [M+ Na]
+
 1,157.5363, found 1,157.5360 for RRSR-56d; 
fluorous analytical HPLC (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 
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mL/min):  tR = 22.9 min (SSRR-56a), 29.5 min (SSSR-56b), 33.9 min (RRRR-56c), 40.5 min 
(RRSR-56d). 
Demixing of Mixture (R)-M-56abcd: 
 Semi-preparative separation of (R)-M-56abcd was carried out on a Waters 600E HPLC 
system.  The mixture (R)-M-56abcd of four compounds was dissolved in THF (4.5 mL) and 
filtered through a Whatman syringe filter (0.45 m pore size) prior to injection.  The separation 
was carried out on a FluoroFlash PF-C8 HPLC column (20 mm x 250 mm).  The separation was 
achieved by gradient elution with 90:10 acetonitrile/water up to 100% acetonitrile in 15 minutes, 
followed by isocratic elution with 100% acetonitrile for 180 minutes with a constant flow rate of 
10.0 mL/min.  A UV detector (230 nm) was used to manually identify the peaks.  Aliquots of 
(R)-M-56abcd (50 mg/mL) were injected per chromatographic run.  The yield of the demixing 
over six injections was 93% and the following four compounds were isolated:  SSRR-56a: 58.8 
mg, tR = 62.2 min; SSRR-56b: 68.2 mg, tR = 91.8 min; SSRR-56c 111.6 mg, tR = 114.9 min; 
SSRR-56d: 60.0 mg, tR = 163.4 min. 
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(4S,5S,7R)-((S)-Dec-1-en-5-yl)-4,5,7-tris(triisopropylsilyloxy)deca-2,9-dienoate, (4S,5S,7S)-
((S)-Dec-1-en-5-yl)-4,5-bis(triisopropyl-silyl-oxy)-7-diisopropyl-(1,1,1,2,2-pentafluorobutyl-
silyl-oxy)deca-2,9-dienoate, (4R,5R,7R)-((S)-Dec-1-en-5-yl)-4,5-bis-(diisopropyl-(1,1,1,2,2-
pentafluorobutylsilyloxy))-7-triisopropylsilyloxy-deca-2,9-dienoate, (4R,5R,7S)-((S)-Dec-1-
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en-5-yl)-4,5,7-tris-(diisopropyl(1,1,1,2,2-pentafluorobutylsilyloxy))-deca-2,9-dienoate ((S)-
M-56abcd):  The same method employed in the preparation of 49 was repeated using mixture 
M-55abcd (977 mg, 1.16 mmol based on average molecular weight), alcohol (S)-18 (236 mg, 
1.51 mmol), NEt3 (1.78 mL), DMAP (369 mg, 3.02 mmol), and 2,4,6-trichlorobenzoyl chloride 
(360 L, 2.32 mmol) in toluene (25.0 mL).  Flash chromatography of the crude product (40:1 
hexanes/EtOAc) gave the title compound as a colorless oil (1.16 g, 100% based on average 
molecular weight):  HRMS (ESI, positive mode): calcd for C47H9405Si3Na [M + Na]
+
 845.6307, 
found 845.6323 for SSRS-56a;  calcd for C48H91O5F5Si3Na [M + Na]
+
 949.5992, found 949.6074 
for SSSS-56b; calcd for C49H88O5F10Si3Na [M + Na]
+
 1,053.5678, found 1,053.5664 for RRRS-
56c; calcd for C50H85O5F15Si3Na [M + Na]
+
 1,157.5363, found 1,157.5306 for RRRS-56d; 
fluorous analytical HPLC (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 
mL/min):  tR = 5.1 min (SSRS-56a), 7.3 min (SSSS-56b), 9.9 min (RRRS-56c), 15.8 min (RRRS-
56d).   
Demixing of (S)-M-56abcd: 
 The semi-preparative separation of the four-compound mixture (S)-M-56abcd was 
carried out in the same manner as (R)-M-56abcd.  Aliquots of (S)-M-56abcd (50 mg/mL) were 
injected per chromatographic run.  The yield of the demixing over six injections was 80% and 
the following four compounds were isolated:  SSRS-56a: 83.0 mg, tR = 37.8 min; SSSS-56b: 92.4 
mg, tR = 54.9 min; RRRS-56c: 90.4 mg, tR = 68.1 min; RRSS-56d: 105.7 mg, tR = 91.5 min. 
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(4S,5S,7R,13R,E)-14-Pentyl-5,6,8-tris-(triisopropyl-silyl-oxy)-oxacyclo-tetra-dec-3-en-2-one, 
(4S,5S,7S,13R,E)-13-Pentyl-4,5-bis-(triisopropyl-silyl-oxy)-7-di-isopropyl-(1,1,1,2,2-penta-
fluoro-butyl-silyl-oxy)-oxacyclo-tetra-dec-2-enone, (4R,5R,7R,13R,E)-13-Pentyl-4,5-bis-(di-
isopropyl(1,1,1,2,2-pentafluoro-butyl-silyloxy)-7-triisopropylsilyloxy)-oxacyclotetra-dec-2-
enone, (4R,5R,7S,13R,E)-13-Pentyl-4,5,7-tris-(diisopropyl-(1,1,1,2,2-pentafluoro-butyl-
silyloxy)-oxacyclotetra-dec-2-enone ((R)-M-57abcd): The procedure for the ring-closing 
metathesis as executed for compound 51 was repeated for mixture (R)-M-55abcd (682 mg, 696 
mol based on average molecular weight) using the 2nd generation Grubbs catalyst (118 mg, 139 
mol) in DCM (210 mL).  Two successive rounds of flash chromatography (40:1 
hexanes/EtOAc) gave the title compound as a pale brown oil (630 mg, 663 mol).  The ring-
closed product (630 mg, 663 mol) was then directly subjected to the partial reduction 
procedures as reported for preparation of compound 52 using Pd/SrCO3 (3.52 g, 663 mol) in 
EtOH (20 mL).  Flash chromatography of the crude product (40:1 hexanes/EtOAc) gave the title 
compound as a colorless oil (584 mg, 88% over two steps, based on average molecular weight):  
HRMS (ESI, positive mode): calcd for C45H92O5Si3Na [M + Na]
+
 819.6145, found 819.6192 for 
SSRR-57a;  calcd for C46H89O5F5Si3Na [M + Na]
+
 923.5836, found 923.5790 for SSSR-57b; 
calcd for C47H86O5F10Si3Na [M + Na]
+
 1,027.5516, found 1,027.5504 for RRRR-57c; calcd for 
C48H83O5F15Si3Na [M + Na]
+
 1,131.5207, found 1,131.5256 for RRSR-57d; fluorous analytical 
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HPLC (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 mL/min):  tR = 5.7 min 
(SSRR-57a), 8.0 min (SSSR-57b), 11.1 min (RRRR-57c), 17.2 min (RRSR-57d). 
Demixing of (R)-M-57abcd: 
 The semi-preparative separation of (R)-M-57abcd was carried out in the same manner as 
(R)-M-56abcd.  Aliquots of (R)-M-57abcd (90 mg/mL) were injected per chromatographic run.  
The yield of the demixing over six injections was 48% and the following four compounds were 
isolated:  SSRR-57a: 82.4 mg, tR = 34.7 min; SSSR-57b: 80.5 mg, tR = 49.7 min; RRRR-57c: 66.8 
mg, tR = 64.7 min; RRSR-57d: 52.3 mg, tR = 87.0 min 
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(4S,5S,7R,13S,E)-14-Pentyl-5,6,8-tris-(tri-isopropyl-silyloxy)-oxacyclo-tetra-dec-3-en-2-one, 
(4S,5S,7S,13S,E)-13-Pentyl-4,5-bis-(tri-isopropyl-silyl-oxy)-7-di-iso-propyl-(1,1,1,2,2-penta-
fluoro-butyl-silyl-oxy)-oxa-cyclo-tetra-dec-2-enone, (4R,5R,7R,13S,E)-13-Pentyl-4,5-bis-(di-
iso-propyl-(1,1,1,2,2-pentafluorobutylsilyloxy)-7-triisopropylsilyloxy)oxacyclotetradec-2-
enone, (4R,5R,7S,13S,E)-13-Pentyl-4,5,7-tris-(di-isopropyl-(1,1,1,2,2-pentafluoro-butyl-
silyloxy)-oxacyclo-tetradec-2-enone ((S)-M-57abcd):  The procedure for the ring-closing 
metathesis as executed for compound 51 was repeated for mixture (S)-M-56abcd (615 mg, 628 
mol based on average molecular weight) using the 2nd generation Grubbs catalyst (107 mg, 126 
mol) in DCM (210 mL).  Two successive rounds of flash chromatography (40:1 
hexanes/EtOAc) gave the title compound as a pale brown oil (564 mg, 576 mol).  The ring-
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closed product (564 mg, 576 mol) was then directly subjected to the partial reduction 
procedures as reported for the preparation of compound 52 using Pd/SrCO3 (3.15 g, 593 mol) in 
EtOH (20 mL).  Flash chromatography of the crude product (40:1 hexanes/EtOAc) gave the title 
compound as a colorless oil (524 mg, 87% over two steps, based on average molecular weight):  
LRMS (EI) (SSRS-57a) m/z 797 (M)
+
; (SSSS-57b) m/z 901 (M)
+
; (RRRS-57c) m/z 1005 (M)
+
; 
(RRSS-57d) m/z 1109 (M)
+
; HRMS (ESI, positive mode): calcd for C45H92O5Si3Na [M]
+
 
796.6253, found 796.6273 for SSRS-57a;  calcd for C46H89O5F5Si3Na [M + Na]
+
 923.5836, found 
923.5803 for SSSS-57b; calcd for C47H86O5F10Si3Na [M + Na]
+
 1,027.5516, found 1,027.5506 
for RRRS-57c; calcd for C48H83O5F15Si3Na [M+ Na]
+
 1,131.5207, found 1,131.5254 for RRSS-
57d; fluorous analytical HPLC (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 
mL/min):  tR = 5.4 min (SSRS-57a), 8.5 min (SSSS-57b), 9.9 min (RRRS-57c), 17.3 min (RRSS-
57d). 
Demixing of (S)-M-57abcd: 
 The semi-preparative separation of (S)-M-57abcd was carried out in the same manner as 
(S)-M-56abcd.  Aliquots of (S)-M-57abcd (90 mg/mL) were injected per chromatographic run.  
The yield of the demixing over six injections was 60% and the following four compounds were 
isolated:  SSRS-57a: 89.1 mg, tR = 50.3 min; SSSS-57b: 69.6 mg, tR = 85.5 min; RRRS-57c: 69.9 
mg, tR = 99.8 min; RRSS-57d: 87.4 mg, tR = 161.7 min. 
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(4S,5S,7R,13R,E)-14-Pentyl-5,6,8-tris-(tri-isopropyl-silyloxy)-oxa-cyclo-tetra-dec-2-en-one 
(SSRR-57a):  From the demixing of (S)-M-57abcd, the first peak SSRR-57a (82.4 mg) at 34.7 
minutes was isolated as a colorless oil:  
1
H NMR (500 MHz, CDCl3)  dd, J1 = 16.0 Hz, J2 
= 2.0 Hz, 1H), 6.11 (dd, J1 = 16.0 Hz, J2 = 2.0 Hz, 1H), 5.04 (m, 1H), 4.65 (t, J = 2.5 Hz, 1H), 
4.32 (quintet, J = 5.0 Hz, 1H), 4.14 (m, 1H), 2.08 (m, 1H), 1.86 (m, 1H), 1.64 (m, 5H), 1.50 (m, 
3H), 1.37 (m, 4H), 1.30 (m, 6H), 1.10 (br s, 63H), 0.89 (t, J = 6.5 Hz, 3H); 
13
C NMR (75 MHz, 
CDCl3) 166.2, 149.0, 122.6, 74.9, 74.5, 73.1, 69.4, 37.0, 35.3, 33.5, 33.1, 31.8, 30.3, 25.3, 23.3, 
22.6, 21.1, 18.3, 18.2, 18.1, 14.0, 13.1, 12.5 FTIR (thin film)  νmax  2943, 2867, 1718, 1463, 
1255, 1200, 1106, 1059, 996, 883 cm1; HRMS calcd (ESI, positive mode) for C45H92O5Si3Na 
[M + Na]
+
:  819.6145, found 819.6192;   6.3425 D  (c 0.76, CHCl3). 
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(4S,5S,7R,13S,E)-14-Pentyl-5,6,8-tris(triisopropylsilyloxy)oxacyclotetradec-2-enone (SSRS-
57a):  From the demixing of (S)-M-57abcd, the first peak SSRS-57a (89.1 mg) at 50.3 minutes 
 119 
was isolated as a colorless oil:  
1
H NMR (600 MHz, CDCl3) dd, J1 = 16.0 Hz, J2 = 4.5 
Hz, 1H), 6.10 (d, J = 16.0 Hz, 1H), 5.00 (m, 1H), 4.58 (t, J = 4.5 Hz, 1H), 4.30 (dt, J1 = 9.0 Hz, 
J2 = 4.5 Hz, 1H), 4.02 (m, 1H), 2.07 (m, 1H), 1.81 (m, 1H), 1.65 (m, 3H), 1.56 (m, 2H), 1.44 (m, 
1H), 1.32 (m, 6H), 1.26 (m, 6H), 1.07 (br s, 63H), 0.89 (t, J = 7.0 Hz, 3H); 
13
C NMR (75 MHz, 
CDCl3) 167.1, 147.7, 123.5, 75.3, 74.5, 72.7, 69.3, 37.3, 37.2, 34.7, 32.7, 31.8, 29.7, 25.1, 24.9, 
22.6, 22.4, 18.3, 18.1, 14.0, 13.0, 12.9, 12.3 FTIR (thin film)  νmax  2942, 2866, 1722, 1462, 
1261, 1106, 1063, 1016 cm1; HRMS calcd (EI) for C45H92O5Si3 [M]
+
:  796.6253, found 
796.6273;   4.3025 D (c 1.12, CHCl3). 
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(4S,5S,7S,13R)-13-Pentyl-4,5-bis-(triisopropylsilyloxy)-7-diisopropyl(1,1,1,2,2-penta-fluoro-
butyl-silyl-oxy)oxa-cyclo-tetra-dec-2-enone (SSSR-57b):  From the demixing of (R)-M-
57abcd, the second peak SSSR-57b (80.5 mg) at 49.7 minutes was isolated as a colorless oil:  
1
H 
NMR (500 MHz, CDCl3)  dd, J1 = 16.0 Hz, J2 = 2.0 Hz, 1H), 6.11 (dd, J1 = 16.0 Hz, J2 = 
2.0 Hz, 1H), 4.99 (m, 1H), 4.62 (m, 1H), 4.25 (quintet, J = 3.0 Hz, 1H), 3.96 (m, 1H), 2.18 (dt, J1 
= 14.5 Hz, J2 = 3.0 Hz, 1H), 2.05 (m, 3H), 1.69 (m, 3H), 1.51 (m, 5H), 1.31 (br s, 10H), 1.11 (br 
s, 42H), 1.03 (br s, 14H), 0.89 (t, J = 6.5 Hz, 3H), 0.78 (m, 2H); 
13
C NMR (75 MHz, CDCl3) 
165.6, 148.7, 120.9, 74.1, 73.9, 73.3, 71.0, 40.7, 35.6, 32.5, 31.8, 30.0, 25.7, 25.4, 23.4, 22.5, 
19.8, 18.2, 18.1, 18.0, 17.9, 17.8, 14.0, 12.9, 12.7, 12.5, 12.4, 1.619F NMR (282 MHz, CDCl3) 
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84.98 (s, 3F), 120.08 (t, 3JHF = 18.0 Hz, 2F); FTIR (thin film)  νmax  2944, 2868, 1717, 1463, 
1258, 1199, 1106, 1056, 1014, 995, 883 cm1; HRMS calcd (ESI, positive mode) for 
C46H89O5F5Si3Na [M + Na]
+
:  923.5836, found 923.5790;   4.2125 D  (c 0.89, CHCl3). 
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(4S,5S,7S,13S)-13-Pentyl-4,5-bis-(triisopropylsilyloxy)-7-diisopropyl(1,1,1,2,2-penta-fluoro-
butylsilyloxy)oxacyclotetradec-2-enone (SSSS-57b):  From the demixing of (S)-M-57abcd, the 
second peak SSSS-57b (69.6 mg) at 85.5 minutes was isolated as a colorless oil:  
1
H NMR (600 
MHz, CDCl3)  dd, J1 = 16.0 Hz, J2 = 6.5 Hz, 1H), 5.98 (d, J = 16.0 Hz, 1H), 4.98 (m, 
1H), 4.57 (t, J = 6.5 Hz, 1H), 4.22 (m, 1H), 4.08 (t, J = 6.5 Hz, 1H), 2.08 (septet, J = 9.0 Hz, 
2H), 1.94 (m, 1H), 1.79 (quintet, J = 7.0 Hz, 3H), 1.65 (m, 4H), 1.53 (m, 4H), 1.40 (m, 2H), 1.30 
(br s, 6H), 1.20 (m, 2H), 1.08 (br s, 56H), 0.89 (t, J = 6.5 Hz, 3H), 0.82 (m, 2H); 
13
C NMR (75 
MHz, CDCl3) 166.1, 148.0, 123.3, 76.3, 75.5, 73.3, 71.5, 41.9, 37.1, 34.2, 31.7, 31.0, 29.7, 
28.0, 25.0, 24.3, 23.9, 22.6, 18.2, 18.1, 18.0, 17.9, 17.8, 14.0, 13.4, 13.1, 12.4, 12.3, 1.519F 
NMR (282 MHz, CDCl3) 84.95 (s, 3F), 120.26 (t, 
3
JHF = 18.0 Hz, 2F); FTIR (thin film)  νmax  
2943, 2867, 1722, 1463, 1261, 1200, 1103, 1065, 996, 884 cm1; HRMS calcd (ESI, positive 
mode) for C46H89O5F5Si3Na [M + Na]
+
:  923.5836, found 923.5803;   15.125 D (c 1.08, CHCl3).  
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(4R,5R,7R,13R)-13-Pentyl-4,5-bis-(diisopropyl(1,1,1,2,2-pentafluorobutylsilyloxy)-7-triiso-
propylsilyloxy)oxacyclotetradec-2-enone (RRRR-57c):  From the demixing of (R)-M-57abcd, 
the third peak RRRR-57c (66.8 mg) at 64.7 minutes was isolated as a colorless oil:  
1
H NMR 
(500 MHz, CDCl3)  dd, J1 = 16.0 Hz, J2 = 6.5 Hz, 1H), 5.95 (d, J = 16.0 Hz, 1H), 5.02 
(m, 1H), 4.44 (t, J = 5.3 Hz, 1H), 4.14 (m, 1H), 4.05 (quintet, J = 3.0 Hz, 1H), 2.05 (m, 4H), 1.79 
(m, 2H), 1.72 (m, 1H), 1.64 (m, 1H), 1.56 (m, 5H), 1.27 (m, 11H), 1.06 (br s, 49H), 0.88 (m, 
7H); 
13
C NMR (75 MHz, CDCl3) 165.6, 146.7, 123.7, 77.2, 75.9, 73.9, 69.9, 42.1, 37.3, 33.8, 
31.7, 31.0, 28.4, 25.4, 25.3, 25.2, 24.1, 22.5, 18.3, 17.7, 17.6, 17.5, 14.0, 13.0, 12.7, 12.6, 12.5, 
0.9, 0.819F NMR (282 MHz, CDCl3) 84.91 (s, 3F), 84.93 (s, 3F), 120.19 (t, 
3
JHF = 17.5 Hz, 
2F), 120.29 (t, 3JHF = 17.5 Hz, 2F); FTIR (thin film)  νmax  2944, 2867, 1721, 1199, 1104, 1065 
cm1; HRMS calcd (ESI, positive mode) for C47H86O5F10Si3Na [M + Na]
+
:  1,027.5516, found 
1,027.5504;   04.225 D  (c 0.90, CHCl3). 
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(4R,5R,7R,13S)-13-Pentyl-4,5-bis-(diisopropyl-(1,1,1,2,2-pentafluorobutyl-silyloxy)-7-triiso-
propyl-silyl-oxy)oxa-cyclo-tetra-dec-2-enone (RRRS-57c):  From the demixing of (S)-M-
57abcd, the third peak RRRS-57c (69.9 mg) at 99.8 minutes was isolated as a colorless oil:  
1
H 
NMR (600 MHz, CDCl3)  dd, J1 = 16.0 Hz, J2 = 2.5 Hz, 1H), 6.06 (dd, J1 = 16.0 Hz, J2 = 
2.5 Hz, 1H), 4.97 (m, 1H), 4.46 (m, 1H), 4.11 (m, 1H), 3.93 (m, 1H), 2.08 (m, 6H), 1.94 (m, 1H), 
1.66 (m, 4H), 1.53 (m, 5H), 1.31 (br s, 8H), 1.08 (br s, 28H), 1.04 (br s, 21H), 0.90 (m, 4H), 0.89 
(t, J = 7.0 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) 165.3, 147.1, 121.6, 74.5, 74.3, 73.7, 70.1, 
40.9, 37.1, 34.2, 32.8, 31.8, 31.0, 30.3, 29.7, 28.0, 26.9, 25.4, 25.3, 25.2, 25.0, 24.3, 23.9, 23.6, 
22.6, 22.5, 20.6, 18.3, 18.2, 17.5, 14.0, 13.4, 13.1, 12.9, 12.6, 12.4, 12.3, 0.919F NMR (282 
MHz, CDCl3) 84.85 (s, 3F), 84.99 (s, 3F), 120.31 (t, 
3
JHF = 17.5 Hz, 2F), 120.48 (t, 
3
JHF = 
17.5 Hz, 2F); FTIR (thin film)  νmax  2944, 2868, 1719, 1463, 1260, 1199, 1106, 1054, 995, 884 
cm1; HRMS calcd (ESI, positive mode) for C47H86O5F10Si3Na [M + Na]
+
:  1,027.5521, found 
1,027.5506;   04.225 D  (c 0.90, CHCl3).  
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(4R,5R,7S,13R)-13-Pentyl-4,5,7-tris-(di-isopropyl-(1,1,1,2,2-penta-fluorobutyl-silyloxy)oxa-
cyclo-tetradec-2-enone (RRSR-57d):  From the demixing of (R)-M-57abcd, the fourth peak 
RRSR-57d (52.3 mg) at 87.0 minutes was isolated as a colorless oil:  
1
H NMR (500 MHz, 
CDCl3)  dd, J1 = 16.0 Hz, J2 = 5.5 Hz, 1H), 6.06 (d, J = 16.0 Hz, 1H), 4.99 (m, 1H), 4.41 
(t, J = 10.0 Hz, 1H), 4.08 (dt, J1 = 10.0 Hz, J2 = 7.5 Hz 1H), 3.85 (m, 1H), 2.05 (m, 6H), 1.71 (m, 
2H), 1.61 (m, 3H), 1.54 (m, 3H), 1.46 (m, 1H), 1.33 (m, 11H), 1.20 (m, 2H), 1.05 (br s, 42H), 
0.89 (7H), 0.82 (m, 2H); 
13
C NMR (75 MHz, CDCl3) 166.4, 145.8, 124.3, 75.6, 74.9, 72.7, 
69.7, 38.9, 36.6, 34.6, 32.5, 31.7, 29.4, 25.5, 25.3, 25.1, 25.0, 24.6, 23.1, 22.5, 17.7, 17.6, 17.4, 
14.0, 13.2, 13.0, 12.8, 12.6, 1.4, 1.3, 0.819F NMR (282 MHz, CDCl3) 84.93 (s, 3F), 84.95 (s, 
3F), 84.98 (s, 3F), 120.09 (t, 3JHF = 17.5 Hz, 2F), 120.24 (t, 
3
JHF = 17.5 Hz, 2F), 120.39 (t, 
3
JHF = 17.5 Hz, 2F); FTIR (thin film)  νmax  2930, 2360, 2340, 1610, 1465, 1195, 1023 cm
1; 
HRMS calcd (ESI, positive mode) for C48H83O5F15Si3Na [M + Na]
+
:  1,131.5207, found 
1,131.5256;   1.1625 D , (c 1.30, CHCl3). 
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(4R,5R,7S,13S)-13-Pentyl-4,5,7-tris-(diisopropyl-(1,1,1,2,2-penta-fluoro-butyl-silyloxy)-oxa-
cyclotetradec-2-enone (RRSS-57d):  From the demixing of (S)-M-57abcd, the fourth peak 
RRSS-57d (87.4 mg) at 161.7 minutes was isolated as a colorless oil:  
1
H NMR (600 MHz, 
CDCl3)  dd, J1 = 16.0 Hz, J2 = 2.5 Hz, 1H), 6.06 (dd, J1 = 16.0 Hz, J2 = 2.0 Hz, 1H), 5.04 
(m, 1H), 4.50 (t, J = 2.5 Hz, 1H), 4.14 (quintet, J = 5.0 Hz, 1H), 4.00 (m, 1H), 2.05 (m, 6H), 1.85 
(m, 1H), 1.68 (m, 1H), 1.62 (m, 1H), 1.57 (m, 2H), 1.50 (m, 4H), 1.31 (m, 5H), 1.26 (br s, 6H), 
1.10 (br s, 14H), 1.1.06 (br s, 14H), 1.01 (br s, 14H), 0.89 (7H), 0.80 (m, 2H); 
13
C NMR (75 
MHz, CDCl3) 165.7, 147.0, 75.3, 74.5, 72.9, 69.8, 37.1, 35.8, 33.7, 32.9, 31.8, 30.4, 30.2, 29.7, 
25.7, 25.6, 25.4, 25.2, 25.1, 24.9, 23.6, 22.7, 22.5, 21.7, 17.6, 17.5, 17.4, 14.1, 14.0, 13.0, 12.9, 
12.8, 12.7, 12.6, 1.5, 0.8, 0.719F NMR (282 MHz, CDCl3) 84.90 (s, 3F), 84.95 (s, 3F), 
84.96 (s, 3F), 120.32 (t, 3JHF = 17.5 Hz, 2F), 120.38 (t, 
3
JHF = 17.5 Hz, 2F), 120.48 (t, 
3
JHF 
= 17.5 Hz, 2F); FTIR (thin film)  νmax  2944, 2869, 1719, 1199, 1106, 1051, 996 cm
 1; HRMS 
calcd (ESI, positive mode) for C48H83O5F15Si3Na [M + Na]
+
:  1,131.5207, found 1,131.5254; 
  1.1625 D  (c 1.30, CHCl3).  
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(4S,5S,7R,13R)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4S,5S,7R,13R)-5):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using SSRR-57a (81.1 mg, 102 mol).  The product 
after flash chromatography (3:1 hexanes/EtOAc, then 100% EtOAc) was dissolved in THF (3.0 
mL), filtered using a Whatman syringe filter (0.45 m pore size), and then further purified using 
a (S,S)-Whelk-O-1 column (25 cm x 21.1 mm).  The purification was done by isocratic elution 
first with 90:10 hexanes/isopropanol for the first 15 minutes, then isocratic elution with 80:20 
hexanes/isopropanol for 30 minutes.  A constant flow rate of 10.0 mL/min was run throughout 
the separation and a UV detector (230 nm) was used to manually identify the peaks.   The 
reaction after purification on the (S,S)-Whelk-O-1 column after three injections furnished the 
title compound as an amorphous white solid (6.4 mg, 19%):  
1
H NMR (700 MHz, CD3OD)  
7.04 (dd, J1 = 15.8 Hz, J2 = 5.3 Hz, 1H), 6.11 (dd, J1 = 15.8 Hz, J2 = 1.5 Hz, 1H), 4.95 (dddd, J1 
= 12.5 Hz, J2 = 7.6 Hz, J3 = 5.0 Hz, J4= 2.3 Hz, 1H), 4.26 (ddd, J1 = 7.0 Hz, J2 = 5.3 Hz, J3 = 1.5 
Hz, 1H), 3.92 (m, 1H), 3.77 (dt, J1 = 7.4 Hz, J2 = 4.5 Hz, 1H), 1.72 (m, 1H), 1.70 (dd, J1 = 5.4 
Hz, J2 = 4.5 Hz, 2H), 1.62 (m, 1H), 1.54 (m, 2H), 1.43 (m, 4H), 1.33 (br s, 7H), 1.19 (br s, 3H), 
0.91 (t, J = 6.9 Hz, 3H); 
13
C NMR (175 MHz, CD3OD) 168.0, 148.7, 123.5, 77.6, 75.8, 74.4, 
69.2, 37.9, 36.8, 36.4, 34.2, 33.0, 29.7, 26.6, 26.4, 25.3, 23.8, 14.5 FTIR (thin film)  νmax  2926, 
 126 
2857, 1705, 1270, 1100 cm1; HRMS calcd (EI) for C18H32O5 [M]
+
:  328.2250, found 328.2243; 
  43.925 D  (c 0.54, MeOH). 
 
O
O
C5H11
OH
OH
OH
 
 
(4S,5S,7S,13R)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4S,5S,7S,13R)-5):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using SSSR-57b (79.3 mg, 88.0 mol).  Flash 
chromatography (3:1 hexanes/EtOAc, then 100% EtOAc) of the crude product gave the title 
compound as an amorphous white solid (14.6 mg, 51%):  
1
H NMR (700 MHz, CD3OD)  6.96 
(dd, J1 = 15.8 Hz, J2 = 5.9 Hz, 1H), 6.10 (dd, J1 = 15.8 Hz, J2 = 1.3 Hz, 1H), 4.93 (m, 1H), 4.03 
(ddd, J1 = 7.6 Hz, J2 = 6.0 Hz, J3 = 1.5 Hz, 1H), 3.54 (td, J1 = 8.5 Hz, J2 = 1.5 Hz, 1H), 3.47 (m, 
1H), 1.76 (ddd, J1 = 14.6 Hz, J2 = 8.5 Hz, J3 = 2.7 Hz, 1H), 1.67 (m, 2H), 1.64 (m, 1H), 1.55 (m, 
2H), 1.52 (m, 2H), 1.34 (br s, 9H), 1.26 (br s, 3H), 0.91 (t, J = 6.9 Hz, 3H); 
13
C NMR (125 MHz, 
CD3OD) 168.1, 149.4, 123.1, 77.8, 75.9, 74.6, 68.3, 43.8, 35.8, 35.6, 33.3, 33.0, 27.6, 26.4, 
24.2, 23.9, 23.8, 14.5 FTIR (thin film)  νmax  3318, 2930, 2854, 1708, 1284 cm
1; HRMS calcd 
(EI) for C18H32O5 [M]
+
:  328.2250, found 328.2260;   8.1825 D  (c 0.77, MeOH). 
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(4R,5R,7R,13R)-4,5,7-Tri-hydroxy-13-pentyl-oxacyclo-tetra-decenone ((4R,5R,7R,13R)-5):  
The same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer 
pilot synthesis (see Chapter 2.0) was followed using RRRR-57c (66.0 mg, 65.8 mol).  Flash 
chromatography (3:1 hexanes/EtOAc, then 100% EtOAc) of the crude product gave the title 
compound as an amorphous white solid (13.1 mg, 60%).  The 
1
H NMR spectrum of this sample 
isolated by detagging RRRR-57c matched the one recorded during the single isomer pilot 
synthesis (see Section 6.1). 
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(4R,5R,7S,13R)-4,5,7-Trihydroxy-13-pentyl-oxacyclotetra-decenone ((4R,5R,7S,13R)-5):  
The same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer 
pilot synthesis (see Chapter 2.0) was followed using RRSR-57d (50.0 mg, 45.0 mol).  Flash 
chromatography of the crude product (3:1 hexanes/EtOAc, then 100% EtOAc) gave the title 
compound as an amorphous white solid (7.6 mg, 51%):  
1
H NMR (700 MHz, CD3OD) 7.07 
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(dd, J1 = 15.8 Hz, J2 = 5.4 Hz, 1H), 6.12 (dd, J1 = 15.8 Hz, J2 = 1.5 Hz, 1H), 4.97 (m, 1H), 4.26 
(td, J1 = 6.5 Hz, J2 = 1.5 Hz, 1H), 3.90 (td, J1 = 6.5 Hz, J2 = 2.8 Hz, 1H), 3.78 (septet, J = 4.20 
Hz, 1H), 1.70 (m, 4H), 1.63 (m, 2H), 1.54 (m, 2H), 1.42 (m, 2H), 1.31 (m, 9H), 1.21 (m, 1H), 
0.91 (t, J = 6.9 Hz, 3H);  
13
C NMR (175 MHz, CD3OD) 168.8, 149.8, 123.2, 75.8, 75.3, 73.8, 
68.9, 38.3, 35.8, 35.5, 33.7, 33.0, 27.8, 26.5, 25.1, 24.5, 23.8, 14.5 FTIR (thin film)  νmax  3195, 
2924, 2854, 1709, 1554, 1272 cm1; HRMS calcd (EI) for C18H32O5 [M]
+
:  328.2250, found 
328.2242;   66.725 D  (c 0.38, MeOH). 
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(4S,5S,7R,13S)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4S,5S,7R,13S)-5):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using SSRS-57a (88.1 mg, 111 mol).  The product 
after flash chromatography (3:1 hexanes/EtOAc, then 100% EtOAc) was further purified using a 
(S,S)-Whelk-O-1 column as described for compound (4S,5S,7R,13R)-5 (see above) and the title 
compound was isolated as an amorphous white solid (5.4 mg, 15%). The 
1
H NMR spectrum 
matched that of (4R,5R,7S,13R)-11 (see above);   04.425 D  (c 0.27, MeOH).  
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(4S,5S,7S,13S)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4S,5S,7S,13S)-5):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using SSSS-57b (68.0 mg, 75.4 mol).  Flash 
chromatography of the crude product (3:1 hexanes/EtOAc, then 100% EtOAc) gave the title 
compound as an amorphous white solid (16.5 mg, 67%).  The 
1
H NMR spectrum matched that of 
(4R,5R,7R,13R)-5 (see above);   9.2525 D  (c 0.83, MeOH). 
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(4R,5R,7R,13S)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4R,5R,7R,13S)-5):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using RRRS-57c (68.8 mg, 68.4 mol).  The product 
after flash chromatography (3:1 hexanes/EtOAc, then 100% EtOAc) was dissolved in 1:1 
hexanes/isopropanol (1.0 mL), filtered through a Whatman syringe filter (0.45 m pore size), 
and further purified using a Chiralcel OD semi-preparative HPLC column. The purification was 
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done with isocratic elution (92:8 hexanes/isopropanol, 4.5 mL/min), a UV detector (230 nm) was 
used to identify the peaks, and the desired compound (4R,5R,7R,13S)-11 was isolated as an 
amorphous white solid (1 injection, 3.2 mg, 14%)  The 
1
H NMR spectrum matched that of 
(4S,5S,7S,13R)-5 (see above);   5.1625 D  (c 0.32, MeOH). 
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(4R,5R,7S,13S)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4R,5R,7S,13S)-5):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using RRSS-57d (84.9 mg, 76.5 mol).  Flash 
chromatography of the crude product (3:1 hexanes/EtOAc, then 100% EtOAc) gave the title 
compound as an amorphous white solid (16.5 mg, 66%).  The 
1
H NMR spectrum matched that of 
(4S,5S,7R,13R)-5 (see above);   3.1125 D  (c 0.89, MeOH). 
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(4S,5S,7R,E)-((R)-Dec-1-en-5-yl)-4,5,7-tris(triisopropylsilyloxy)deca-2,9-dienoate (SSRR-
56a):  From the demixing of (R)-M-56abcd, the first peak SSRR-56a (58.8 mg) at 62.2 minutes 
was isolated as a colorless oil:  
1
H NMR (500 MHz, CDCl3) dd, J1 = 15.8 Hz, J2 = 4.0 
Hz, 1H), 6.08 (dd, J1 = 15.8 Hz, J2 = 1.6 Hz, 1H), 5.93 (m, 1H), 5.80 (ddt, J1 = 16.9 Hz, J2 = 10.2 
Hz, J3 = 6.6 Hz, 1H), 5.01 (m, 5H), 4.58 (td, J1 = 4.0 Hz, J2 = 2.7 Hz, 1H), 4.20 (sextet, J = 4.0 
Hz, 1H), 4.10 (m, 1H), 2.43 (m, 1H), 2.33 (ddd, J1 = 12.9 Hz, J2 = 8.0 Hz, J3 = 4.4 Hz, 1H), 2.06 
(m, 2H), 1.80 (ddd, J1 = 13.5 Hz, J2 = 8.1 Hz, J3 = 4.9 Hz, 1H), 1.66 (m, 3H), 1.59 (2H), 1.29 (m, 
6H), 1.07 (br s, 63 H), 0.88 (t, J = 6.6 Hz); 
13
C NMR (75 MHz, CDCl3) 165.8, 147.6, 138.0, 
135.0, 122.5, 116.9, 114.8, 76.4, 73.7, 72.6, 68.3, 41.6, 41.2, 34.2, 33.4, 31.2, 29.7, 29.6, 25.0, 
22.6, 18.3, 18.2, 18.1, 14.0, 12.8, 12.7, 12.4 FTIR (thin film) νmax  2943, 2867, 1722, 1463, 
1261, 1106, 1063, 994 cm1; HRMS calcd (ESI, positive mode) for C47H94O5Si3 [M + Na]
+
:  
845.6307, found 845.6340;   1.2425 D  (c 1.10, CHCl3).  
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(4S,5S,7R,E)-((S)-Dec-1-en-5-yl) 4,5,7-tris(triisopropylsilyloxy)deca-2,9-dienoate (SSRS-
56a):  From the demixing of (S)-M-56abcd, the first peak SSRS-56a (83.0 mg) at 37.8 minutes 
was isolated as a colorless oil:  
1
H NMR (500 MHz, CDCl3) dd, J1 = 16.0 Hz, J2 = 4.0 
Hz, 1H), 6.08 (dd, J1 = 16.0 Hz, J2 = 1.5 Hz, 1H), 5.94 (m, 1H), 5.81 (ddt, J1 = 17.0 Hz, J2 = 10.0 
Hz, J3 = 6.5 Hz, 1H), 5.01 (m, 5H), 4.58 (m, 1H), 4.20 (m, 1H), 4.10 (m, 1H), 2.43 (m, 1H), 2.34 
(ddd, J1 = 13.0 Hz, J2 = 8.5 Hz, J3 = 4.5 Hz, 1H), 2.09 (m, 2H), 1.80 (ddd, J1 = 13.5 Hz, J2 = 8.o 
Hz, J3 = 5.0 Hz, 1H), 1.68 (m, 3H), 1.57 (m, 2H), 1.29 (m, 6H), 1.10 (br s, 42 H), 1.05 (br s, 
21H), 0.88 (t, J = 7.0 Hz); 
13
C NMR (75 MHz, CDCl3) 165.8, 147.6, 138.0, 135.0, 122.5, 
116.9, 114.8, 76.4, 73.7, 72.6, 68.3, 41.6, 41.2, 34.0, 33.4, 31.8, 29.7, 24.9, 22.6, 18.3, 18.2, 18.1, 
14.0, 12.8, 12.7, 12.4 FTIR (thin film)  νmax  2946, 2868, 1722, 1465, 1262, 1201, 1111, 1064, 
995 cm1; HRMS calcd (ESI, positive mode) for C47H94O5Si3 [M + Na]
+
:  845.6307, found 
845.6323;   8.2225 D  (c 1.07, CHCl3). 
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(4S,5S,7S,E)-((R)-Dec-1-en-5-yl)-4,5-bis(triisopropylsilyloxy)-7-diisopropyl(1,1,1,2,2-penta-
fluorobutylsilyloxy)deca-2,9-dienoate (SSSR-56b):  From the demixing of (R)-M-56abcd, the 
second peak SSSR-56b (68.2 mg) at 91.8 minutes was isolated as a colorless oil:  
1
H NMR (500 
MHz, CDCl3) (dd, J1 = 15.7 Hz, J2 = 4.0 Hz, 1H), 6.08 (dd, J1 = 15.7 Hz, J2 = 1.7 Hz, 
1H), 5.86 (m, 1H), 5.81 (ddt, J1 = 16.9  Hz, J2 = 10.3 Hz, J3 = 6.6 Hz, 1H), 5.01 (m, 5H), 4.59 
(td, J1 = 4.5 Hz, J2 = 1.8 Hz, 1H), 4.07 (m, 1H), 4.02 (ddd, J1 = 9.8 Hz, J2 = 4.5 Hz, J3 = 2.4 Hz, 
1H), 2.38 (m, 1H), 2.09 (m, 5H), 1.89 (ddd, J1 = 13.2 Hz, J2 = 11.0 Hz, J3 = 2.2 Hz, 1H), 1.66 
(m, 2H), 1.50 (m, 3H), 1.28 (m, 6H), 1.10 (br s, 21H), 1.07 (br s, 21H), 1.02 (br s, 14H), 0.88 (t, 
J = 6.6 Hz, 3H), 0.80 (m, 2H); 
13
C NMR (75 MHz, CDCl3) 165.8, 147.2, 138.0, 134.8, 122.5, 
117.3, 114.8, 74.2, 73.7, 73.1, 69.5, 40.9, 39.8, 34.1, 33.4, 31.8, 29.7, 29.6, 25.4, 24.9, 22.6, 18.2, 
18.1, 17.7, 17.6, 14.0, 13.1, 12.9, 12.5, 0.8 19F NMR (282 MHz, CDCl3) 85.02 (s, 3F), 
120.42 (t, 3JHF = 17.5 Hz, 2F); FTIR (thin film)  νmax  2946, 2869, 1721, 1465, 1267, 1107, 994 
cm1; HRMS calcd (ESI, positive mode) for C48H91O5F5Si3 [M + Na]
+
:  949.5992, found 
949.6046;   0.4125 D  (c 1.28, CHCl3).  
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(4S,5S,7S,E)-((S)-Dec-1-en-5-yl)-4,5-bis(triisopropylsilyloxy)-7-diisopropyl(1,1,1,2,2-penta-
fluorobutylsilyloxy)deca-2,9-dienoate (SSSS-56b):  From the demixing of (S)-M-56abcd, the 
second peak SSSS-56b (92.4 mg) at 54.9 minutes was isolated as a colorless oil:  
1
H NMR (500 
MHz, CDCl3) (dd, J1 = 16.0 Hz, J2 = 4.0 Hz, 1H), 6.08 (dd, J1 = 16.0 Hz, J2 = 1.5 Hz, 
1H), 5.86 (m, 1H), 5.80 (ddt, J1 = 17.0  Hz, J2 = 10.0 Hz, J3 = 6.5 Hz, 1H), 5.01 (m, 5H), 4.59 
(m, 1H), 4.08 (m, 1H), 4.03 (m, 1H), 2.38 (m, 1H), 2.09 (m, 5H), 1.89 (ddd, J1 = 13.0 Hz, J2 = 
10.5 Hz, J3 = 2.0 Hz, 1H), 1.67 (m, 2H), 1.52 (m, 3H), 1.29 (m, 6H), 1.10 (br s, 21H), 1.07 (br s, 
21H), 1.02 (br s, 14H), 0.88 (t, J = 6.5 Hz, 3H), 0.80 (m, 2H); 
13
C NMR (75 MHz, CDCl3) 
165.8, 147.2, 138.0, 134.8, 122.5, 117.3, 114.7, 74.3, 73.7, 73.1, 69.5, 40.9, 39.8, 34.1, 33.4, 
31.7, 29.7, 25.7, 25.4, 24.9, 22.6, 18.2, 18.1, 17.7, 17.6, 14.0, 13.1, 12.9, 12.5, 0.8 19F NMR 
(282 MHz, CDCl3) 85.03 (s, 3F), 120.43 (t, 
3
JHF = 17.5 Hz, 2F); FTIR (thin film)  νmax  2946, 
2869, 1722, 1465, 1267, 1107, 994 cm1; HRMS calcd (ESI, positive mode) for C48H91O5F5Si3 
[M + Na]
+
:  949.5992, found 949.6074;   4.4625 D  (c 1.08, CHCl3). 
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(4R,5R,7R,E)-((R)-Dec-1-en-5-yl)-4,5-bis(diisopropyl(1,1,1,2,2-pentafluorobutylsilyloxy))-7-
triisopropylsilyloxy-deca-2,9-dienoate (RRRR-56c):  From the demixing of (R)-M-56abcd, the 
third peak RRRR-56c (111.6 mg) at 114.9 minutes was isolated as a colorless oil:  
1
H NMR (500 
MHz, CDCl3) 7.05(dd, J1 = 15.8 Hz, J2 = 4.9 Hz, 1H), 6.00 (dd, J1 = 15.8 Hz, J2 = 1.5 Hz, 
1H), 5.90 (ddt, J1 = 17.0 Hz, J2 = 10.5 Hz, J3 = 7.2 Hz, 1H), 5.80 (ddt, J1 = 17.0 Hz, J2 = 10.5 
Hz, J3 = 6.5 Hz 1H), 5.02 (m, 5H), 4.44 (m, 1H), 4.04 (m, 1H), 3.95 (dt, J1 = 13.5 Hz, J2 = 4.0 
Hz, 1H), 2.37 (m, 1H), 2.20 (m, 1H), 2.05 (m, 6H), 1.88 (ddd, J1 = 13.5 Hz, J2 = 9.0 Hz, J3 = 4.0 
Hz, 1H), 1.67 (m, 2H), 1.54 (m, 3H), 1.28 (br s, 21H), 1.06 (br s, 28H), 0.88 (m, 4H); 
13
C NMR 
(75 MHz, CDCl3) 165.4, 146.2, 137.9, 134.3, 122.9, 117.3, 114.8, 74.4, 74.0, 73.3, 68.6, 41.1, 
39.1, 34.1, 33.4, 31.7, 29.6, 25.7, 25.6, 25.4, 25.3, 25.1, 22.5, 17.7, 17.6, 17.5, 14.1, 14.0, 13.0, 
12.8, 12.7, 12.6, 12.5, 1.6, 0.9;19F NMR (282 MHz, CDCl3) 84.93 (s, 3F), 85.01 (s, 3F), 
120.44 (m, 4F); FTIR (thin film)  νmax  2946, 2869, 1723, 1201, 1108 cm
1; HRMS calcd (ESI, 
positive mode) for C49H88O5F10Si3 [M + Na]
+
:  1,053.5678, found 1,053.5725;   4.2225 D  (c 
1.11, CHCl3).  

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(4R,5R,7R,E)-((R)-Dec-1-en-5-yl)-4,5-bis(diisopropyl(1,1,1,2,2-pentafluorobutylsilyloxy))-7-
triisopropylsilyloxy-deca-2,9-dienoate (RRRS-56c):  From the demixing of (S)-M-56abcd, the 
third peak RRRS-56c (90.4 mg) at 68.1 minutes was isolated as a colorless oil:  
1
H NMR (500 
MHz, CDCl3) 7.05(dd, J1 = 16.0 Hz, J2 = 5.0 Hz, 1H), 6.00 (dd, J1 = 16.0 Hz, J2 = 1.5 Hz, 
1H), 5.90 (ddt, J1 = 17.0 Hz, J2 = 10.5 Hz, J3 = 7.0 Hz, 1H), 5.80 (ddt, J1 = 17.0 Hz, J2 = 10.5 
Hz, J3 = 6.5 Hz 1H), 5.02 (m, 5H), 4.44 (t, J = 3.5 Hz, 1H), 4.04 (sextet, J = 4.5 Hz, 1H), 3.95 
(m, 1H), 2.38 (m, 1H), 2.21 (m, 1H), 2.05 (m,  6H), 1.88 (ddd, J1 = 13.5 Hz, J2 = 9.0 Hz, J3 = 4.0 
Hz, 1H), 1.66 (m, 2H), 1.55 (m, 3H), 1.33 (m, 6H), 1.06 (br s, 49H), 0.88 (m, 4H); 
13
C NMR (75 
MHz, CDCl3) 165.4, 146.2, 137.9, 134.3, 122.9, 117.3, 114.8, 74.3, 74.0, 73.3, 68.6, 41.0, 
39.1, 34.1, 33.4, 31.7, 29.6, 25.7, 25.6, 25.4, 25.3, 25.1, 24.9, 22.5, 17.6, 17.5, 14.0, 13.0, 12.7, 
12.6, 1.6, 0.9;19F NMR (282 MHz, CDCl3) 84.95 (s, 3F), 85.02 (s, 3F), 120.42 (t, 
3
JHF = 
17.0 Hz, 2F), 120.48 (t, 3JHF = 17.0 Hz, 2F); FTIR (thin film)  νmax  2947, 2870, 1723, 1466, 
1266, 1201, 1107, 1065, 994, 885 cm1; HRMS calcd (ESI, positive mode) for C49H88O5F10Si3 
[M + Na]
+
:  1,053.5678, found 1,053.5664;   9.2225 D  (c 1.08, CHCl3). 

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(4R,5R,7S,E)-((R)-Dec-1-en-5-yl)-4,5,7-tris(diisopropyl(1,1,1,2,2-penta-fluorobutylsilyloxy)) 
deca-2,9-dienoate (RRSR-56d):  From the demixing of (R)-M-56abcd, the fourth peak RRSR-
56d (60.0 mg) at 163.4 minutes was isolated as a colorless oil:  
1
H NMR (500 MHz, CDCl3) 
dd, J1 = 15.8 Hz, J2 = 4.5 Hz, 1H), 6.03 (dd, J1 = 15.8 Hz, J2 = 1.5 Hz, 1H), 5.79 (m, 2H), 
5.02 (m, 5H), 4.45 (td, J1 = 4.5 Hz, J2 = 1.5 Hz, 1H), 4.05 (m, 1H), 4.01 (m, 1H), 2.32 (m, 2H), 
2.04 (m, 8H), 1.70 (m, 3H), 1.57 (m, 3H), 1.28 (m, 6H), 1.04 (br s, 42H), 0.88 (m, 4H), 0.82 (m, 
2H); 
13
C NMR (75 MHz, CDCl3) 165.4, 145.9, 137.9, 133.9, 123.1, 117.8, 114.8, 75.9, 74.1, 
72.7, 69.1, 41.8, 40.8, 34.0, 33.3, 31.7, 29.7, 29.6, 25.6, 25.5, 25.4, 25.3, 25.2, 25.0, 24.9, 22.5, 
17.8, 17.7, 17.6, 17.5, 13.9, 13.1, 13.0, 12.9, 12.8, 12.6, 12.5, 1.3, 1.2, 0.819F NMR (282 MHz, 
CDCl3) 84.99 (s, 3F), 85.03 (s, 3F), 85.05 (s, 3F) 120.42 (m, 6F);FTIR (thin film)  νmax  
2947, 2871, 1723, 1200, 1107, 1063, 993, 887 cm1; HRMS calcd (ESI, positive mode) for 
C50H85O5F15Si3 [M + Na]
+
:  1,157.5363, found 1,157.5360;   6.1825 D  (c 1.11, CHCl3).


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(4R,5R,7S,E)-((S)-Dec-1-en-5-yl)-4,5,7-tris(diisopropyl(1,1,1,2,2-penta-fluoro-butylsilyloxy)) 
deca-2,9-dienoate (RRSS-79):  From the demixing of (S)-M-56abcd, the fourth peak RRSS-56d 
(105.7 mg) at 91.5 minutes was isolated as a colorless oil:  
1
H NMR (500 MHz, CDCl3) 
dd, J1 = 16.0 Hz, J2 = 4.5 Hz, 1H), 6.03 (dd, J1 = 16.0 Hz, J2 = 1.5 Hz, 1H), 5.79 (m, 2H), 
5.02 (m, 5H), 4.45 (m, 1H), 4.05 (m, 1H), 4.01 (m, 1H), 2.32 (m, 2H), 2.04 (m, 8H), 1.70 (m, 
3H), 1.57 (m, 3H), 1.28 (m, 6H), 1.04 (br s, 42H), 0.88 (m, 4H), 0.82 (m, 2H); 
13
C NMR (75 
MHz, CDCl3) 165.4, 145.9, 137.9, 133.9, 123.1, 117.8, 114.8, 75.9, 74.1, 72.7, 69.1, 41.8, 
40.8, 34.1, 33.3, 31.7, 29.6, 25.7, 25.6, 25.4, 25.3, 25.2, 25.1, 25.0, 24.9, 22.5, 17.8, 17.7, 17.6, 
17.5, 14.0, 13.1, 13.0, 12.9, 12.8, 12.6, 12.5, 1.3, 1.2, 0.819F NMR (282 MHz, CDCl3) 84.99 
(s, 3F), 85.03 (s, 3F), 85.05 (s, 3F), 120.40 (t, 3JHF = 18.0 Hz, 2F), 120.47 (t, 
3
JHF = 18.0 
Hz, 2F), 120.48 (t, 3JHF = 18.0 Hz, 2F);FTIR (thin film)  νmax  2949, 2870, 1723, 1200, 1107, 
1065, 993, 886 cm1; HRMS calcd (ESI, positive mode) for C50H85O5F15Si3 [M + Na]
+
:  
1,157.5363, found 1,157.5306;   7.1825 D  (c 1.12, CHCl3). 
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(4S,5S,7R,E)-((R)-Dec-1-en-5-yl)-4,5,7-trihydroxydeca-2,9-dienoate ((4S,5S,7R,15R)-58):  
The same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer 
pilot synthesis (see Chapter 2.0) was followed using SSRR-56a.  Flash chromatography of the 
crude product (1:1 hexanes/EtOAc) gave the title compound as a colorless oil (16.5 mg, 65%).  
The 
1
H NMR spectrum matched that of (4R,5R,7S,15S)-58 (see below);   7.3025 D , (c 1.08, 
MeOH). 
 
O
O
OH
OH
OH
C5H11
 
 
(4S,5S,7S,E)-((R)-Dec-1-en-5-yl)-4,5,7-Trihydroxydeca-2,9-dienoate ((4S,5S,7S,15R)-58):  
The same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer 
pilot synthesis (see Chapter 2.0) was followed using SSSR-56b (68.2 mg, 44.1 mol).  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the title compound as a 
colorless oil (15.6 mg, 94%).  The 
1
H NMR spectrum matched that of (4R,5R,7R,15S)-58 (see 
below);   1.1525 D  (c 0.83, MeOH). 
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(4R,5R,7R,2E)-((R)-Dec-1-en-5-yl)-4,5,7-Trihydroxydeca-2,9-dienoate ((4R,5R,7R,15R)-58):  
The same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer 
pilot synthesis (see Chapter 2.0) was followed using RRRR-56c (112 mg, 108 mol).  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the title compound as a 
colorless oil (26.4 mg, 69%).  The 
1
H NMR spectrum matched that of (4S,5S,7S,15S)-58 (see 
below);   9.1725 D  (c 1.02, MeOH).  
 
O
O
OH
OH
OH
C5H11
 
 
(4R,5R,7S,2E)-((R)-Dec-1-en-5-yl)-4,5,7-Trihydroxydeca-2,9-dienoate ((4R,5R,7S,15R)-58):  
The same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer 
pilot synthesis (see Chapter 2.0) was followed using RRSR-56d (137 mg, 120 mol).  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the title compound as a 
colorless oil (11.0 mg, 63%).  The 
1
H NMR spectrum matched that of (4S,5S,7R,15S)-58 (see 
below);   6.3425 D  (c 1.43, MeOH). 
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(4S,5S,7R)-((S)-Dec-1-en-5-yl)-4,5,7-trihydroxydeca-2,9-dienoate ((4S,5S,7R,15S)-58):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using SSRS-56a (83.0 mg, 101 mol).  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the title compound as a 
colorless oil (23.9 mg, 67%):  
1
H NMR (600 MHz, CD3OD) 7.05dd, J1 = 15.7 Hz, J2 = 4.7 
Hz, 1H),  6.10dd, J1 = 15.7 Hz, J2 = 1.7 Hz, 1H), 5.87 (ddt, J1 = 17.2 Hz, J2 = 10.2 Hz, J3 = 7.0 
Hz, 1H),  5.82 (ddt, J1 = 16.9 Hz, J2 = 10.2 Hz, J3 = 6.7 Hz, 1H), 5.02 (m, 5H), 4.19 (td, J1 = 4.7 
Hz, J2 = 1.7 Hz, 1H), 3.87 (m, 2H), 2.24 (m, 2H), 2.07 (m, 2H), 1.68 (m, 2H), 1.58 (m, 2H), 1.54 
(m, 2H), 1.32 (br s, 6H), 0.90 (t, J = 6.9 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) 168.1, 149.8, 
139.2, 136.5, 122.8, 117.5, 115.6, 75.5, 75.2, 71.8, 68.8, 43.9, 40.6, 35.4, 34.8, 32.9, 30.9, 26.2, 
23.8, 14.5 FTIR (thin film)  νmax  3364, 2925, 2857, 1696, 1641, 1271, 1172, 1066, 990 cm
1; 
HRMS calcd (ESI, positive mode) for C20H34O5Na [M+Na]
+
:  377.2304, found 377.2276; 
  0.2325 D  (c 1.20, MeOH). 
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(4S,5S,7S)-((S)-Dec-1-en-5-yl)-4,5,7-trihydroxydeca-2,9-dienoate ((4S,5S,7S,15S)-58):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using SSSS-56b (92.4 mg, 99.6 mol).  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the title compound as a 
colorless oil (30.1 mg, 85%):  
1
H NMR (600 MHz, CD3OD) 7.05dd, J1 = 15.7 Hz, J2 = 4.6 
Hz, 1H),  6.11dd, J1 = 15.7 Hz, J2 = 1.8 Hz, 1H), 5.87 (ddt, J1 = 17.2 Hz, J2 = 10.2 Hz, J3 = 7.0 
Hz 1H),  5.82 (ddt, J1 = 16.9 Hz, J2 = 10.2 Hz, J3 = 6.7 Hz, 1H), 5.00 (m, 5H), 4.22 (td, J1 = 4.5 
Hz, J2 = 1.8 Hz, 1H), 3.87 (m, 1H), 3.82 (quintet, J = 4.3 Hz, 1H), 2.25 (m, 2H), 2.08 (m, 2H), 
1.74 (dt, J1 = 14.2 Hz, J2 = 4.4 Hz, 1H), 1.67 (m, 2H), 1.59 (m, 2H), 1.55 (dt, J1 = 17.2 Hz, J2 = 
8.7 Hz, 1H), 1.32 (br s, 6H), 0.90 (t, J = 6.9 Hz); 
13
C NMR (125 MHz, CDCl3) 168.1, 149.9, 
139.2, 136.2, 122.8, 117.7, 115.6, 75.2, 74.7, 73.8, 70.9, 43.1, 39.8, 35.4, 34.8, 32.9, 31.0, 26.2, 
23.7, 14.5 FTIR (thin film)  νmax  3364, 2925, 2858, 1697, 1274, 1172 cm
1; HRMS calcd (ESI, 
positive mode) for C20H34O5Na [M + Na]
+
:  377.2304, found 377.2279;   3.1325 D  (c 1.51, 
MeOH). 
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(4R,5R,7R)-((S)-Dec-1-en-5-yl)-4,5,7-trihydroxydeca-2,9-dienoate ((4R,5R,7R,15S)-58):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using RRRS-56c (90.4 mg, 87.6 mol).  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the title compound as a 
colorless oil (23.8 mg, 77%):  
1
H NMR (600 MHz, CD3OD) 7.05dd, J1 = 15.7 Hz, J2 = 4.6 
Hz, 1H),  6.11dd, J1 = 15.7 Hz, J2 = 1.7 Hz, 1H), 5.87 (ddt, J1 = 17.2 Hz, J2 = 10.2 Hz, J3 = 7.1 
Hz 1H),  5.82 (ddt, J1 = 16.9 Hz, J2 = 10.2 Hz, J3 = 6.7 Hz, 1H), 5.01 (m, 5H), 4.22 (td, J1 = 4.4 
Hz, J2 = 1.8 Hz, 1H), 3.87 (m, 1H), 3.82 (quintet, J = 4.4 Hz, 1H), 2.25 (m, 2H), 2.08 (m, 2H), 
1.74 (dt, J1 = 14.1 Hz, J2 = 4.4 Hz, 1H), 1.68 (m, 2H), 1.59 (m, 2H), 1.54 (dt, J1 = 14.1 Hz, J2 = 
8.7 Hz, 1H), 1.32 (br s, 6H), 0.90 (t, J = 6.9 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) 168.1, 
149.9, 139.2, 136.2, 122.8, 117.7, 115.6, 75.2, 74.7, 73.8, 70.9, 43.1, 39.8, 35.4, 34.8, 32.9, 31.0, 
26.2, 23.8, 14.5; FTIR (thin film)  νmax  3388, 2927, 2859, 1698, 1656, 1270, 1077  cm
 1; 
HRMS calcd (ESI, positive mode) for C20H34O5Na [M + Na]
+
:  377.2304, found 377.2305; 
  2.1525 D  (c 1.19, MeOH). 
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(4R,5R,7S)-((S)-Dec-1-en-5-yl)-4,5,7-trihydroxydeca-2,9-dienoate ((4R,5R,7S,15S)-58):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using RRSS-56d (106 mg, 93.1 mol).  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the title compound as a 
colorless oil (29.0 mg, 88%):  
1
H NMR (600 MHz, CD3OD) 7.05dd, J1 = 15.7 Hz, J2 = 4.7 
Hz, 1H),  6.11dd, J1 = 15.7 Hz, J2 = 1.7 Hz, 1H), 5.87 (ddt, J1 = 17.2 Hz, J2 = 10.2 Hz, J3 = 7.1 
Hz 1H),  5.82 (ddt, J1 = 17.0 Hz, J2 = 10.2 Hz, J3 = 6.7 Hz, 1H), 5.00 (m, 5H), 4.19 (td, J1 = 4.7 
Hz, J2 = 1.7 Hz, 1H), 3.88 (m, 2H), 2.24 (m, 2H), 2.08 (m, 2H), 1.68 (m, 2H), 1.55 (m, 4H), 1.32 
(br s, 6H), 0.90 (t, J = 6.9 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) 168.1, 149.8, 139.2, 136.5, 
122.8, 117.5, 115.6, 75.5, 75.2, 71.8, 68.8, 44.0, 40.6, 35.4, 34.8, 32.9, 31.0, 26.2, 23.8, 14.5 
FTIR (thin film)  νmax  3344, 2924, 2857, 1695, 1642, 1269, 1172  cm
1; HRMS calcd (ESI, 
positive mode) for C20H34O5Na [M + Na]
+
:  377.2304, found 377.2277;   2.3325 D (c 1.45, 
MeOH). 
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6.3 EXPERIMENTAL DATA FOR THE FMS OF THE 4,5-CIS-DIHYDROXY 
FAMILY OF SCH725674 
OPMBHO  
 
(E)-5-(4-Methoxybenzyloxy)pent-2-en-1-ol (60):
93
  CAS registry number:  [158817-21-1].  
DIBAL-H (9.21 mL, 9.21 mmol) was added to a solution of aldehyde 40 in CH2Cl2 (40 mL) at 
78 °C.  The reaction mixture was stirred at this temperature for 4 h and quenched by addition of 
ethyl acetate (20 mL) at 78 °C.  The mixture was then stirred at room temperature for 15 min, 
and a solution of sat. aq. Rochelle’s salt (100 mL) was added at room temperature for 1 h.  The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (3 x 150 mL).  The 
combined organic extracts were washed with water (75 mL), brine (75 mL), and then dried over 
MgSO4.  Flash chromatography of the crude product (1:1 hexanes/EtOAc) gave the title 
compound as a colorless oil (1.49 g, 87%):    
1
H NMR (300 MHz, CDCl3) δ 7.26 (d, J = 6.8 Hz, 
2H), 6.90 (d, J = 6.8 Hz, 2H), 5.73 (m, 2H), 4.46 (s, 2H), 4.10 (m, 2H), 3.81 (s, 3H), 3.50 (t, J = 
6.8 Hz, 1H), 2.37 (m, 2H). 
 
OPMBHO
O
 
 
((2S,3S)-3-(2-(4-Methoxybenzyloxy)ethyl)oxiran-2-yl)methanol (61):
93
  CAS registry number:  
[736140-63-9].  L-(+)-Diisopropyl tartrate (338 L, 1.60 mmol), Ti(iPrO)4 (403 L, 1.33 mmol), 
and t-butyl hydroperoxide (3.64 mL, 20.0 mmol) were added to a stirring slurry of molecular 
sieves (~5 g) in CH2Cl2 (35 mL) at -20 °C.  The catalyst mixture was allowed to age at this 
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temperature for 30 min prior to the addition of the allylic alcohol 60 (1.48 g, 6.67 mmol) in 
CH2Cl2 (20 mL) by cannula transfer.  The resultant reaction mixture was stirred at 20 °C for 20 
h and was passed over a pad of Celite.  The reaction was quenched by addition to a freshly 
prepared solution of FeSO4 (~8 g) and citric acid monohydrate (~3.5 g) in 40 mL deionized 
water.  The aqueous solution changed from a bright blue solution to an orange suspension after 
addition of the reaction mixture.  The layers were separated and the aqueous layer extracted with 
Et2O (3 x 50 mL).  The combined organic extracts were washed with water (100 mL), brine (100 
mL), and dried over MgSO4.  Flash chromatography of the crude product (1:2 hexanes/EtOAc) 
gave the title compound as a colorless oil (1.10 g, 69%):  
1
H NMR (300 MHz, CDCl3) δ 7.27 (d, 
J = 6.8 Hz, 2H), 6.89 (d, J = 6.8 Hz, 2H), 4.46 (s, 2H), 3.91 (dq, J1 = 2.6 Hz, J2 = 12.5 Hz, 1H), 
3.82 (s, 3H), 3.65 (m, 1H), 3.50 (t, J = 6.8 Hz, 1H), 3.11 (ddd, J1 = 2.3 Hz, J2 = 4.9 Hz, J3 = 6.7 
Hz, 1H), 2.98 (dt, J1 = 2.3 Hz, J2 = 4.3 Hz, 1H), 1.87 (m, 2H), 1.69 (m, 1H), 1.62 (m, 1H). 
 
OPMB
O
MeO2C  
 
(E)-Methyl-3-((2S,3S)-3-(2-(4-methoxybenzyloxy)ethyl)oxiran-2-yl)acrylate (62):  SO3-
pyridine complex (2.63 g, 16.2 mmol) added in one portion to a solution of epoxy alcohol 61 
(1.10 g, 4.63 mmol) and NEt3 (3.23 mL, 23.1 mmol) in 4:1 DCM/DMSO (50 mL) at 0 °C.
94
  The 
reaction mixture was stirred at room temperature for 30 min and then quenched 0 °C by addition 
of sat. aq. NH4Cl (40 mL).  The suspension was then poured into a separatory funnel.  The 
aqueous layer was then extracted with DCM (3 x 75 mL) and the combined organic extracts were 
washed with 30% aqueous CuSO4 solution (3 x 100 mL) to remove pyridine.  The organic phase 
was then washed with sat. aq. NaHCO3 (100 mL) and brine (100 mL), dried over MgSO4, and 
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concentrated in vacuo.  The crude product was taken to the next step without further purification 
(1.03 g): 
1
H NMR (300 MHz, CDCl3) δ 9.03 (d, J = 6.2 Hz, 1H), 7.26 (d, J = 6.8 Hz, 2H), 6.90 
(d, J = 6.8 Hz, 2H), 5.84 (m, 1H), 4.47 (s, 2H), 3.82 (s, 3H), 3.61 (m, 2H), 3.41 (m, 1H), 3.22 
(dd, J1 = 1.9 Hz, J2 = 6.3 Hz, 1H), 1.95 (m, 2H). 
 The general procedure for the Masamune-Roush olefination
54
 was followed with the 
crude aldhehyde (1.03 g, 4.38 mmol), trimethylphosphonoacetate (773 L, 5.25 mmol), LiCl 
(223 mg, 5.25 mmol), and DBU (735 L, 4.82 mmol) in acetonitrile (42 mL).  1H NMR analysis 
of the crude product showed a single E isomer.  Flash chromatogtaphy of the crude product (3:1 
hexanes/EtOAc) gave the E-isomer as a colorless oil (814 mg, 64% over 2 steps):  
1
H NMR (300 
MHz, CDCl3) δ 7.27 (d, J = 6.8 Hz, 2H), 6.89 (d, J = 6.8 Hz, 2H), 6.69 (dd, J1 = 7.1 Hz, J2 = 
15.7 Hz, 1H), 6.13 (d, J = 15.7 Hz, 1H), 4.46 (s, 2H), 3.82 (s, 3H), 3.76 (s, 3H), 3.59 (t, J = 6.2 
Hz, 2H), 3.28 (dd, J1 = 2.0 Hz, J2 = 7.0 Hz, 1H), 3.04 (m, 1H), 1.91 (m, 2H); HRMS (EI) calcd 
for C16H20O5 292.1311, found 292.1298. 
 
O
O
O
OH
 
 
2-Deoxy-3,4-O-isopropylidene-D-ribose ((4R,5S)-63):
98
 CAS registry number:  [86795-47-3].  
p-Toluenesulfonic acid (5.61 g, 28.9 mmol) was added to a stirring solution of 2-deoxy-D-ribose 
(20.0 g, 0.145 mol) and 2-methoxypropene (14.3 mL, 0.145 mol) in N,N′-dimethylformamide 
(300 mL) at 0 °C.  After stirring at 0 °C for 1 h, another stoichiometric amount of 2-
methoxypropene (14.3 mL, 0.145 mmol) was added and the reaction was stirred at 0 °C for 
another 2 h.  The reaction was quenched at 0 °C by addition of saturated aqueous NaHCO3 (~100 
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mL) and the resultant suspension was stirred for 1 h at 0 °C.  The suspension was then 
transferred to a separatory funnel and partitioned with diethyl ether (~400 mL).  The layers were 
separated and the aqueous layer was extracted with diethyl ether (3 x 300 mL).  The combined 
organic extracts were washed with water (150 mL), brine (150 mL), dried over MgSO4, and 
concentrated in vacuo.  Flash chromatography of the crude product (1:1 hexanes/EtOAc) gave 
the title compound as a colorless oil, isolated as a 4:1  anomeric composition (6.79 g, 27%):  
1
H NMR (300 MHz, d6-DMSO) δ 6.24 (d, J = 5.2 Hz, 1H), 4.94 (dt, J1 = 7.0 Hz, J2 = 4.3 Hz, 
1H), 4.34 (dt, J1 = 6.2 Hz, J2 = 4.4 Hz, 1H), 4.05 (m, 1H), 3.78 (dd, J1 = 12.6 Hz, J2 = 3.6 Hz, 
1H), 3.46 (dd, J1 = 12.5 Hz, J2 = 3.8 Hz, 1H), 1.93 (dt, J1 = 14.5 Hz, J2 = 4.2 Hz, 1H), 1.63 (ddd, 
J1 = 14.5 Hz, J2 = 7.1 Hz, J3 = 4.4 Hz, 1H), 1.36 (s, 3H), 1.24 (s, 3H). 
 
O
O
O
HO
 
 
2-Deoxy-3,4-O-isopropylidene-L-ribose ((4S,5R)-63):
98
  CAS registry number:  [522608-67-9].  
The procedure for the preparation of (4R,5S)-63 was repeated using 2-deoxy-L-ribose (24.5 g, 
0.179 mol), 2-methoxypropene (34.4 mL, 0.350 mol), and p-toluenesulfonic acid (6.95 g, 35.8 
mmol).  Flash chromatography of the crude product (1:1 hexanes/EtOAc) gave the title 
compound as a colorless oil, isolated as a 4:1  anomeric composition (7.81 g, 25%).  The 1H 
NMR spectrum matched that of (4R,5S)-63 (see above);   3.4725 D  (c 0.13, water), literature 
value reported for the D-enantiomer:   0.4625 D  (c 0.10, water). 
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((4R,5S)-5-Allyl-2,2-dimethyl-1,3-dioxolan-4-yl)-methanol ((4R,5S)-64):
97
  CAS registry 
number:  [663176-89-4].  Butyllithium (1.6 M in hexanes, 68.2 mL, 0.109 mol) was added 
dropwise by syringe to a stirred suspension of methyltriphenylphosphonium iodide (48.8 g, 
0.117 mol) in THF (450 mL) at 78 °C.  The reaction was stirred at 78 °C for 15 min, then 
warmed to 0 °C and stirred at this temperature for 30 min.  A solution of the acetonide (4R,5S)-
63 (6.79 g, 39.0 mmol) in THF (50 mL) was then transferred to the stirring suspension at 78 °C 
by cannula (along with a 10 mL THF rinse of the original flask containing the acetonide).  The 
reaction mixture was stirred at 78 °C for 30 min and then warmed to room temperature.  After 4 
h at room temperature, the reaction was quenched by addition of sat. aq. NH4Cl (200 mL).  The 
layers were then separated and the aqueous layer was extracted with ether (3 x 300 mL).  The 
combined organic extracts were then washed with water (200 mL), brine (200 mL), dried over 
MgSO4, and concentrated in vacuo.  Flash chromatography of the crude product (2:1 
hexanes/EtOAc) gave the title compound as a colorless oil (5.74 g, 85%): 
1
H NMR (400 MHz, 
CDCl3) δ 5.85 (ddt, J1 = 17.1 Hz, J2 = 10.2 Hz, J3 = 6.7 Hz, 1H), 4.27 (dt, J1 = 8.2 Hz, J2 = 6.0 
Hz, 1H), 4.19 (quartet, J = 5.8 Hz, 1H), 3.66 (t, J = 5.8 Hz, 1H), 2.42 (m, 1H), 2.30 (m, 1H), 1.89 
(t, J = 5.8 Hz, 1H), 1.50 (s, 3H), 1.39 (s, 3H). 
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((4S,5R)-5-Allyl-2,2-dimethyl-1,3-dioxolan-4-yl)methanol ((4S,5R)-64):  The procedure used 
for the preparation of (4R,5S)-64 was employed with acetonide (4S,5R)-63 (7.81 g, 44.8 mmol), 
methyltriphenylphosphonium iodide (59.2 g, 0.144 mol), and butyllithium (1.6 M in hexanes, 
81.4 mL, 0.135 mol).  Flash chromatography of the crude product gave the title compound as a 
colorless oil (6.12 g, 79%).  The 
1
H NMR spectrum of (4S,5R)-64 matched that of its enantiomer 
(see above);   6.1125 D  (c 0.29, CHCl3). 
 
CO2Me
O
O
 
 
(E)-Methyl-3-((4R,5S)-5-allyl-2,2-dimethyl-1,3-dioxolan-4-yl)acrylate ((4R,5S)-65):  The 
two-step oxidation-olefination
54, 94
 sequence used for 62 was repeated with (4R,5S)-64 (5.74 g, 
33.3 mmol) using SO3-pyridine complex (18.9 g, 0.117 mol), NEt3 (23.9 mL, 0.167 mol) in 4:1 
DCM/DMSO (350 mL) at 0 °C.  The crude aldehyde product was taken to the next step without 
further purification (5.29 g, 31.1 mmol): 
1
H NMR (300 MHz, CDCl3) δ 9.69 (d, J = 3.5 Hz, 1H), 
5.84 (m, 1H), 5.17 (dq, J1 = 7.1 Hz, J2 = 1.5 Hz, 1H), 5.13 (t, J = 1.2 Hz, 1H), 4.44 (td, J1 = 7.5 
Hz, J2 = 5.5 Hz, 1H), 4.32 (dd, J1 = 7.1 Hz, J2 = 3.1 Hz, 1H), 2.44-2.25 (m, 2H), 1.61 (s, 3H), 
1.43 (s, 3H). 
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 The general procedure for the Masamune-Roush olefination
54
 was used with the crude 
aldhehyde (5.29 g, 31.1 mmol), trimethylphosphonoacetate (5.56 mL, 37.3 mmol), LiCl (1.61 g, 
37.3 mmol), and DBU (5.27 mL, 34.2 mmol) in acetonitrile (350 mL).  
1
H NMR analysis of the 
crude product showed a 4:1 E/Z mixture of geometric isomers.  Flash chromatography of the 
crude product (10:1 hexanes/EtOAc) gave the E-isomer as a colorless oil (4.01 g, 57% over 2 
steps):  
1
H NMR (300 MHz, CDCl3) δ 6.88 (dd, J1 = 15.6 Hz, J2 = 5.9 Hz, 1H), 6.11 (dd, J1 = 
15.6 Hz, J2 = 1.4 Hz, 1H), 5.81 (m, 1H), 5.14 (ddd, J1 = 17.8 Hz, J2 = 11.0 Hz, J3 = 6.8 Hz, 2H), 
4.71 (td, J1 = 6.3 Hz, J2 = 1.3 Hz, 1H), 4.33 (dt, J1 = 8.2 Hz, J2 = 6.0 Hz, 1H), 3.77 (s, 3H), 2.24 
(m, 2H), 1.54 (s, 3H), 1.40 (s, 3H);  
13
C NMR (75 MHz, CDCl3) δ 166.3, 143.7, 133.8, 122.6, 
117.7, 109.0, 77.6, 77.1, 51.6, 35.1, 27.9, 25.4; FTIR (thin film)  νmax 2987, 2939, 1726, 1380, 
1307, 1256, 1217, 1165 cm1; HRMS calcd (ESI) for C12H18O4Na [M + Na]
+
:  249.1103, found 
249.1086;   8.1225 D  (c 1.26, CHCl3). 
 
CO2Me
O
O
 
 
(E)-Methyl 3-((4S,5R)-5-allyl-2,2-dimethyl-1,3-dioxolan-4-yl)acrylate ((4S,5R)-65).  The 
alcohol (4S,5R)-64 (6.12 g, 35.5 mmol) was taken through the same two-step 
oxidation/olefination
54, 94
 procedure as reported for (4R,5S)-62 using SO3-pyridine complex (20.2 
g, 0.124 mol), NEt3 (25.0 mL, 0.178 mol) in 4:1 DCM/DMSO (350 mL).  The crude aldehyde 
product was taken to the next olefination step without further purification:  
1
H NMR (300 MHz, 
CDCl3) δ 9.69 (d, J = 3.5 Hz, 1H), 5.84 (m, 1H), 5.17 (dq, J1 = 7.1 Hz, J2 = 1.5 Hz, 1H), 5.13 (t, 
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J = 1.2 Hz, 1H), 4.44 (td, J1 = 7.5 Hz, J2 = 5.5 Hz, 1H), 4.32 (dd, J1 = 7.1 Hz, J2 = 3.1 Hz, 1H), 
2.44-2.25 (m, 2H), 1.61 (s, 3H), 1.43 (s, 3H). 
 The general procedure for the Masamune-Roush olefination
54
 was used with the crude 
aldehyde (4.11 g, 24.1 mmol), trimethylphosphonoacetate (4.27 mL, 29.0 mmol), LiCl (1.25 g, 
29.0 mmol), and DBU (4.05 mL, 26.6 mmol) in MeCN (250 mL).  
1
H NMR analysis of the crude 
product showed a 4:1 E/Z mixture of geometric isomers.  Flash chromatogtaphy of the crude 
product (10:1 hexanes/EtOAc) gave the E-isomer (3.40 g, 62% over 2 steps).  The 
1
H NMR 
spectrum of (4S,5R)-65 matched that of its enantiomer (see above);   1.1325 D  (c 1.04, CHCl3). 
 
CO2Me
OH
OH
 
 
(4R,5S,E)-Methyl-4,5-dihydroxyocta-2,7-dienoate ((4R,5S)-66):  Acetyl chloride (3.82 mL, 
52.5 mmol) was added by syringe to a stirring solution of the acetal (4R,5S)-65 in MeOH (170 
mL) at 0 °C.  The reaction was stirred for 15 min at 0 °C, and warmed to room temperature.  The 
reaction was stirred at room temperature for 3 h, and then concentrated in vacuo.  Flash 
chromatography of the crude product (1:1 hexanes/EtOAc) gave the title compound as a pale 
yellow syrup (3.15 g, 97%):  
1
H NMR (300 MHz, CDCl3) δ 6.99 (dd, J1 = 15.8 Hz, J2 = 4.9 Hz, 
1H), 6.16 (dd, J1 = 15.8 Hz, J2 = 1.8 Hz, 1H), 5.83 (m, 1H), 5.18 (m, 2H), 4.41 (m, 1H), 3.82 (m, 
1H), 3.76 (s, 3H), 2.48 (m, 1H), 2.27 (m, 2H), 2.18 (m, 1H);  
13
C NMR (75 MHz, CDCl3) δ 
166.9, 145.9, 134.1, 122.0, 118.5, 73.4, 73.0, 51.8, 36.4; FTIR (thin film)  νmax 3426, 2953, 1708, 
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1438, 1281, 1198, 1174 cm1; HRMS calcd (EI) for C9H15O4 [M]
+
:  187.0970, found 187.0964; 
  5.1625 D  (c 1.34, CHCl3). 
 
CO2Me
OH
OH
 
 
(4R,5S,E)-Methyl-4,5-dihydroxyocta-2,7-dienoate ((4S,5R)-66):  The procedure used for the 
preparation of (4R,5S)-66 was repeated using (4S,5R)-65 (3.40 g, 15.0 mmol) with acetyl 
chloride (3.28 mL, 45.1 mmol) in MeOH (150 mL).  Flash chromatography of the crude product 
(1:1 hexanes/EtOAc) gave the title compound as a pale yellow syrup (2.70 g, 97%).  The 
1
H 
NMR spectrum of (4S,5R)-66 matched that of its enantiomer (see above);    3.1625 D  (c 1.56, 
CHCl3). 
 
MeO2C
OTIPS
OTIPS
 
 
(4S,5R,E)-Methyl 4,5-bis(triisopropylsilyloxy)octa-2,7-dienoate (SR-67).  The same 
procedure for the preparation of compound SS-42a was followed using the diol (4R,5S)-66 (2.70 
g, 14.5 mmol), TIPSOTf (10.1 mL, 36.2 mmol), and 2,6-lutidine (5.15 mL, 43.5 mL) in DCM 
(100 mL).  Flash chromatography of the crude product (40:1 hexanes/EtOAc) gave the title 
compound as a colorless oil (6.74 g, 93%):  
1
H NMR (300 MHz, CDCl3) δ 7.00 (dd, J1 = 15.8 
Hz, J2 = 6.6 Hz, 1H), 5.96 (dd, J1 = 15.8 Hz, J2 = 1.2 Hz, 1H), 5.80 (m, 1H), 5.10 (ddd, J1 = 16.8 
 154 
Hz, J2 = 10.7 Hz, J3 = 7.7 Hz, 2H), 4.39 (dq, J1 = 6.6 Hz, J2 = 1.3 Hz, 1H), 4.01 (ddd, J1 = 7.9 
Hz, J2 = 5.1 Hz, J3 = 2.5 Hz, 1H), 3.76 (s, 3H), 2.35 (m, 2H), 1.07 (br s, 42H);  
13
C NMR (75 
MHz, CDCl3) δ 166.7, 148.5, 134.4, 121.5, 117.8, 77.0, 75.5, 51.5, 39.2, 18.2 (br s), 12.7 (br s); 
FTIR (thin film)  νmax 2944, 2893, 2867, 1731, 1464, 1271, 1244, 1166, 1119, 1064 cm
 1; 
HRMS calcd (ESI) for C27H54O4Si2Na [M + Na]
+
:  521.3458, found 521.3481;   4.1225 D  (c 
1.44, CHCl3). 
 
MeO2C
OTIPSF5
OTIPSF5
 
 
(4R,5S,E)-Methyl-4,5-bis(Diisopropyl-(3,3,4,4,4-pentafluorobutyl)silyloxy)octa-2,7-dienoate 
(RS-67).  The general procedure for fluorous tagging
105
 was followed using the diol (4R,5S)-66 
(3.08 g, 16.5 mmol), (3,3,4,4,4-pentafluorobutyl)diisopropylsilane (12.3 g, 45.6 mmol), 
CF3SO3H (3.85 mL, 42.9 mmol), and 2,6-lutidine (5.87 mL, 49.5 mmol) in DCM (100 mL).  
Flash chromatography of the crude product (40:1 hexanes/EtOAc) afforded the title compound as 
a colorless oil (10.5 g, 90%):  
1
H NMR (300 MHz, CDCl3) δ 6.92 (dd, J1 = 15.8 Hz, J2 = 6.7 Hz, 
1H), 5.96 (dd, J1 = 15.8 Hz, J2 = 1.0 Hz, 1H), 5.76 (m, 1H), 5.12 (ddd, J1 = 16.4 Hz, J2 = 10.9 
Hz, J3 = 5.4 Hz, 2H), 4.30 (dd, J1 = 6.7 Hz, J2 = 1.8 Hz, 1H), 3.89 (m, 1H), 3.76 (s, 3H), 2.29 (m, 
2H), 2.05 (m, 4H), 1.04 (br s, 28H), 0.85 (m, 4H);  
13
C NMR (75 MHz, CDCl3) δ 166.2, 146.6, 
133.7, 122.6, 118.5, 76.8, 75.5, 51.7, 38.7, 25.2 (m), 18.8, 17.6, 17.5 (br s), 17.4, 13.4, 12.9, 
12.8, 12.7, 12.6, 10.4, 1.0, 0.9; 
19
F NMR (282 MHz, CDCl3) 85.01 (s, 3F), 85.06 (s, 3F), 
120.46 (m, 4F); FTIR (thin film)  νmax 2948, 2870, 1732, 1464, 1440, 1381, 1333, 1276, 1244, 
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1198, 1107 cm1; HRMS calcd (ESI) for C29H48O4F10Si2Na [M + Na]
+
:  729.2829, found 
729.2823;   25.125 D  (c 1.14, CHCl3). 
 
O
MeO2C
OTIPS
OTIPS
 
 
(4S,5R,E)-Methyl-7-oxo-4,5-bis(triisopropylsilyloxy)hept-2-enoate (SR-43).  The same 
method employed for the preparation of RS-43 (see below) was followed using 2,6-lutidine (3.17 
mL, 26.8 mmol), OsO4 (2.5 wt. %, 3.36 mL, 0.27 mmol), NaIO4 (11.6 g, 53.6 mmol), and the 
alkene SR-67 (6.68 g, 13.4 mmol) in 3:1 dioxane/water (120 mL) at room temperature.  Flash 
chromatography of the crude product (10:1 hexanes/EtOAc) gave the title compound as a pale 
brown oil (5.32 g, 79%):  
1
H NMR (300 MHz, CDCl3) δ 9.91 (m, 1H), 6.90 (dd, J1 = 15.8 Hz, J2 
= 6.4 Hz, 1H), 6.10 (dd, J1 = 15.8 Hz, J2 = 1.3 Hz, 1H), 4.56 (dd, J1 = 6.3 Hz, J2 = 1.4 Hz, 1H), 
4.31 (m, 1H), 3.76 (s, 3H), 2.63 (m, 2H), 1.09 (broad s, 42H); 
13
C NMR (75 MHz, CDCl3) δ 
200.9, 166.3, 147.9, 122.3, 77.3, 72.5, 51.7, 46.7, 18.1 (br s), 12.5 (br s); FTIR (thin film)  νmax  
2945, 2892, 2867, 1728, 1463, 1274, 1243, 1166, 1131 cm1; HRMS calcd (ESI) for 
C26H52O5Si2Na [M + Na]
+
:  523.3251, found 523.3285;   13.025 D  (c 1.26, CHCl3). 
 
O
MeO2C
OTIPSF5
OTIPSF5
 
 
(4R,5S,2E)-Methyl-4,5-bis(diisopropyl(3,3,4,4,4-pentafluorobutyl)silyloxy)-7-oxohept-2-
enoate (RS-43):  2,6-lutidine (1.60 mL, 13.5 mmol), OsO4 (2.5 wt. %, 1.70 mL, 0.135 mmol), 
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and NaIO4 (5.96 g, 27.1 mmol) were sequentially added to a solution of the alkene RS-67 (4.78 
g, 6.76 mmol) in 3:1 dioxane/water (80 mL) at room temperature.  The resultant suspension was 
stirred for 4 h at room temperature, and then water (100 mL) and DCM (200 mL) were added.  
The bilayer was then transferred to a separatory funnel and the layers were separated.  The 
aqueous layer was extracted with DCM (3 x 100 mL) and the combined organic extracts were 
then washed with water (100 mL), brine (100 mL), dried over MgSO4, and then concentrated in 
vacuo.  Flash chromatography of the crude product (10:1 hexanes/EtOAc) gave the title 
compound as a pale brown oil (3.27 g, 68%):  
1
H NMR (300 MHz, CDCl3) δ 9.82 (m, 1H), 6.85 
(dd, J1 = 15.8 Hz, J2 = 6.5 Hz, 1H), 5.99 (d, J = 15.8 Hz, 1H), 4.36 (m, 2H), 3.76 (s, 3H), 2.67 
(m, 2H), 2.05 (m, 4H), 1.10 (broad s, 28H), 0.85 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ 199.5, 
165.9, 146.1, 123.2, 76.8, 71.8, 51.7, 47.3, 25.1 (m), 17.4 (br s), 12.6 (br s), 0.9, 0.8; 
19
F NMR 
(282 MHz, CDCl3) 84.96 (s, 3F), 85.00 (s, 3F), 120.29 (t, 
3
JHF = 17.5 Hz, 2F), 120.39 (t, 
3
JHF = 17.5 Hz, 2F); FTIR (thin film)  νmax  2948, 2870, 1729, 1196, 991 cm
1; HRMS calcd 
(ESI) for C28H46O5Si2F10K [M + K]
+
:  747.2361, found 747.2334;   00.325 D  (c 1.06, CHCl3). 
 
MeO2C
OTIPS
O OTIPS
TIPS
 
 
(4S,5R,7R,)-Methyl-4,5,7-tris(triisopropylsilyloxy)deca-2,9-dienoate (SRR-46e):  The in situ 
preparation
79
 of the Brown reagent used for preparation of RRS-46d was repeated with 
allylmagnesium bromide (9.92 mL, 9.92 mmol), (+)-DIP-Cl (3.55 g, 10.5 mmol), and aldehyde 
SR-43 (1.51 g, 3.01 mmol) in Et2O (25 mL) at 78 °C.  Flash chromatography of the crude 
product (10:1 hexanes/EtOAc) gave the untagged homoallylic alcohol as an inseparable mixture 
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of diastereomers (~6:1 d.r.) along with 3-pinanol by-product.  This mixture was taken to the next 
tagging step without further purification. 
 The same silylation procedure used to obtain SS-42a was used for the inseparable mixture 
of diastereomers using TIPSOTf (0.90 mL, 3.26 mmol) and 2,6-lutidine (0.52 mL, 4.34 mmol) in 
DCM (30 mL).  Flash chromatography of the crude product gave the title compound as an 
inseparable mixture of diastereomers (1.04 g, 8:1 d.r., 54% over 2 steps):  
1
H NMR (300 MHz, 
CDCl3) δ 7.00 (dd, J1 = 15.8 Hz, J2 = 6.3 Hz, 1H), 5.95 (d, J = 15.8 Hz, 1H), 5.82 (m, 1H), 5.04 
(dd, J1 = 17.2 Hz, J2 = 10.1 Hz, J2 = 9.6 Hz, 2H), 4.48 (d, J = 6.5 Hz, 1H), 4.10 (t, J = 6.5 Hz, 
1H), 4.02 (quintet, J = 4.9 Hz, 1H), 3.75 (s, 3H), 2.30 (m, 2H), 1.75 (m, 2H), 1.07 (broad s, 
63H); 
13
C NMR (75 MHz, CDCl3) δ 166.6, 148.7, 134.4, 121.4, 117.4, 74.2, 69.2, 51.6, 41.7, 
40.8, 18.3 (br s), 12.7 (br s); FTIR (thin film)  νmax  2945, 2868, 1733, 1465, 1062, 996 cm
 1; 
HRMS calcd (ESI, positive mode) for C38H78O5Si3Na [M + Na]
+
:  721.5055, found 721.5110; 
  10.525 D  (c 1.93, CHCl3). 
 
MeO2C
OTIPS
O OTIPSF5
TIPS
 
 
(4S,5R,7S,2E)-Methyl-7-(di-isopropyl-(3,3,4,4,4-penta-fluoro-butyl)-silyloxy)-4,5-bis(triiso-
propyl-silyloxy)deca-2,9-dienoate (SRS-46f).  The in situ preparation
79
 of the Brown reagent 
used for RRS-46d was repeated with aldehyde SR-43 (1.29 g, 3.01 mmol), ()-DIP-Cl (3.04 g, 
8.99 mmol), and allylmagnesium bromide (8.48 mL, 8.48 mmol) in Et2O (25 mL).  Flash 
chromatography of the crude product (10:1 hexanes/EtOAc) gave the untagged homoallylic 
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alcohol as an inseparable mixture of diastereomers (~6:1 d.r.) along with 3-pinanol by-product.  
This mixture was taken to the next tagging step without further purification. 
 The general procedure for fluorous tagging
105
 was used for the inseparable mixture of 
diastereomers with (3,3,4,4,4-pentafluorobutyl)diisopropylsilane (1.17 g, 4.45 mmol), triflic acid 
(0.36 mL, 3.92 mmol), and 2,6-lutidine (0.64 mL, 5.34 mmol) in DCM (40 mL).  Flash 
chromatography of the crude product (40:1 hexanes/EtOAc) gave the title compound as an 
inseparable mixture of diastereomers (1.27 g, 6:1 d.r., 61% over 2 steps):  
 1
H NMR (300 MHz, 
CDCl3) δ 7.00 (dd, J1 = 15.8 Hz, J2 = 6.4 Hz, 1H), 5.97 (d, J = 15.8 Hz, 1H), 5.80 (m, 1H), 5.07 
(ddd, J1 = 16.7 Hz, J2 = 10.5 Hz, J3 = 6.2 Hz, 2H), 4.38 (d, J = 6.5 Hz, 1H), 4.03 (t, J = 6.5 Hz), 
3.87 (quintet, J = 5.6 Hz), 3.76 (s, 3H), 2.25 (m, 2H), 2.05 (m, 2H), 1.76 (m, 2H), 1.08 (broad s, 
56H), 0.83 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 166.4, 148.0, 134.2, 121.7, 117.7, 76.7, 74.3, 
69.7, 51.6, 42.4, 41.7, 25.4 (m), 18.1 (br s), 13.2 (br s), 0.9; 
19
F NMR (282 MHz, CDCl3) 84.97 
(s, 3F), 120.35 (t, 3JHF = 17.7 Hz, 2F); FTIR (thin film) νmax  2947, 2869, 1733, 1466, 1201, 
1168, 1096, 1060, 994 cm1; HRMS calcd (ESI, positive mode) for C39H75O5F5Si3Na [M + 
Na]
+
:  825.4740, found 825.4711;   41.625 D , (c 1.57, CHCl3). 
 
MeO2C
OTIPSF5
O OTIPS
TIPSF5
 
 
(4R,5S,7S)-Methyl-4,5-bis-(di-iso-propyl-(3,3,4,4,4-penta-fluoro-butyl)-silyl-oxy)-7-(tri-iso-
propyl-silyl-oxy)deca-2,9-dienoate (RSR-46g).  The in situ preparation
79
 of the Brown reagent 
used for RRS-46d was repeated with aldehyde RS-43 (1.17 g, 1.65 mmol), (+)-DIP-Cl (1.95 g, 
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5.77 mmol), and allylmagnesium bromide (5.44 mL, 5.44 mmol) in Et2O (30 mL).  Flash 
chromatography of the crude product (10:1 hexanes/EtOAc) gave the untagged homoallylic 
alcohol as an inseparable mixture of diastereomers (~6:1 d.r.) along with 3-pinanol by-product.   
 This mixture was taken to the next tagging step using TIPSOTf (0.813 mL, 2.95 mmol), 
2,6-lutidine (0.40 mL) in DCM (15 mL) in the same manner reported for SS-42a.  Flash 
chromatography of the crude product (40:1 hexanes/EtOAc) gave the title compound as an 
inseparable mixture of diastereomers (977 mg, 4:1 d.r., 65% over 2 steps):   
1
H NMR (300 MHz, 
CDCl3) δ 6.94 (dd, J1 = 15.8 Hz, J2 = 6.7 Hz, 1H), 5.97 (dd, J1 = 15.8 Hz, J2 = 1.1 Hz, 1H), 5.85 
(m, 1H), 5.08 (ddd, J1 = 17.1 Hz, J2 = 10.3 Hz, J3 = 8.7 Hz, 2H), 4.27 (d, J = 6.5 Hz, 1H), 4.01 
(td, J1 = 6.5 Hz, J2 = 1.9 Hz, 1H), 3.91 (quintet, J = 6.5 Hz, 1H), 3.76 (s, 3H), 2.29 (m, 2H), 2.05 
(m, 4H), 1.67 (t, J = 6.7 Hz, 1H), 1.06 (broad s, 49H), 0.86 (m, 4H); 
13
C NMR (75 MHz, CDCl3) 
δ 166.0, 146.2, 134.0, 122.7, 121.3, 117.7, 117.5, 74.4, 68.9, 51.7, 41.9, 25.4 (m), 17.6 (br s), 
12.9 (br s), 1.3, 0.9; 
19
F NMR (282 MHz, CDCl3) δ 85.01 (s, 3F), 85.04 (s, 3F), 120.47 (m, 
4F); FTIR (thin film) νmax  2948, 2870, 1734, 1200, 1104, 1061, 993 cm
1; HRMS calcd (ESI, 
positive mode) for C40H72O5F10Si3Na [M + Na]
+
:  929.4426, found 929.4446;   88.325 D  (c 
1.04, CHCl3). 
 
MeO2C
OTIPSF5
O OTIPSF5
TIPSF5
 
 
(4R,5S,7S,E)-Methyl-4,5,7-tris-(di-isopropyl-(3,3,4,4,4-pentafluorobutyl)-silyloxy)-deca-2,9-
dienoate (RSS-46g).   The in situ preparation
79
 of the Brown allylborane used for the preparation 
of RRS-46d was followed using the aldehyde RS-43 (1.02 g, 1.65 mmol), ()-DIP-Cl (1.95 g, 
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5.77 mmol), and allylmagnesium bromide (5.40 mL, 5.40 mmol) in Et2O (30 mL).  Flash 
chromatography of the crude product (10:1 hexanes/EtOAc) gave the untagged homoallylic 
alcohol as an inseparable mixture of diastereomers (~6:1 d.r.) along with 3-pinanol by-product.  
This mixture was taken to the next tagging step using the general procedure for fluorous 
tagging
105
 with (3,3,4,4,4-pentafluorobutyl)diisopropylsilane (0.861 g, 3.28 mmol), CF3SO3H 
(0.27 mL, 3.02 mmol), and 2,6-lutidine (0.47 mL, 3.94 mmol) in DCM (13 mL).  Flash 
chromatography of the crude product (40:1 hexanes/EtOAc) gave the title compound as an 
inseparable mixture of diastereomers (1.17 g, 8:1 d.r., 80% over 2 steps):   
1
H NMR (300 MHz, 
CDCl3) δ 6.91 (dd, J1 = 15.8 Hz, J2 = 6.5 Hz, 1H), 5.94 (d, J = 15.8 Hz, 1H), 5.76 (m, 1H), 5.07 
(ddd, J1 = 15.9 Hz, J2 = 10.8 Hz J3 = 9.0 Hz, 2H), 4.34 (d, J = 6.6 Hz, 1H), 4.02 (m, 1H), 3.95 
(m, 1H), 3.77 (s, 3H), 2.27 (m, 2H), 2.05 (m, 6H), 1.68 (m, 2H), 1.05 (broad s, 42H), 0.87 (m, 
6H); 
13
C NMR (75 MHz, CDCl3) δ 166.0, 146.4, 133.5, 122.6, 118.1, 76.9, 74.0, 69.4, 51.7, 
41.5, 40.9, 25.4 (m), 17.5 (br s), 13.0 (br s), 1.2, 0.9, 0.8; 
19
F NMR (282 MHz, CDCl3) 84.97 (s, 
3F), 84.99 (s, 3F), 85.03 (s, 3F), 120.45 (m, 6F); FTIR (thin film) νmax  2949, 2870, 1733, 
1198, 1066, 993, 886 cm1; HRMS calcd (ESI, positive mode) for C41H69O5F15Si3Na [M + 
Na]
+
:  1,033.4111, found 1,033.4084;   26.525 D  (c 1.02, CHCl3). 
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HO
O
OTIPSF5
OTIPSF5
OTIPS
HO
O
OTIPSF5
OTIPSF5
OTIPSF5
HO
O
OTIPS
OTIPS
OTIPS
HO
O
OTIPS
OTIPS
OTIPSF5
+ + +
 
 
(4S,5R,7R,E)-4,5,7-Tris-(tri-iso-propyl-silyl-oxy)deca-2,9-dienoic acid, (4S,5R,7S,E)-4,5-Bis-
(triiso-propylsilyloxy)-7-((1,1,1,2,2)-penta-fluorobutyldiisopropyl-silyloxy)-deca-2,9-dienoic 
acid, (4R,5S,7R,E)-4,5-Bis((1,1,1,2,2)-penta-fluoro-butyl-(di-isopropyl-silyl-oxy))-7-(triiso-
propyl-silyloxy)-deca-2,9-dienoic acid, (4R,5S,7S,E)-4,5,7-Tris((1,1,1,2,2)-pentafluorobutyl-
(diisopropylsilyloxy))deca-2,9-dienoic acid (M-55efgh).  The same procedure employed for 
compound 43 was repeated using SRR-46e (300 mg, 0.43 mmol), SRS-46f (345 mg, 0.43 mmol), 
RSR-46g (389 mg, 0.43 mmol), RSS-46h (434 mg, 0.43 mmol), and TMSOK (3.61 g, 25.36 
mmol) in Et2O (17.0 mL).  Flash chromatography of the crude product (3:1 hexanes/EtOAc) 
gave the title compound as a colorless oil (1.14 g, 80% based on average molecular weight):  
LRMS (ESI, positive mode) (SRR-55e) m/z 708 (M + Na)
+
; (SRS-55f) m/z 811 (M + Na)
+
; (RSR-
55g) m/z 915 (M + Na)
+
; (RSS-55h) m/z 1019 (M + Na)
+
; fluorous analytical HPLC (90:10 
MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 mL/min):  tR = 15.0 min (SRR-55e), 
18.5 min (SRS-55f), 20.9 min (RSR-55g), 24.0 min (RSS-55h). 
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(4S,5R,7R)-((R)-Dec-1-en-5-yl)-4,5,7-tris(triisopropylsilyloxy)deca-2,9-dienoate, (4S,5R,7S)-
((R)-Dec-1-en-5-yl)-4,5-bis(triisopropylsilyloxy)-7-diisopropyl-(1,1,1,2,2-penta-fluoro-butyl-
silyloxy)deca-2,9-dienoate, (4R,5S,7R)-((R)-Dec-1-en-5-yl)-4,5-bis-(di-iso-propyl-(1,1,1,2,2-
pentafluorobutylsilyloxy))-7-tri-isopropyl-silyl-oxy-deca-2,9-dienoate, (4R,5S,7S)-((R)-Dec-
1-en-5-yl)-4,5,7-tris(diisopropyl(1,1,1,2,2-pentafluorobutylsilyloxy))-deca-2,9-dienoate ((R)-
M-56efgh):  The same method employed in the preparation of 49 was repeated using mixture M-
55efgh (548 mg, 652 mol based on average molecular weight), alcohol (R)-18 (132 mg, 847 
mol), NEt3 (186 L), DMAP (163 mg, 1.30 mmol), and 2,4,6-trichlorobenzoyl chloride (110 
L, 684 mol) in toluene (13.0 mL).  Flash chromatography of the crude product (40:1 
hexanes/EtOAc) gave the title compound as a colorless oil (577 mg, 90% based on average 
molecular weight):  LRMS (ESI, positive mode) (SRRR-56e) m/z 846 (M + Na)
+
; (SRSR-56f) m/z 
950 (M + Na)
+
; (RSRR-56g) m/z 1054 (M + Na)
+
; (RSSR-56h) m/z 1158 (M + Na)
+
; fluorous 
analytical HPLC (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 mL/min):  tR 
= 17.8 min (SRRR-56e), 21.4 min (SRSR-56f), 24.7 min (RSRR-56g), 30.3 min (RSSR-56h). 
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(4S,5R,7R)-((S)-Dec-1-en-5-yl)-4,5,7-tris(triisopropylsilyloxy)deca-2,9-dienoate, (4S,5R,7S)-
((S)-Dec-1-en-5-yl)-4,5-bis(triisopropylsilyloxy)-7-di-isopropyl-(1,1,1,2,2-penta-fluorobutyl-
silyloxy)deca-2,9-dienoate, (4R,5S,7R)-((S)-Dec-1-en-5-yl)-4,5-bis-(di-iso-propyl-(1,1,1,2,2-
penta-fluorobutylsilyloxy))-7-triisopropylsilyloxy-deca-2,9-dienoate, (4R,5S,7S)-((S)-Dec-1-
en-5-yl)-4,5,7-tris(diisopropyl(1,1,1,2,2-pentafluorobutylsilyloxy))-deca-2,9-dienoate ((S)-
M-56efgh):  The same method employed in the preparation of 49 was repeated using mixture M-
55efgh (584 mg, 694 mol based on average molecular weight), alcohol (S)-18 (141 mg, 902 
mol), NEt3 (197 L), DMAP (173 mg, 1.39 mmol), and 2,4,6-trichlorobenzoyl chloride (117 
L, 729 mol) in toluene (14.0 mL).  Flash chromatography of the crude product (40:1 
hexanes/EtOAc) gave the title compound as a colorless oil (607 mg, 89% based on average 
molecular weight):  LRMS (ESI, positive mode) (SRRS-56e) m/z 846 (M + Na)
+
; (SRSS-56f) m/z 
950 (M + Na)
+
; (RSRS-56g) m/z 1054 (M + Na)
+
; (RSSS-56h) m/z 1158 (M + Na)
+
; fluorous 
analytical HPLC (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 mL/min):  tR 
= 17.7 min (SRRS-56e), 21.4 min (SRSS-56f), 24.9 min (RSRS-56g), 30.9 min (RSSS-56h). 
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(4S,5R,7R,13R)-14-Pentyl-5,6,8-tris-(tri-iso-propyl-silyl-oxy)-oxa-cyclo-tetra-dec-2-enone, 
(4S,5R,7S,13R)-13-Pentyl-4,5-bis(triisopropylsilyloxy)-7-diisopropyl-(1,1,1,2,2-penta-fluoro-
butyl-silyl-oxy)oxa-cyclo-tetra-dec-2-enone, (4R,5S,7R,13R)-13-Pentyl-4,5-bis-(di-isopropyl-
(1,1,1,2,2-pentafluoro-butyl-silyloxy)-7-tri-iso-propyl-silyl-oxy)-oxacyclo-tetra-dec-2-enone, 
(4R,5S,7S,13R)-13-Pentyl-4,5,7-tris-(di-isopropyl-(1,1,1,2,2-pentafluoro-butyl-silyloxy)-oxa-
cyclotetradec-2-enone ((R)-M-57efgh):  The procedure for the ring-closing metathesis as 
executed for preparation of compound 51 was repeated for mixture (R)-M-56efgh (577 mg, 589 
mol based on average molecular weight) using the 2nd generation Grubbs catalyst (103 mg, 118 
mol) in DCM (200 mL).  Two successive rounds of flash chromatography (40:1 
hexanes/EtOAc) gave the title compound as a pale brown oil (541 mg, 569 mol).  The ring-
closed product (528 mg, 555 mol) was then directly subjected to the partial reduction 
procedures as reported for the preparation of compound 52 using Pd/SrCO3 (2.95 g, 555 mol) in 
EtOH (27 mL).  Flash chromatography of the crude product (40:1 hexanes/EtOAc) gave the title 
compound as a colorless oil (463 mg, 84% over two steps, based on average molecular weight):  
LRMS (ESI, positive mode) (SRRR-57e) m/z 820 (M + Na)
+
; (SRSR-57f) m/z 924 (M + Na)
+
; 
(RSRR-57g) m/z 1028 (M + Na)
+
; (RSSR-57h) m/z 1132 (M + Na)
+
; HRMS (ESI, positive mode): 
calcd for C45H92O5Si3Na [M + Na]
+
 819.6150, found 819.6223 for SRRR-57e;  calcd for 
C46H89O5F5Si3Na [M + Na]
+
 923.5836, found 923.5826 for SRSR-57f; calcd for 
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C47H86O5F10Si3Na [M + Na]
+
 1,027.5521, found 1,027.5491 for RSRR-57g; calcd for 
C48H83O5F15Si3Na [M + Na]
+
 1,131.5207, found 1,131.5283 for RSSR-57h; fluorous analytical 
HPLC (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 mL/min):  tR = 15.0 min 
(SRRR-57e), 18.0 min (SRSR-57f), 22.8 min (RSRR-57g), 28.4 min (RSSR-57h). 
Demixing of (R)-M-57efgh: 
 The semi-preparative separation of (R)-M-57efgh was carried out in the same manner as 
(R)-M-56abcd (see Section 6.2).  Aliquots of (R)-M-56efgh (90 mg/mL) were injected per 
chromatographic run.  The yield of the demixing over five injections was 69% and the following 
four compounds were isolated:  SRRR-57e: 59.2 mg, tR = 29.2 min; SRSR-57f: 94.1 mg, tR = 39.4 
min; RSRR-57g: 114 mg, tR = 58.9 min; RSSR-57h: 41.5 mg, tR = 78.4 min. 
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(4S,5R,7R,13R,E)-14-Pentyl-5,6,8-tris-(tri-isopropyl-silyloxy)oxacyclo-tetra-dec-3-en-2-one, 
(4S,5R,7S,13R,E)-13-Pentyl-4,5-bis-(tri-isopropyl-silyloxy)-7-di-iso-propyl-(1,1,1,2,2-penta-
fluoro-butyl-silyloxy)-oxacyclo-tetra-dec-2-enone, (4R,5S,7R,13R,E)-13-Pentyl-4,5-bis-(di-
isopropyl(1,1,1,2,2-pentafluoro-butyl-silyloxy)-7-tri-isopropyl-silyloxy)oxacyclo-tetradec-2-
enone, (4R,5S,7S,13R,E)-13-Pentyl-4,5,7-tris-(di-iso-propyl-(1,1,1,2,2-penta-fluoro-butyl-
silyloxy)-oxacyclotetradec-2-enone ((S)-M-57efgh): The procedure for the ring-closing 
metathesis as executed for compound 51 was repeated for mixture (S)-M-56efgh (607 mg, 620 
mol based on average molecular weight) using the 2nd generation Grubbs catalyst (109 mg, 124 
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mol) in DCM (200 mL).  Two successive rounds of flash chromatography (40:1 
hexanes/EtOAc) gave the title compound as a pale brown oil (584 mg, 614 mol).  The ring-
closed product (572 mg, 601 mol) was then directly subjected to the partial reduction 
procedures as reported for the preparation of compound 52 using Pd/SrCO3 (3.20 g, 601 mol) in 
EtOH (30 mL).  Flash chromatography of the crude product (40:1 hexanes/EtOAc) gave the title 
compound as a colorless oil (547 mg, 94% over two steps, based on average molecular weight):  
LRMS (ESI, positive mode) (SRRS-57e) m/z 820 (M + Na)
+
; (SRSS-57f) m/z 924 (M + Na)
+
; 
(RSRS-57g) m/z 1028 (M + Na)
+
; (RSSS-57h) m/z 1132 (M + Na)
+
; HRMS (ESI, positive mode): 
calcd for C45H92O5Si3Na [M]
+
 796.6253, found 796.6250 for SRRS-57e;  calcd for 
C46H89O5F5Si3Na [M + Na]
+
 923.5836, found 923.5859 for SRSS-57f; calcd for 
C47H86O5F10Si3Na [M + Na]
+
 1,027.5521, found 1,027.5510 for RSRS-57g; calcd for 
C48H83O5F15Si3Na [M + Na]
+
 1,131.5207, found 1,131.5223 for RSSS-57h; fluorous analytical 
HPLC (90:10 MeCN/H2O for 10 min, then 100% MeCN for 60 min, 1.0 mL/min):  tR = 15.7 min 
(SRRS-57e), 19.8 min (SRSS-57f), 21.0 min (RSRS-57g), 27.0 min (RSSS-57h). 
Demixing of (S)-M-57efgh: 
 The semi-preparative separation of (S)-M-57efgh was carried out in the same manner as 
(R)-M-56abcd (see Section 6.2).  Aliquots of (S)-M-57efgh (50 mg/mL) were injected per 
chromatographic run.  The yield of the demixing over ten injections was 56% and the following 
four compounds were isolated:  SRRS-57e: 73.4 mg, tR = 30.2 min; SRSS-57f: 52.0 mg, tR = 42.8 
min; RSRS-57g: 60.3 mg, tR = 42.1 min; RSSS-57h: 65.8 mg, tR = 70.9 min.  Four additional 
injections were needed for compound RSRS-57g to improve its quasiisomeric purity. 
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(4S,5R,7R,13R,E)-14-Pentyl-5,6,8-tris-(tri-iso-propyl-silyl-oxy)oxa-cyclo-tetra-dec-2-en-one 
(SRRR-57e):  From the demixing of (R)-M-57efgh, the first peak SRRR-57e (59.2 mg) at 29.2 
minutes was isolated as a colorless oil:  
1
H NMR (600 MHz, CDCl3) dd, J1 = 15.8 Hz, J2 
= 3.0 Hz, 1H), 6.00 (d, J = 15.8 Hz, 1H), 4.98 (m, 1H), 4.24 (m, 1H), 3.91 (d, J = 9.0 Hz, 1H), 
3.73 (d, J = 9.0 Hz, 1H), 2.36 (td, J1 = 12.6 Hz, J2 = 8.4 Hz, 1H), 2.05 (t, J = 12.1 Hz, 1H), 1.95 
(m, 1H), 1.89 (m, 1H), 1.78-1.58 (m, 5H), 1.57-1.43 (m, 5H), 1.40-1.22 (m, 6H), 1.10 (br s, 
63H), 0.89 (t, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) 166.2, 148.5, 128.4, 77.3, 74.5, 
72.3, 68.7, 36.8, 34.6, 32.5, 32.3, 32.1, 31.8, 31.6, 30.6, 30.3, 22.6(br s), 18.4 (br s), 14.1 FTIR 
(thin film)  νmax  2944, 2867, 1731, 1464, 1255, 1200, 1106, 1059, 998, 883 cm
1; HRMS calcd 
(ESI) for C45H92O5Si3Na [M + Na]
+
:  819.6150, found 819.6223;   36.125 D  (c 1.26, CHCl3).  
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(4S,5R,7R,13S,E)-14-Pentyl-5,6,8-tris(triisopropylsilyloxy)oxacyclotetradec-2-enone (SRRS-
57e):  From the demixing of (S)-M-57efgh, the first peak SRRS-57e (73.4 mg) at 30.2 minutes 
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was isolated as a colorless oil:  
1
H NMR (600 MHz, CDCl3) dd, J1 = 16.0 Hz, J2 = 8.2 
Hz, 1H), 5.84 (dd, J1 = 16.0 Hz, J2 = 4.7 Hz, 1H), 4.91 (m, 1H), 4.57 (d, J = 8.2 Hz, 1H), 4.09 
(m, 1H), 3.59 (br s, 1H), 2.00 (t, J = 14.3 Hz, 1H), 1.79 (ddd, J1 = 11.5 Hz, J2 = 7.0 Hz, J3 = 3.7 
Hz, 1H), 1.70 (m, 2H), 1.63 (m, 3H), 1.55 (m, 2H), 1.48 (m, 1H), 1.42 (m, 1H), 1.30 (br s, 6H), 
1.17 (m, 3H), 1.07 (br s, 63 H), 0.89 (t, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) 165.6, 
150.1, 121.5, 77.6, 76.3, 75.7, 68.9, 34.7, 34.3, 31.8, 31.6, 29.7, 28.6, 24.7, 22.6, 20.1, 18.3 (br 
s), 14.0, 13.0 (br s) FTIR (thin film)  νmax  2944, 2867, 1723, 1464, 1259, 1058, 1014, 995, 883 
cm1; HRMS calcd (EI) for C45H92O5Si3 [M]
+
:  796.6253, found 796.6250;   0.1225 D  (c 1.10, 
CHCl3). 
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(4S,5R,7S,13R)-13-Pentyl-4,5-bis-(tri-isopropylsilyloxy)-7-diisopropyl(1,1,1,2,2-pentafluoro-
butylsilyloxy)oxacyclotetradec-2-enone (SRSR-57f):  From the demixing of (R)-M-57efgh, the 
second peak SRSR-57f (94.1 mg) at 39.4 minutes was isolated as a colorless oil:  
1
H NMR (600 
MHz, CDCl3)  dd, J1 = 15.8 Hz, J2 = 2.9 Hz, 1H), 6.07 (dd, J1 = 15.8 Hz, J2 = 2.2 Hz, 
1H), 4.96 (m, 1H), 4.77 (m, 1H), 3.95 (d, J = 9.0 Hz, 1H), 3.64 (td, J1 = 10.3 Hz, J2 = 6.6 Hz, 
1H), 2.45 (td, J1 = 12.8 Hz, J2 = 4.1 Hz, 1H), 2.05 (m, 2H), 1.70 (m, 2H), 1.62-1.45 (m, 8H), 
1.40-1.25 (m, 6H), 1.20 (m, 3H), 1.10 (br s, 42H),  1.07 (br s, 14H), 0.89 (t, J = 6.8 Hz, 3H), 0.83 
(m, 2H); 
13
C NMR (75 MHz, CDCl3) 165.4, 148.4, 121.6, 77.0, 74.3, 73.7, 69.5, 42.4, 34.0, 
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33.4, 32.7, 32.3, 32.2, 31.7, 30.3, 29.9, 25.4, 23.1, 22.6, 20.0, 18.3, 17.8, 1.519F NMR (282 
MHz, CDCl3) 84.99 (s, 3F), 120.26 (t, 
3
JHF = 18.0 Hz, 2F); FTIR (thin film)  νmax  2945, 2868, 
1720, 1464, 1257, 1120, 1054, 992, 884 cm1; HRMS calcd (ESI, positive mode) for 
C46H89O5F5Si3Na [M + Na]
+
:  923.5836, found 923.5826;   7.1225 D  (c 1.37, CHCl3).  
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(4S,5R,7S,13S)-13-Pentyl-4,5-bis-(triisopropylsilyloxy)-7-diisopropyl-(1,1,1,2,2-pentafluoro-
butylsilyloxy)oxacyclotetradec-2-enone (SRSS-57f):  From the demixing of (S)-M-57efgh, the 
second peak SRSS-57f (52.0 mg) at 42.8 minutes was isolated as a colorless oil:  
1
H NMR (600 
MHz, CDCl3)  dd, J1 = 15.9 Hz, J2 = 8.6 Hz, 1H), 5.86 (d, J = 15.9 Hz, 1H), 4.91 (m, 
1H), 4.66 (d, J = 8.5 Hz, 1H), 3.88 (td, J1 = 10.5 Hz, J2 = 6.5 Hz, 1H), 3.78 (dd, J1 = 10.5 Hz, J2 
= 3.5 Hz, 1H), 2.43 (m, 1H), 2.08 (m, 4H), 1.74-1.45 (m, 9H), 1.44-1.21 (m, 8H), 1.08 (br s, 
56H), 0.89 (t, J = 6.8 Hz, 3H), 0.85 (m, 2H); 
13
C NMR (75 MHz, CDCl3) 166.0, 149.3, 121.6, 
178.9, 75.7, 75.5, 70.3, 42.6, 35.1, 34.3, 31.8, 31.7, 27.1, 25.1, 23.2, 18.2, 14.5, 12.5, 1.519F 
NMR (282 MHz, CDCl3) 84.98 (s, 3F), 120.34 (t, 
3
JHF = 18.0 Hz, 2F); FTIR (thin film)  νmax  
2945, 2868, 1722, 1465, 1261, 1200, 1052, 993, 884 cm1; HRMS calcd (ESI, positive mode) 
for C46H89O5F5Si3Na [M + Na]
+
:  923.5836, found 923.5859;   0.2025 D  (c 1.01, CHCl3). 
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(4R,5S,7R,13R)-13-Pentyl-4,5-bis-(di-isopropyl-(1,1,1,2,2-pentafluorobutylsilyloxy)-7-triiso-
propylsilyloxy)oxacyclotetradec-2-enone (RSRR-57g):  From the demixing of (S)-M-57efgh, 
the third peak RSSR-57h (114.0 mg) at 58.9 minutes was isolated as a colorless oil:  
1
H NMR 
(600 MHz, CDCl3)  dd, J1 = 15.9 Hz, J2 = 8.7 Hz, 1H), 5.86 (d, J = 15.9 Hz, 1H), 4.91 
(m, 1H), 4.54 (d, J = 8.6 Hz, 1H), 3.92 (td, J1 = 10.2 Hz, J2 = 2.0 Hz, 1H), 3.74 (d, J = 8.6 Hz, 
1H), 2.05 (m, 4H), 1.72-1.60 (m, 4H), 1.60-1.48 (m, 4H), 1.41 (m, 2H), 1.30 (br s, 6H), 1.08 (br 
s, 49 H), 0.88 (m, 7H); 
13
C NMR (75 MHz, CDCl3) 165.7, 147.2, 122.7, 76.2, 75.5, 69.7, 69.5, 
42.8, 42.2, 36.1, 35.1, 34.7, 34.5, 33.4, 32.0, 30.3, 27.2, 25.6, 22.5, 18.3, 14.0, 13.4, 13.0, 12.8, 
1.5, 0.919F NMR (282 MHz, CDCl3) 85.00 (s, 3F), 85.03 (s, 3F), 120.19 (m, 4F); FTIR 
(thin film)  νmax  2946, 2869, 1723, 1465, 1200, 1106, 1051, 993, 885 cm
1; HRMS calcd (ESI, 
positive mode) for C47H86O5F10Si3Na [M + Na]
+
:  1,027.5521, found 1,027.5491;   6.1525 D  (c 
1.17, CHCl3).  
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(4R,5S,7R,13S)-13-Pentyl-4,5-bis-(diisopropyl-(1,1,1,2,2-pentafluorobutyl-silyloxy)-7-triiso-
propylsilyloxy)oxacyclotetradec-2-enone (RSRS-57g):  From the demixing of (S)-M-57efgh, 
the third peak RSRS-57g (60.3 mg) at 42.1 minutes was isolated as a colorless oil:  
1
H NMR (600 
MHz, CDCl3) d, J = 15.6 Hz, 1H), 6.03 (dd, J1 = 15.6 Hz, J2 = 2.2 Hz, 1H), 4.97 (m, 1H), 
4.64 (m, 1H), 3.91 (d, J = 10.3 Hz, 1H), 3.68 (m, 1H), 2.43 (t, J = 9.7 Hz, 1H), 2.05 (m, 4H), 
1.71 (m, 2H), 1.60-1.47 (m, 4H), 1.42 (m, 2H), 1.30 (br s, 9H), 1.21 (m, 2H), 1.08 (br s, 49 H), 
0.92 (m, 4H), 0.89 (t, J = 6.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) 165.1, 146.8, 122.0, 77.2, 
74.5, 73.9, 68.8, 42.7, 33.9, 31.8, 30.2, 26.5, 25.7, 25.5, 25.4 (m), 23.3, 22.6, 18.2, 1.0, 0.719F 
NMR (282 MHz, CDCl3) 85.01 (br s, 6F), 120.38 (m, 4F); FTIR (thin film)  νmax  2946, 2869, 
1720, 1464, 1260, 1201, 1108, 1054, 992, 885 cm1; HRMS calcd (ESI, positive mode) for 
C47H86O5F10Si3Na [M + Na]
+
:  1,027.5521, found 1,027.5510;   27.925 D  (c 1.12, CHCl3). 
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(4R,5S,7S,13R)-13-Pentyl-4,5,7-tris-(di-isopropyl(1,1,1,2,2-penta-fluoro-butyl-silyloxy)-oxa-
cyclotetradec-2-enone (RSSR-57h):  From the demixing of (R)-M-57efgh, the fourth peak 
RSSR-57h (41.5 mg) at 78.4 minutes was isolated as a colorless oil:  
1
H NMR (600 MHz, CDCl3) 
 dd, J1 = 16.0 Hz, J2 = 7.9 Hz, 1H), 5.88 (d, J = 16.0 Hz, 1H), 4.92 (m, 1H), 4.47 (d, J = 
7.9 Hz, 1H), 3.97 (m, 1H), 3.54 (m, 1H), 2.05 (m, 6H), 1.72-1.58 (m, 8H), 1.58-1.43 (m, 4H), 
1.30 (m, 6H), 1.18 (m, 2H), 1.07 (br s, 42H), 0.88 (9H); 
13
C NMR (75 MHz, CDCl3) 165.2, 
147.8, 122.7, 76.2, 76.0, 75.7, 69.2, 35.1, 34.8, 34.2, 31.7, 28.2, 24.8 (m), 22.5, 17.7, 13.2, 12.8, 
1.5, 0.8, 0.719F NMR (282 MHz, CDCl3) 85.01 (s, 3F), 85.04 (s, 3F), 85.09 (s, 3F), 120.45 
(m, 6F); FTIR (thin film) νmax  2947, 2870, 1724, 1465, 1200, 1105, 1052, 993, 886, 750 cm
 1; 
HRMS calcd (ESI, positive mode) for C48H83O5F15Si3Na [M + Na]
+
:  1,131.5207, found 
1,131.5283;   88.825 D , (c 1.08, CHCl3).  
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(4R,5S,7S,13S)-13-Pentyl-4,5,7-tris-(diisopropyl-(1,1,1,2,2-penta-fluoro-butyl-silyloxy)-oxa-
cyclotetradec-2-enone (RSSS-57h):  From the demixing of (S)-M-57efgh, the fourth peak 
RSSS-57h (65.8 mg) at 70.9 minutes was isolated as a colorless oil:  
1
H NMR (600 MHz, CDCl3) 
d, J = 15.9 Hz, 1H), 6.00 (d, J = 15.9 Hz, 1H), 5.05 (m, 1H), 4.48 (br s, 1H), 3.95 (m, 
2H), 2.05 (m, 6H), 1.81 (m, 1H), 1.74 (m, 1H), 1.71-1.60 (m, 3H), 1.59-1.48 (m, 5H), 1.40-1.21 
(m, 10H), 1.09 (br s, 42H), 0.89 (t, J = 6.5 Hz, 3H), 0.83 (m, 6H); 
13
C NMR (75 MHz, CDCl3) 
166.5, 146.5, 125.5, 76.0, 73.0, 69.4, 68.7, 40.3, 37.2, 34.3, 32.5, 31.7, 30.3, 29.7, 25.7, 25.3 
(m), 22.5 (br s), 17.8, 17.5 (br s), 14.0, 19F NMR (282 MHz, CDCl3) 84.96 (s, 3F), 
85.02 (s, 3F), 85.05 (s, 3F), 120.44 (m, 6F); FTIR (thin film) νmax  2948, 2871, 1730, 1466, 
1200, 1105, 1062, 995, 886, 750 cm1; HRMS calcd (ESI, positive mode) for C48H83O5F15Si3Na 
[M + Na]
+
:  1,131.5207, found 1,131.5223;   19.025 D  (c 1.17, CHCl3). 
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4S,5R,7R,13R)-4,5,7-Trihydroxy-13-pentyl-oxa-cyclo-tetradecenone ((4S,5R,7R,13R)-5). 
The macrolactone SRRR-57e (91.4 mg, 115 mol) was dissolved in DCM (3.0 mL) and 
transferred to a polyethylene culture tube.  The solution was diluted with acetonitrile (8.0 mL).  
Aqueous hydrofluoric acid
103
 (48 wt. %, 0.60 mL) was then added to the solution at room 
temperature and the reaction mixture was stirred for 16 h at room temperature.  The reaction was 
quenched by addition of sat. aq. NaHCO3 (10.0 mL) at 0 °C and the layers were separated.  The 
aqueous layer was extracted with ether (3 x 20 mL).  The combined organic extracts were then 
washed with brine, dried over MgSO4, and concentrated in vacuo.  The product after flash 
chromatography (3:1 hexanes/EtOAc, then 100% EtOAc) was further purified using a (S,S)-
Whelk-O-1 column as described for (4S,5S,7R,13R)-5, and the desired compound was isolated as 
an amorphous white solid (6 injections, 11.0 mg, 29%):  
1
H NMR (700 MHz, CD3OD) 6.94 
(dd, J1 = 15.8 Hz, J2 = 4.7 Hz, 1H), 6.09 (dd, J1 = 15.8 Hz, J2 = 1.8 Hz, 1H), 5.01 (m, 1H), 4.47 
(ddd, J1 = 4.7 Hz, J2 = 3.0 Hz, J3 = 1.8 Hz, 1H), 3.89 (ddd, J1 = 7.2 Hz, J2 = 4.7 Hz, J3 = 3.0 Hz, 
1H), 3.71 (m, 1H), 1.76 (m, 2H), 1.71 (ddd, J1 = 14.6 Hz, J2 = 7.2 Hz, J3 = 4.7 Hz, 1H), 1.63 (m, 
1H), 1.56 (m, 1H), 1.45 (m, 5H), 1.33 (m, 8H) 1.21 (m, 2H), 1.11 (m, 1H), 0.90 (t, J = 6.9 Hz, 
3H); 
13
C NMR (175 MHz, CD3OD) 168.0, 148.6, 123.4, 77.4, 74.6, 72.3, 68.8, 39.1, 36.4, 
35.7, 34.4, 33.0, 30.3, 26.6, 26.0, 24.3, 23.8, 14.5 FTIR (thin film)  νmax  3288, 2922, 2855, 
 175 
1703, 1265, 1183, 990 cm1; HRMS calcd (ESI, positive mode) for C18H32O5Na [M + Na]
+
:  
351.2147, found 351.2142;   5.1525 D  (c 0.55, MeOH). 
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(4S,5R,7S,13R)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4S,5R,7S,13R)-5):  The 
same method employed in the preparation of (4R,5R,7R,15R)-5 during the single isomer pilot 
synthesis (see Chapter 2.0) was followed using SRSR-57f (91.1 mg, 101 mol).  The product 
after flash chromatography (3:1 hexanes/EtOAc, then 100% EtOAc) was further purified using a 
(S,S)-Whelk-O-1 column as described for (4S,5S,7R,13R)-5, and the desired compound was 
isolated as an amorphous white solid (12.4 mg, 37%, 14:1 d.r.):  
1
H NMR (700 MHz, CD3OD)  
7.00 (dd, J1 = 15.8 Hz, J2 = 3.6 Hz, 1H), 6.06 (dd, J1 = 15.8 Hz, J2 = 2.2 Hz, 1H), 4.95 (m, 1H), 
4.46 (m, 1H), 3.95 (ddd, J1 = 7.6 Hz, J2 = 4.5 Hz, J3 = 2.2 Hz, 1H), 3.68 (septet, J = 4.5 Hz, 1H), 
2.02 (ddd, J1 = 14.1 Hz, J2 = 8.1 Hz, J3 = 4.5 Hz, 1H, 1H), 1.69 (m, 2H), 1.61 (m, 2H), 1.54 (m, 
3H), 1.34 (m, 9H), 1.28 (m, 3H), 0.90 (t, J = 6.9 Hz, 3H); 
13
C NMR (175 MHz, CD3OD) 168.0, 
150.2, 122.3, 76.1, 75.7, 72.1, 68.8, 39.5, 34.9, 34.6, 33.0, 32.8, 28.6, 26.6, 24.9, 23.4, 14.5 
FTIR (thin film)  νmax  2932, 2360, 2340, 1717, 1270, 1009 cm
1; HRMS calcd (ESI, positive 
mode) for C18H32O5Na [M + Na]
+
:  351.2147, found 351.2171;   66.125 D  (c 0.54, MeOH). 
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(4R,5S,7R,13R)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4R,5S,7R,13R)-5, (+)-
nat-Sch725674):  The same method employed in the preparation of (4S,5R,7R,13R)-5 was 
followed using RSRR-57g (55.1 mg, 54.8 mol).  The product after flash chromatography (3:1 
hexanes/EtOAc, then 100% EtOAc) was further purified using a (S,S)-Whelk-O-1 column as 
described for (4S,5S,7R,13R)-5, and the desired compound was isolated as an amorphous white 
solid (6 injections, 5.7 mg); total yield for this isomer (11.4 mg, 32%).  The NMR spectroscopic 
data of (4R,5S,7R,13R)-5 are in complete agreement with those of the natural product
32
:  
1
H 
NMR (700 MHz, CD3OD) 6.87 (dd, J1 = 15.8 Hz, J2 = 6.1 Hz, 1H), 6.08 (dd, J1 = 15.8 Hz, J2 = 
1.5 Hz, 1H), 4.95 (dddd, J1 = 10.4 Hz, J2 = 7.9 Hz, J3 = 5.4 Hz, J4 = 2.9 Hz,1H), 4.49 (ddd, J1 = 
5.8 Hz, J2 = 2.7 Hz, J3 = 1.5 Hz, 1H), 3.99 (quintet, J = 6.2 Hz, 1H), 3.85 (m, 1H), 1.83 (dt, J1 = 
14.7 Hz, J2 = 6.1 Hz,  1H), 1.71 (dddd, J1 = 14.2 Hz, J2 = 6.7 Hz, J3 = 4.6 Hz, J4 = 2.0 Hz, 1H), 
1.65 (dt, J1 = 14.7 Hz, J2 = 5.0 Hz,1H), 1.61 (m, 1H), 1.55 (m, 2H), 1.46 (m, 1H), 1.34 (m, 10H) 
1.18 (m, 3H), 0.90 (t, J = 6.9 Hz, 3H); 
13
C NMR (175 MHz, CD3OD) 168.4, 149.3, 123.1, 
77.6, 76.0, 72.9, 69.5, 38.3, 36.8, 36.5, 34.1, 33.0, 29.5, 27.0, 26.4, 25.8, 23.8, 14.5 FTIR (thin 
film)  νmax  3436, 2926, 2857, 1703, 1461, 1274, 1077 cm
1; HRMS calcd (EI) for C18H32O5 
[M]
+
:  328.2250, found 328.2248;   15.525 D  (c 0.27, MeOH). 
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(4R,5S,7S,13R)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4R,5S,7S,13R)-5):  The 
same method employed in the preparation of (4S,5R,7R,13R)-5 was followed using RSSR-57h 
(40.1 mg, 36.1 mol).  The product after flash chromatography (3:1 hexanes/EtOAc, then 100% 
EtOAc) was further purified using a (S,S)-Whelk-O-1 column as described for (4S,5S,7R,13R)-5, 
and the desired compound was isolated as an amorphous white solid (3 injections, 4.7 mg, 40%).  
1
H NMR (700 MHz, CD3OD)  6.95 (dd, J1 = 15.8 Hz, J2 = 4.2 Hz, 1H), 6.14 (dd, J1 = 15.8 Hz, 
J2 = 1.4 Hz, 1H), 4.93 (m,1H), 4.54 (m, 1H), 3.89 (dt, J1 = 8.8 Hz, J2 = 2.1 Hz, 1H), 3.38 (m, 
1H), 2.02 (ddd, J1 = 14.6 Hz, J2 = 8.8 Hz, J3 = 2.4 Hz, 1H), 1.65 (m, 3H), 1.54 (m,1H), 1.48 (m, 
2H), 1.40 (m, 1H), 1.32 (m, 10H), 1.20 (m, 3H), 0.90 (t, J = 6.9 Hz, 3H); 
13
C NMR (175 MHz, 
CD3OD) 169.0, 150.0, 121.8, 75.5, 75.0, 72.1, 68.8, 40.5, 36.2, 35.9, 33.9, 33.0, 27.2, 26.5, 
24.7, 24.5, 23.8, 14.5 FTIR (thin film)  νmax  3360, 2935, 2340, 1715, 1286 cm
1; HRMS calcd 
(ESI, positive mode) for C18H32O5Na [M + Na]
+
:  351.2147, found 351.2174;   6.3825 D  (c 
0.24, MeOH). 
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(4S,5R,7R,13S)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4S,5R,7R,13S)-5):  The 
same method employed in the preparation of (4S,5R,7R,13R)-5 was followed using SRRS-57e 
(72.7 mg, 91.2 mol).  The product after flash chromatography (3:1 hexanes/EtOAc, then 100% 
EtOAc) was further purified using a (S,S)- Whelk-O-1 column as described for (4S,5S,7R,13R)-
5, and the desired compound was isolated as an amorphous white solid (5 injections, 13.4 mg, 
45%).  The 
1
H NMR spectrum matched that of (4R,5S,7S,13R)-5 (see above);   7.3825 D  (c 
0.67, MeOH). 
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(4S,5R,7S,13S)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4S,5R,7S,13S)-5):  The 
same method employed in the preparation of (4S,5R,7R,13R)-5 was followed using SRSS-57f 
(87.0 mg, 96.5 mol).  The product after flash chromatography (3:1 hexanes/EtOAc, then 100% 
EtOAc) was further purified using a (S,S)-Whelk-O-1 column as described for (4S,5S,7R,13R)-5, 
and the desired compound was isolated as an amorphous white solid (3 injections, 5.5 mg, 17%).  
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The 
1
H NMR spectrum matched that of (4R,5S,7R,13R)-5 (see above);    93.225 D , (c 0.21, 
MeOH). 
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(4R,5S,7R,13S)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4R,5S,7R,13S)-5):  The 
same method employed in the preparation of (4S,5R,7R,13R)-5 was followed using RSRS-57g 
(59.1 mg, 58.8 mol).  The product after flash chromatography (3:1 hexanes/EtOAc, then 100% 
EtOAc) was further purified using a (S,S)-Whelk-O-1 column as described for (4S,5S,7R,13R)-5, 
and the desired compound was isolated as an amorphous white solid (4 injections, 14.0 mg, 
73%).  The 
1
H NMR spectrum matched that of (4S,5R,7S,13R)-5 (see above);    14.225 D , (c 
0.70, MeOH). 
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(4R,5S,7S,13S)-4,5,7-Trihydroxy-13-pentyloxacyclotetradecenone ((4R,5S,7S,13S)-5):  The 
same method employed in the preparation of (4S,5R,7R,13R)-5 was followed using RSSS-57h 
 180 
(59.1 mg, 58.8 mol).  The product after flash chromatography (3:1 hexanes/EtOAc, then 100% 
EtOAc) was further purified using a (S,S)-Whelk-O-1 column as described for (4S,5S,7R,13R)-5, 
and the desired compound was isolated as an amorphous white solid (3 injections, 6.9 mg, 36%).  
The 
1
H NMR spectrum matched that of (4S,5R,7R,13R)-5 (see above);    8.1325 D  (c  0.35, 
MeOH).  
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APPENDIX 
1.  
1
H and 
13
C NMR spectra of macrocycles 5 
2.  
1
H and 
13
C NMR spectra of ring-open triols 58 
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